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Abstract 
Tissue engineering and regenerative medicine is a constantly evolving field of science that 
directs the use of cells to repair damaged or diseased tissue. Currently, stem cells are the 
most widely used source of cells due to their inherent characteristics of self-renewal and 
differentiation. However, stem cell regenerative therapies are still lacking, upon removal 
from the body, stem cell grow dysplastically towards unwanted lineages, compounded by 
their limited number makes the therapeutic potential of these cells difficult to obtain. These 
problems are due to the lack of knowledge of the underlying systems and mechanisms of 
phenotypical commitment through differentiation.  
In an attempt to circumvent these problems, scientists have begun the construction of 
dynamic surfaces, that is, surfaces that mimic the constantly evolving and changing 
environment in which stem cells reside in the body, known as the niche. These biomimetic 
strategies aim to reproduce the physical architecture, chemical composition and plasticity of 
the in vivo environment in vitro. This physical architecture can provide the cells with 
behavioural cues, mainly through transmembrane receptors known as integrins which link 
the extracellular matrix to the cytoskeleton; and therefore convey physical architecture of 
the environment to the cell. Scientists consciously design biomimetic systems to incorporate 
integrin binding ligands such as the adhesive tripeptide arginine-glycine-aspartic acid 
(RGD). The chemical composition of the niche depends on the in vivo milieu, and the needs 
of the body at this specified time. More specifically, mesenchymal stem cells reside in a 
variety of niches, with the bone marrow being a prime example. Upon osteogenesis, many 
chemical signals are delivered to this niche, with arguably the strongest osteogenic signal 
from bone morphogenetic protein 2 (BMP-2). This growth factor can activate osteogenic 
genes within the mesenchymal stem cell and predetermine differentiation of the cell towards 
an osteoblastic fate.  
In this work, we have developed a genetically engineered non-pathogenic bacteria, 
Lactococcus lactis to display the III7-10 fragment of fibronectin to allow mammalian cell 
integrin adhesion. This fragment contains two important sequences, the RGD adhesive 
tripeptide and the synergy sequence proline-histidine-serine-arginine-asparagine (PHSRN). 
RGD allows the mammalian cells to interact with the bacteria through promiscuous integrin 
attachment. The PHSRN sequence binds synergistically with RGD to some integrins, such 
as α5β1. These bacteria have also been modified to express the osteogenic growth factor, 
BMP-2 to direct mesenchymal stem cell differentiation towards an osteoblastic fate.  
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These bacteria readily form spontaneous two-dimensional biofilms on a variety of surfaces, 
and can therefore act as a living interface between the synthetic surface below and the 
mammalian cells seeded above. The results of this thesis demonstrate that Lactococcus lactis 
can be used as a successful dynamic surface to control the adhesion, proliferation and 
differentiation of mesenchymal stem cells.  
Mesenchymal stem cells seeded over BMP-2 secreting Lactococcus lactis demonstrate 
decreased cell proliferation at short time points and increased osteoblastic markers at longer 
time points. Further to this, the interface has been made dynamic by making the bacteria 
inducible, that is, BMP-2 can be expressed in a temporal manner, and at different 
concentrations to finely tailor specific protein production.  
In the future, this system can be further exploited to express or deliver almost any protein or 
small molecule that can aid in the development of new tissues from their progenitor cells. 
As demonstrated, these proteins can both be secreted into the medium or displayed as cell 
wall bound proteins; and can also be constitutively or inducibly expressed. This interface, 
based on non-pathogenic bacteria establishes a new paradigm in surface functionalisation 
for regenerative medicine applications. 
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1. Introduction 
1.1 Tissue Engineering and Implantable Devices 
 
Tissue engineering (TE) combines the methods and practises of the life sciences and 
engineering to overcome the problems understanding the structure-function relationship of 
tissues and their disease states. The answers aid in the assembly of materials and techniques 
to begin the construction of artificial organs and/or tissues. Irrespective of clinical feasibility, 
the potential of TE is innumerable; its uses can range from ex vivo construction, to 
autologous grafts or complete organ replacements (Bianco and Robey 2001). Cells must be 
isolated and cultured in order to synthetically grow new tissues where biomaterials play a 
crucial role. Biomaterials aim to recapitulate the critical aspects of the extracellular matrix 
(ECM), which is to facilitate the interaction of the cells with the material and the surrounding 
microenvironment. These materials must display some kind of biocompatibility, usually 
characterised by the material’s ability to coexist in the body without causing harm (Williams 
2008). However, there are many issues that must be overcome to ensure the creation of a 
successful biomaterial. Biomimetic synthetic polymers and naturally occurring polymers 
have been fashioned to overcome initial problems with biocompatibility, yet issues with 
biomimicry still exist. Artificial scaffolds are still designed on the macroscale to support cell 
growth and these do not recapitulate the nanoscale detail observed in real organs (Ratner and 
Bryant 2004, Lenas, Luyten et al. 2011, Ding, Fan et al. 2016, Yousefi, James et al. 2016). 
All approaches to TE require a source of cells. Stem cells are typically used as they possess 
inherent differentiation capabilities and can thus have myriad uses (Duscher, Barrera et al. 
2016, Muzzarelli, El Mehtedi et al. 2016). Furthermore, many appropriate sources of stem 
cells as well as culture techniques have been established. The potential of stem cell therapies 
is however, limited. Upon removal from the body uncontrollable differentiation to undesired 
lineages occurs and thus, the creation of a synthetic tissue is severely hindered. This issue 
also poses clinical complications, for example, this can lead to the improper formation of 
tissue surrounding implantable devices, a leading cause of implant failure. Figure 1.1 
highlights the current workflow for tissue engineering organs. 
To combat this problem, the use of dynamic surfaces, which aim to better emulate the 
extracellular matrix have come to the forefront of TE (Dhowre, Rajput et al. 2015, Anderson, 
Sahoo et al. 2016). These surfaces react to externally derived stimuli and ultimately alter the 
phenotype of the cells through alterations in the ECM. Fundamentally, these surfaces 
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presently provide the best user controlled mechanism for studying spatiotemporal alterations 
to the niche in a reductionist manner. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2 Dynamic Surfaces and the Extracellular Matrix 
 
Cells are innately sensitive to their extracellular environment on the macro, micro and 
nanoscale and thus, both chemistry and topography play a vital role in cellular development 
and behaviour (Dalby, Gadegaard et al. 2007, McMurray, Gadegaard et al. 2011, Nikukar, 
Reid et al. 2013). Understanding how cells interact with materials is of utmost importance 
Figure 1.1 Cells in tissue engineering. Cells are isolated from the body before expansion in culture. The 
cells are usually then cultured on a scaffold to aid in the generation of organs before being implanted. Jake 
Hay unpublished work. 
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to engineer microenvironments. Genes must be activated in the correct sequence and 
synchrony in order to express the numerous proteins needed for proliferation and 
differentiation to hierarchical organisation within organs; extrinsic signals from the ECM 
are mandatory to direct distinct development (Stevens and George 2005). In vivo, the ECM 
is a heterogeneous setting and comprises an elaborate natural web of proteins and growth 
factors; this instructive background ultimately guides cell behaviour (Scott 1995, Aumailley 
and Gayraud 1998, Wallner, Yang et al. 1998). This complex array of nanofibers, proteins, 
growth factors and chemicals reveals a level of detail unmatched outside the biological 
world. However, the ability to synthesise these materials is rapidly becoming a reality 
(Hench and Polak 2002, Shin, Jo et al. 2003, Zhang 2003, Ratner and Bryant 2004, Lutolf 
and Hubbell 2005, Rosso, Marino et al. 2006, Zisch, Ehrbar et al. 2006, Chen and Hunt 2007, 
Ma 2008, Liu, Smith et al. 2009, Zheng, Zhang et al. 2010, Cordonnier, Sohier et al. 2011, 
Lendlein 2011, Ebara, Kotsuchibashi et al. 2014). There have been many attempts at 
synthetic replication of the niche, and recently, dynamic user controlled surfaces have been 
developed in which the surface is spatially and temporally controlled. These surfaces react 
to externally derived stimuli and ultimately alter the phenotype of the cells through 
alterations in the ECM. Previously, different types of triggering mechanisms have been 
utilised including light (Wirkner, Weis et al. 2011, Lee, Garcia et al. 2015), temperature 
(Ebara, Yamato et al. 2004) and enzymes (Todd, Scurr et al. 2009, Zelzer, Scurr et al. 2012). 
The requirement for synthetic materials that mimic the characteristics of the ECM is essential 
in biomedical engineering to comprehend the complex and dynamic behaviour of cells. 
Recent studies have advanced the theory that inherent material properties can encourage, or 
even induce lineage specific cell differentiation through innate characteristics such as 
stiffness (Engler, Sen et al. 2006, Lee, Abdeen et al. 2013), nanotopograhy (Dalby, 
Gadegaard et al. 2007, Yim, Darling et al. 2010, McMurray, Gadegaard et al. 2011) chemical 
functionality (Benoit, Schwartz et al. 2008, Saha, Mei et al. 2011) and enzyme responsive 
surfaces (Roberts, Sahoo et al. 2016). These studies clearly show that these synthetic 
materials can produce a milieu from which stem cell fate can be user controlled. The addition 
of other co-factors or biochemical supplements further compounds the results. To ensure 
increased control over stem cell behaviour, it is necessary to ascertain a deeper understanding 
of how inherent material properties under defined chemical conditions influence stem cell 
fate. For effective control of stem cells, litanies of material properties that influence cell fate 
will have to be produced. Presently, for control of cells through biochemical means, specific 
and time controlled addition of supplements are added in a particular sequence; the same will 
be needed for exact material control. The availability of the material to change therefore 
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directly affects cellular behaviour, compounded with biochemical cocktails can create a 
synthetic surface with the potential to mimic the stem cell niche (Murphy, McDevitt et al. 
2014). In the future, we can expect a material which can be altered upon external demand in 
a temporal sequence that relates material properties to gene activation. 
We hypothesise that biofilms formed by non-pathogenic bacteria can be utilised to 
accomplish a successful dynamic surface. They can be genetically modified to express or 
secrete different proteins which can be used to direct cell behaviour and ultimately control 
stem cell fate. In that case, bacterial cell to mammalian cell communication can be facilitated 
on the level of the bacterial biofilm interface due to bacterial capability to colonise many 
different biomaterials to form a monolayer. 
1.3 Cell Adhesion and integrins 
 
Many molecules are involved in ECM construction. The organisation and assembled 
structure of collagens, proteoglycans, laminins and fibronectin (FN) all play a crucial role in 
the finalised ECM. Furthermore, different cells require different behavioural cues and thus 
all ECMs vary from each other, this multiplicity arises from the amalgamation of 
unambiguous molecular interactions and countless number of protein isoforms. In addition, 
the ratios, geometrical arrangements, intercellular interactions, nanotopography and 
molecular mechanisms create an environment with abounding informational cues (Stevens 
and George 2005). Individually, ECM components have evolved specific biological 
functions and together form highly particular hierarchical structures. A major constituent of 
the ECM is the protein FN. FN size ranges from 230-270 kDa and binds into dimers via two 
disulfide bonds at the C-termini of the proteins. The structure of FN is composed of three 
types of repeating modules, I, II and III. Both type I and II contain intramolecular disulfide 
bonds to stabilize the folded structure, while type III lacks these disulfide bonds. Type I and 
II modules are structured in beta-sheets enclosing a hydrophobic core that contains highly 
conserved aromatic amino acids (Mao and Schwarzbauer 2005, Singh, Carraher et al. 2010). 
The type III repeats hold the well characterised arginine-glycine-aspartic acid tri-peptide 
(RGD) in the III10 repeat and the proline-histidine-serine-arginine-asparagine (PHSRN) in 
the III9 repeat which are required for interactions with mammalian cell surface receptors 
known as integrins (Mouw 2014). In this thesis, we use the FN repeats III7-10 (FNIII7-10) as 
it houses the RGD domain and has been previously shown to induce mammalian cell integrin 
attachment (Saadeddin, Rodrigo-Navarro et al. 2013, Rodrigo-Navarro, Rico et al. 2014). 
The rationale for using FNIII7-10 as opposed to the whole FN molecule is based mainly on 
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the size of the protein. FN is 220-270 kDa and the largest protein known to be able to be 
synthesised using the bacterial secretion system is 160 kDa (Le Loir, Azevedo et al. 2005). 
It would therefore be impossible to synthesise the whole FN molecule. Moreover, it has been 
previously shown that short RGD containing peptides can induce a similar level of 
mammalian cell attachment as native FN through mammalian transmembrane receptors 
known as integrins (Pierschbacher and Ruoslahti 1984, Dsouza, Ginsberg et al. 1991, Rico, 
Gonzalez-Garcia et al. 2010).  
 
Integrins are a diverse family of heterodimeric integral membrane glycoproteins comprised 
of an  and  subunit which anchor cells to the ECM through focal adhesions.  In humans 
there are 18 α subunits and 8 β subunits that can combine to form 24 αβ combinations. 
Integrins are the principal mediators of cell-ECM focal adhesions and recognise integrin 
binding motifs, such as the RGD sequence. Focal adhesion formation serves to both anchor 
cells to their surrounding matrix, and to transmit signals between the ECM and the cell.  
Integrins are associated with focal adhesions via cytoplasmic anchor proteins talin, tensin, 
paxillin and vinculin, amongst others which can then alter tension on the actin cytoskeleton 
(Hynes 2009) resulting in biochemical signaling cascades utilising various signal 
transduction molecules including focal adhesion kinase (FAK) (Hanks and Polte 1997, Sieg, 
Hauck et al. 1999, Mitra, Hanson et al. 2005). Focal adhesions form in protrusive parts of 
cells, such as filopodia and lamellipodia and during this initial stage of attachment, transient 
focal complexes (<1 µm in length) begin to establish allowing primary migration (Nobes 
and Hall 1995).  Focal complexes (1-5 µm in length) quickly form and dissociate as the 
leading edge of the cell advances (Ridley and Hall 1992). Maturation of focal complexes 
into fully developed focal adhesions corresponds to their recruitment of additional proteins 
such as RhoA and α actinin (Ridley and Hall 1992). Focal adhesions can in turn, further 
mature into fibrillary adhesions, which are large collectives of integrin rich focal complexes 
(Friedland, Lee et al. 2009).  
The loss of integrin mediated cell contact leads to apoptosis through anoikis (cell 
‘homelessness’) (Frisch and Francis 1994)  in a majority of cell types, this includes 
mesenchymal stem cells (MSCs) (Benoit, Tripodi et al. 2007). Anoikis is triggered by 
inappropriate or inadequate cell-matrix contacts and demonstrates an evolutionary safeguard 
mechanism in vivo as it prevents detached cells from reattaching to a new matrix and 
growing dysplastically (Frisch and Ruoslahti 1997). It has been proven that integrins play a 
vital role in anoikis inhibition as demonstrated by many authors (Giancotti and Ruoslahti 
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1999, Giancotti 2000, Bissell and Radisky 2001, Alahari, Reddig et al. 2002, Guo and 
Giancotti 2004, Ramsay, Marshall et al. 2007).  The detachment of integrins from ECM 
proteins leads to the absence of apoptotic inhibitory signals ultimately resulting in caspase 
activity and cell anoikis (Frisch and Screaton 2001). This proves that adhesion is of utmost 
importance for cell survival and that integrin attachment leads to the synthesis of a diverse 
array of genetic products to ensure cell survival. Moreover, this validates the importance of 
integrins ability to influence cellular fate and thus, cell-ECM interactions are tightly 
regulated as misguided adhesion often result in pathological conditions which can vary from 
wound healing deficiencies to tumourigenesis  (Hynes 2002, Kumar and Weaver 2009, 
Schiller and Fassler 2013, Wolfenson, Lavelin et al. 2013). 
Integrin-ligand binding is regulated through their interaction with divalent metal cations 
(Mg2+, Mn2+ and Ca2+) (Valdramidou, Humphries et al. 2008, Raborn and Luo 2012). 
Crystallography and electron microscopy have highlighted the regions of cation binding to 
specific areas on the β subunit known as the metal ion dependent adhesion site. Cation 
occupancy then directs the coupling of the subunits followed by the subsequent unfolding of 
the integrins during their transition from inactive to an active confirmation, highlighted in 
Figure 1.2 (Luo and Springer 2006). 
Further studies into integrin structure have highlighted three divergent conformations, which 
directly relate to their function and activation state shown in Figure 1.2. In the ‘closed’ 
configuration, integrins exist in a bent shape with the head directed towards the membrane; 
but can adopt an ‘open’ state to bind a ligand. This rearrangement occurs when divalent metal 
ions bind and cause a change in the tertiary and quaternary structure. For example, studies 
involving the binding of the RGD tripeptide highlighted the importance of this structural 
change where the arginine residue coordinates into a cleft within the α subunit while the 
aspartic acid is drawn toward the Mg2+ ion within the β subunit (Xiong, Stehle et al. 2002, 
Takagi 2007, Wang, Fu et al. 2010, Nagae, Re et al. 2012).  
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In addition to their roles in anchorage to the ECM, integrins play a fundamental role in 
dictating cellular behaviour, by transmitting chemical signals into the cell (outside-in 
signalling) (Hynes 2002). These signals detail location, local environment, adhesive state 
and the surrounding matrix which in turn determines the cellular response (Miranti and 
Brugge 2002). Behaviours such as migration, differentiation and motility are all partially 
controlled through integrin signalling. Integrins can also regulate their affinity for ECM 
ligands by enduring conformational changes. Their extracellular domain is modified in 
response to signals that alter their cytoplasmic tail, a process termed inside-out signalling 
(Calderwood 2004).  
Upon cellular migration, focal adhesions are recycled and transported to the leading edge of 
the cell. This disassembly is of significant importance for cells, as it assures their mobility 
and recycling of integrin receptors and adapter proteins. This turnover of focal adhesions is 
primarily controlled from within the cell by intracellular signalling (Bretscher 1984, 
Bretscher 1992). 
 
1.4 Stem cells 
  
Stem cells are widely regarded as the future of regenerative medicine due to their inherent 
capability to differentiate into a variety of cell types; as well as their ability to self-renew 
(Duscher, Barrera et al. 2016). This sets them apart from other cell types in that they can 
Figure 1.2. Integrin conformation. In their low affinity state integrins adopt a bent conformation 
concealing the ligand binding site. Extension of the subunits reveals the ligand binding domain resulting 
in a ‘primed’ state. Further changes to the structure enable ligand binding. Figure shows the low-affinity, 
high-affinity and ligand-bound structures for "I-less integrins (Luo and Springer, 2006). 
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replenish their reserves, and then commit to a specific cell type on demand. There are three 
widely accepted varieties of stem cells, embryonic stem cells (ESCs), somatic stem cells 
(SSCs) and induced-pluripotent stem cells (iPSCs). ESCs are derived from the inner cell 
mass of blastocyst stage embryos and are pluripotent, that is, they can form any cell type. 
They were first made accessible from mice in 1981 by Evans and Kaufman (Evans and 
Kaufman 1981), and 17 years later in 1998, human ESCs were isolated by Thomson 
(Thomson, Itskovitz-Eldor et al. 1998).  The use of ESCs in research is complex due to the 
nature of their isolation; from fertilised human embryos and therefore ethical approval is 
needed before use.  
In context, SSCs are present in adult tissues, within dedicated niches. These niches exist in 
order to control the proliferative and differentiation potential of the stem cells and include 
tissues such as brain tissue, adipose tissue and bone marrow, amongst many others 
(Gronthos, Graves et al. 1994, Watt and Hogan 2000, Alvarez-Buylla, Seri et al. 2002, Zuk, 
Zhu et al. 2002, Mendez-Ferrer, Michurina et al. 2010). Their main purpose is to serve as a 
bank of readily available cells to replenish dead cells or to help in would healing and 
remodelling. SSCs are multipotent, and can only form a specific set of cell types. SSCs do 
not have the same ability as ESCs to form every cell type.  
There are many types of SSCs and each can be found in specific areas in the body. For 
example, MSCs were first identified in 1963 in the bone marrow (Becker, Mc et al. 1963) 
but have been found in other niches since (Campagnoli, Roberts et al. 2001, Tan, Zheng et 
al. 2017). They strongly resemble fibroblasts in morphology but can become very large well 
spread cells if space is available. Since their discovery, they have become a very popular cell 
type to work with due to their ease of use and relatively simple isolation from the body. As 
they are taken from adult patients, the ethical dispute surrounding ESCs is avoided and MSCs 
are not subject to the same constrictions of use (de Wert and Mummery 2003). 
iPSCs are somatic cells that have been reprogrammed to display ESC like qualities. The 
original method for the generation of iPSCs was developed by Yamanaka in 2006 and utilised 
the retroviral transduction of the four key transcription factors Oct4, Sox2, Klf4, and c-myc 
into the nucleus of a mouse cell (Takahashi and Yamanaka 2006). iPSCs display a higher 
plasticity than SSCs and are not surrounded by the same ethical disputes as ESCs. However, 
a major drawback in iPSC work is the fact that they tend to cause tumour growth due to the 
oncogenetic nature of some of the transcription factors (Knoepfler 2009, Kooreman and Wu 
2010). 
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More specifically, MSCs, a subset of SSCs will be used in this thesis, due to their 
comparative ease of use and their differentiation characteristics fit the work to be completed. 
MSCs are stromal cells that are capable of differentiating into and replenishing cells of the 
mesenchymal germ layer, such as bone, cartilage, muscle, adipose, ligaments and tendons. 
They have the ability to expand in culture whilst maintaining their multipotency and were 
first described as a subpopulation of bone marrow cells which were found to be plastic 
adherent. Friedenstein and colleagues placed whole bone marrow in plastic dishes and 
removed the non-adherent fraction after 4 hours, thus discarding most of the hematopoietic 
stem cells. The adherent cells were found to be fibroblast like, and had a high capacity for 
proliferation after 2-4 days of culture (Friedenstein, Petrakova et al. 1968, Friedenstein, 
Deriglasova et al. 1974). Further studies demonstrated the potential for these cells to begin 
differentiation towards cellular deposits that resembled bone or cartilage (Owen and 
Friedenstein 1988, Benayahu, Kletter et al. 1989). Friedenstein’s observations were further 
tested by other groups throughout the 80s; and it was concluded that the cells isolated by his 
methods were multipotent and could differentiate into cells of the mesenchymal germ layer 
(Osdoby and Caplan 1981, Sparks and Scott 1986, Filipak, Estervig et al. 1989). Newer, 
faster methods for MSC isolation have been implemented and these rely on the expression 
of specific molecules; such as STRO-1, CD29, CD73, CD105 and CD146 amongst many 
others, and are negative for CD14, CD34 and CD45 (Arvidson, Abdallah et al. 2011).  
1.5 Bone Morphogenetic Protein 2 (BMP-2) 
 
Bone Morphogenetic proteins (BMPs) were discovered in 1965 and are multifunctional 
cytokines belonging to the larger transforming growth factor-beta (TGF-β) family (Urist 
1965, Urist 1997). As well as being a regulator in bone induction, maintenance and repair, 
BMPs play a vital role in mammalian embryonic development with defects in BMP 
production leading to various diseases including cancer and cardiovascular diseases. More 
than 20 homo and heterodimeric BMP ligands are encoded in the human genome and these 
can be divided into four discrete groups based primarily on their function, amino acid 
homology and structures: (i) BMP-2 and 4; (ii) BMP-5, 6, 7, 8a and 8b; (iii) BMP-8 and 10; 
and (iv) BMP12, 13 and 14. Of these, only BMP-2, BMP-4 through to 7 and BMP-9 have 
shown the potential to induce bone formation whereas the others have not displayed 
osteogenic capability (Carreira, Lojudice et al. 2014). Table 1.1 displays BMP subtypes and 
their biological functions (Rahman, Akhtar et al. 2015).  
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BMPs are synthesised by osteoblasts as a mature 400-500 amino acid preprotein before 
cleavage reveals the biologically active protein. The preprotein consists of a hydrophobic N-
terminal secretory leader signal and a non-conserved domain attached to the biologically 
active mature C-terminal. This active C-terminal comprises 100-140 amino acids and has a 
region of conserved cysteine amino acids which form part of a cysteine knot with two finger 
like double stranded sheets (Bessa, Casal et al. 2008). Generally, the C-terminal is cleaved  
at a consensus sequence Arg-x-x-Arg site and is released from the preprotein to form dimers 
by means of a disulphide bond, a precondition for bone induction (Sopory, Nelsen et al. 
2006). More specifically, BMP-2 shown in Figure 1.3 is a multifunctional growth factor 
comprising two 114 amino acid subunits. Two receptor binding sites have been identified in 
the dimer, a wrist epitope which utilises motifs from both subunits and has a high affinity 
for the receptor BMPRIA while the knuckle epitope consists of one subunit and binds weakly 
to the receptor BMPRII (Miyazono, Kamiya et al. 2010). BMPs have sites for N and O 
glycosylation which has been shown to increase the stability of the protein, however, it has 
been proven that this modification has no effect on the osteogenic capability of the growth 
factor (Bessho, Konishi et al. 2000, Schmoekel, Schense et al. 2004, Lee, Kim et al. 2010, 
Kim, Lee et al. 2011, van de Watering, van den Beucken et al. 2012). 
 
BMPs react with BMPRs (bone morphogenetic protein receptors) which comprise three 
parts: a short extracellular domain, a membrane spanning membrane domain and an 
intracellular domain which houses the active serine/threonine kinase region (Rao, Ugale et 
al. 2013). There are many different BMPRs, but they can be categorised into two families. 
Three BMPRI (BMPRIA or ALK3, BMPRIB or ALK6 and ALK2: IA activin receptors) and 
three BMPRII (BMPRIIB, ACTRIIA and ACTRIIB) are known to bind BMP. Of the three 
BMPRI, BMPRIA and B are highly similar with ALK2 showing some sequence divergence. 
However, they all possess a highly conserved TTSGSGSG motif which is necessary for 
kinase activity (Lin and Hankenson 2011). BMPRIIs have a constitutively active kinase 
domain which when brought into contact with BMPRI leads to the activation of downstream 
effectors and ultimately leads to an alteration of phenotype. Normally, signalling is initiated 
by the binding of BMP-2 to a BMPRI which begins the recruitment of the other receptors. 
Once two of each type of receptor has been recruited to form a ternary holocomplex 
signalling can occur (Allendorph, Vale et al. 2006). From the current understanding, 
heteromeric complexes of BMPRI and BMPRII are essential for signal propagation. It is 
believed that the specificity of signals and binding is largely determined by BMPRI whereas 
BMPRII is used to stabilise the complex and initiate downstream signalling.  
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Table 1.1. Biological functions of the BMPs (Rahman, Akhtar et al. 2015). 
 
Figure 1.3 (created with PyMol (DeLano 2009) using data from the Protein Data Bank 
(PDB)) shows how BMP-2 monomers dimerise to form the biologically active molecule; 
and how this osteogenic factor binds to its receptors in the membrane. BMP binding to the 
membrane leads to the recruitment of the pathway restricted SMADs (R-SMADs 1, 5 and 8) 
shown in Figure 1.4 (Itoh, Itoh et al. 2000, Moustakas, Souchelnytskyi et al. 2001, Derynck 
and Zhang 2003). These are then released from the receptor and recruit the common mediator 
SMAD (SMAD 4) and then this complex migrates to the nucleus and induces expression of 
osteogenic transcription factors (Watanabe, Masuyama et al. 2000, Xiao, Watson et al. 2001, 
Inman, Nicolas et al. 2002). Two main routes for osteogenic induction have been discovered 
after BMP extracellular binding. Either through activating the transcription factors RUNX2 
(runt- related transcription factor 2) and/or osterix (OSX) through the SMAD proteins 
(canonical BMP signalling) (Shi and Massague 2003, Afzal, Pratap et al. 2005, Massague, 
Seoane et al. 2005). Or through p38MAPK (mitogen-activated protein kinase) and JNK (c-
Jun N-terminal kinase) cascades (non-canonical BMP signalling) which is similar to the 
Subtype(s) Biological Function(s) 
BMP1 
Cleaves procollagens to produce fragments that self-associate for 
cartilage formation 
BMP2/BMP2a Induced bone morphogenesis and involved in heart formation 
BMP3A/Osteogenin 
Negative regulator of bone morphogenesis, induces synthesis and 
secretion of TGF-β1 
BMP3B 
Negative regulator of bone morphogenesis in embryonic stage, 
with opposite effect in mature animals 
BMP4/BMP2B 
Involved in bone induction, cartilage, limb and kidney formation, 
tooth development and fracture repair 
BMP5 
Role in early developmental skeleton patterning, limb 
development and bone morphogenesis 
BMP6 Active role in osteoblast lineage specific differentiation 
BMP7 Role in bone homeostasis and calcium regulation 
BMP8A Role in bone morphogenesis 
BMP8B Found only in mice spermatogenesis 
BMP9 Active role in osteogenesis and in mature osteoblasts 
BMP10 Heart morphogenesis 
BMP11 Role during embryogenesis and skeletal patterning 
BMP12 Involved in tendon and ligament formation 
BMP13 Involved in chondrogenesis and hypertrophy 
BMP14 
Survival promoting molecule for neurons and enhances tendon 
healing and bone formation 
BMP15 Role in ovarian development and function 
BMP16 Embryonic patterning 
BMP17 Embryonic patterning 
BMP18 Embryonic patterning 
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pathways induced by integrin binding (Guicheux, Lemonnier et al. 2003). There are strict 
genetic commitments necessary to predispose MSCs to the osteoblastic phenotype, these 
genes are activated by numerous transcription factors which are ultimately guided by 
regulatory pathways governed by cell receptors such as those for growth hormones and 
integrins (Chamberlain, Fox et al. 2007, Shih, Tseng et al. 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. BMP-2 and its receptors. Images constructed in PyMol using structures from the Protein 
Data Bank (PDB). Red and blue show BMP-2 monomers (PDB reference 3BMP), yellow and green show 
BMPRI and white and pink show BMPRII (PDB reference 3EVS). It is believed that a ternary 
homocomplex of two of each receptor is needed to bind BMP-2 in order to propagate osteogenic 
signalling. Accessed December 2016 using PyMol 1.7.x. 
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1.6 MAPK signalling pathway 
 
The transmission of extracellular events into the cell are largely mediated by a network of 
interacting proteins that propagate a diverse range of intracellular changes. Many efforts 
have led to the discovery of a highly complex signalling mechanism, collectively involving 
the activation of many membrane signalling molecules, and their subsequent intracellular 
induction. This is known as the MAPK signalling cascade (Seger and Krebs 1995). Classical 
MAPK pathways utilise the extracellular signal-regulated kinases 1 and 2 (ERK1/2), c-Jun 
N-terminal kinases 1-3 (JNK 1-3) and p38 (α, β, γ and δ) amongst many others (Cargnello 
and Roux 2011). Extracellular signals are amplified and transmitted along a series of 
regulatory molecules in the cytoplasm towards the nucleus, where cellular processes such as 
proliferation and differentiation are controlled. 
MAPK signalling can be initiated in a variety of ways, from stress (Aikawa, Komuro et al. 
1997, Xia, Makris et al. 2000, Xu, Wang et al. 2013), growth factors (such as BMP-2) (Kao, 
Jaiswal et al. 2001, von Kriegsheim, Baiocchi et al. 2009), G protein coupled receptors 
(Crespo, Xu et al. 1994, Koch, Hawes et al. 1994) and integrins (Aplin and Juliano 1999, 
Figure 1.4. BMP-2 dependent osteogenesis. BMP-2 signalling begins with the binding of BMP-2 to its 
receptors in the membrane. Then the phosphorylation of the recruiter Smad leads to the recruitment of Co-
Smads and subsequent translocation to the nucleus. Here, the induction of osteogenic genes take place. 
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Fincham, James et al. 2000). Activation by these means leads to stimulation of MAP3Ks, a 
group of kinases which in turn phosphorylate and activate MAP2Ks, which again, activate 
MAPKs (Plotnikov, Zehorai et al. 2011, Humphreys, Piala et al. 2013). MAPKs can then 
either translocate to the nucleus or activate additional kinases (Roux et al., 2007), this 
cascade can be viewed in Figure 1.5  (Escos, Risco et al. 2016) (Nagai, Urushihara et al. 
2016).  
 
 
The main pathways contain few constituents, with the core mediators being used in most 
pathways. However, the number of proteins that feed in and out of the network exponentially 
increase as you extend out of the pathways. Computational analysis was used to ascertain 
the amount of proteins with a direct physical link to the MAPK pathway and assembled a 
list of 2000 proteins (Bandyopadhyay, Tsuji et al. 2006). Figure 1.6 summarises the effect 
of BMP-2 through both canonical (smad 1/5/8) and non-canonical (p38, ERK1/2 and 
JNK1/2). 
Two decades ago, MAPK pathways were identified as major components in skeletal 
development and bone homeostasis. Although the MAPK pathways are vast with far reaching 
effects, the activities of p38 and ERK are predominantly involved in shaping osteoblast 
commitment and differentiation. Many hundreds of publications detail both in vivo and in 
Figure 1.5. MAPK signalling cascades. Classical MAPK signalling pathways can be divided into 
four cascades (ERK1/2, p38, JNK and ERK5). The MAP3Ks are activated in response to 
numerous extracellular stimuli and propagate via MAP2Ks and MAPKs. MAPKs can engage with 
target transcription factors within the nucleus altering gene expression and functional output. 
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vitro analysis of p38 and ERK through the osteoblastic differentiation process, from a 
mesenchymal progenitor into a fully functional anabolic bone cell (Ehrlich and Lanyon 2002, 
Bai, Lu et al. 2004). Most work completed highlights the use of genetic knockouts and 
inhibitors on MAPK activity which aid in the determination of ERK and p38 on specific 
processes within the cell (Aouadi, Binetruy et al. 2006, Chang, Sonoyama et al. 2007).  
 
ERK induction in terms of MSC differentiation occurs primarily through integrin signalling 
through tension and mechanical stress (Kanno, Takahashi et al. 2007, Ward, Salasznyk et al. 
2007, Zhang, Wu et al. 2012). It has been shown that tensile stress plays a vital role in 
osteoblastic differentiation, in that externally applied tension alone can induce differentiation 
(Engler, Sen et al. 2006, Kilian, Bugarija et al. 2010). Integrin signalling through ERK leads 
to the activation of RUNX2, a transcription factor that is essential for bone growth in vivo. It 
has been proved that RUNX2 knockouts develop many skeletal irregularities with death the 
Figure 1.6. BMP-2 can activate MAPK. MAPK cascades can be activated by growth factors. They 
can activate additional downstream kinases and also interact with transcription factors within the 
nucleus altering gene expression. 
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final outcome due to a lack of ossification (Komori, Yagi et al. 1997). Similarly, RUNX2 
inhibits the adipogenic transcription factor PPARγ (Hu, Kim et al. 1996).  
p38 can be activated through the methods listed above, but again, is primarily through 
integrin binding and BMP-2 activation. The osteogenic potential of p38 is due to its ability 
to phosphorylate and activate key transcription factors, like ERK, p38 can activate RUNX2 
(Ge, Xiao et al. 2009, Greenblatt, Shim et al. 2010). BMP-2 signalling and p38 work together 
to induce osteogenesis, BMP-2 can increase DLX5 activation of the osterix promoter, but 
first DLX5 must be phosphorylated by p38 (Ulsamer, Ortuno et al. 2008). Additionally, 
DLX3, another DLX member is induced by BMP-2 by cooperation through SMAD5 and p38 
which ultimately leads to osterix activation (Yang, Yuan et al. 2014). These pathways are 
simplified in Figure 1.7 (Rodriguez-Carballo, Gamez et al. 2016). MAPK pathways play vital 
roles in many aspects of osteoblastic differentiation. These have been proven by both ERK 
and p38 deletion hampering osteoblast differentiation in vivo.  
It is apparent that BMP-2 can directly affect osteogenic differentiation of MSCs, through 
both smad (canonical) and p38/ERK1/2 (non-canonical) mechanisms. The MAPK pathways 
are thus important in healthy bone development and are a necessary constituent of 
differentiation.  
 
Figure 1.7. p38 implication in osteoblast differentiation. p38-mediated phosphorylation promotes 
progression in osteogenesis by the enhancement of the activity or expression of osteoblast-specific 
transcription factors genes such as RUNX2, DLX5 and osterix. Direct arrows indicate direct phosphorylation 
whole dashed arrows indicate indirect action of p38. Image courtesy of (Rodriguez-Carballo, Gamez et al. 
2016). 
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1.7 Genetic Engineering 
 
The field of genetic engineering (GE) utilises techniques to directly manipulate an 
organism’s genome. These techniques involve insertion, deletion or modification of the 
existing genetic material. IUPAC defines GE as ‘the process of inserting new genetic 
information into existing cells to modify a specific organism for the purpose of changing its 
characteristics’ (Vert, Doi et al. 2012). There are many examples and types of manipulation 
possible, the most common being the insertion of a foreign gene from one species into 
another. Others involve altering a specific gene (mutagenesis), activating, silencing or 
changing the expression levels of one or more multiple genes. These can be accomplished 
through multiple techniques, such as RNA interference, antisense oligonucleotides, 
ribozymes, catalytic RNA molecules that possess the ability cut RNA strands at desired 
locations amongst many more (Tollefsbol 2007, Kole, Krainer et al. 2012, Wilson and 
Doudna 2013). In this thesis, we are using the technique known as Gibson Assembly 
(Gibson, Young et al. 2009) which will be covered in more detail later. Genetic engineering 
encompasses the use of recombinant nucleic acid techniques, either DNA or RNA, to 
synthesise new genetic sequences. These are then inserted into living organisms, transiently 
or permanently, via direct modification of the genome using vectors.  
Many strains of bacteria have undergone serious research as a host of genetic manipulation, 
the most important of these is the gram negative bacteria Escherichia coli (E. coli) (Boyer 
and Roulland-Dussoix 1969, Chong 2001, Sawitzke, Thomason et al. 2007). This strain has 
been extensively studied and used in plasmid engineering, however, there are also many 
other bacteria with commercially available tools for genetic manipulation, including gram 
positive strains. The choice of bacteria will be explained in the next section. Of these 
bacteria, the lactic acid bacteria clade, especially Lactococcus lactis (L. lactis) displayed the 
greatest amount of potential due to the current availability of genetic manipulation tools, 
combined with its ability to form 2D biofilms. 
Once a suitable host organism has been chosen, it is also important to select an appropriate 
genetic vector. These can range from plasmids to artificial chromosomes. Plasmids usually 
contain promoters, either constitutive or inducible, several selectable genetic markers and 
multiple cloning sites where restriction sites are readily available. The use of promoters 
depends on the outcome of the application, e.g., bacterial kill-switches cannot be 
constitutively expressed and must be controlled by an inducer. In contrast, constitutive 
promoters are always ‘on’. Inducible promoters can be controlled in a stimulus derived 
fashion, with the use of chemicals, pH, temperature and light, among many others (de Vos 
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1999, Mierau and Kleerebezem 2005, Siren, Salonen et al. 2009). Upon choosing the correct 
organism and vector, the sequence of DNA to be cloned needs to be obtained and amplified 
using the polymerase chain reaction (PCR). This allows biologists to obtain more than 
suitable amounts of DNA. PCR is a highly specific and extremely versatile technique that 
can add specific DNA sequences to either 5’ or 3’ ends of sequences, induce single 
nucleotide polymorphisms, create deletions and mutate DNA.  Upon the completion of a 
PCR reaction, the mixture comprises many proteins, including the polymerase, nucleic acids 
including the sequence and primers and dNTPs. Usually, this mixture needs purifying before 
further steps can be completed. 
Next, the chosen DNA and vector need to be ligated. Conventional cloning techniques utilise 
restriction enzymes in order to linearise the destination vector generating blunt or sticky ends 
where the foreign DNA fragment can be inserted. DNA ligase is also added to the mixture 
which leads to the ligation of the vector and the chosen DNA sequence. DNA ligase works 
by creating a phosphodiester bond in the sugar backbone between the two DNA sequences 
resulting in the insertion of the chosen DNA sequence at the exact desired point.  
More recently, the use of restriction endonucleases have been made more redundant. 
Techniques such as TOPO, Gateway, overlap extension PCR or Gibson assembly use the 
power of PCR to generate fragments with overlapping sequences that can be partially 
digested with exonuclease, repaired and joined together again (Xu and Li 2008, Gibson, 
Young et al. 2009, Bryksin and Matsumura 2010, Petersen and Stowers 2011). Once the 
DNA is constructed, it must be inserted into the host cell. In bacterial cells, electroporation 
and heat-shock transformation are most widely used.  
For gram positive cells, such as L. lactis, electroporation is used due to the structure of the 
cell wall. Firstly, the bacteria of choice need to be made electrocompetent, usually by 
growing the cells in a glycine rich medium which leads to the weakening of the cell wall. 
Upon the addition of an electric pulse to the system, the bacteria becomes porous and if 
plasmid has been added to the mixture, DNA can enter the cells. Heat-shock works by 
altering the bacterial membrane fluidity creating a number of small pores. Cells are kept at 
0 °C with calcium chloride as this creates a positive charge on the bacterial membrane 
allowing the negatively charged DNA to stick to the bacteria. By increasing the temperature 
to 42 °C, the membrane fluidity changes creating pores allowing the plasmid to enter the 
cell. The temperature is then decreased to 0 °C again returning the membrane fluidity to 
normal.  
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After the transformation step, the transformed cell, that is the ones with the new plasmid 
inside needs to be separated from the wild type cells. Generally, engineered plasmid vectors 
contain at least one antibiotic resistance gene, so that if a cell has been transformed with the 
plasmid, it will be able to grow on an agar plate supplemented with that antibiotic. This is 
not only limited to bacteria, for instance, mammalian cell vectors usually contain a geneticin-
resistance gene. Geneticin is largely toxic to all cell types and therefore correctly 
transformed cells will display a resistance. A further method to screen for positively 
transformed cells is to look for marker proteins, such as GFP (Tsien 1998). GFP is 
fluorescent under normal conditions; that is room temperature and a neutral pH and can 
therefore be detected non-destructively in real time with UV light excitation (395 nm). 
Correctly transformed cells would display GFP fluorescence at 509 nm once excited with 
light of 395 nm.   
Genetic engineering has evolved over the last few decades and has given rise to synthetic 
biology. Genetic engineering approaches are usually ad hoc, whereas synthetic biology aims 
to apply engineering principles such as standardisation, modularisation, and reusability. This 
allows the creation of new genes, and in the long term, the potential to tailor new organisms 
for a desired application. For example, pT1NX, one of the plasmids used in this thesis which 
will be described later is comprised of DNA from different species including phage T7, 
Enterococcus faecalis and Staphylococcus aureus. These convey specific functionality, and 
have been joined together to create a useful tool for both cell wall bound and secreted 
heterologous protein expression in Lactococcus.  
 
1.8 Gibson assembly 
 
In 2009, Dr Gibson at the J. Craig Venter Institute developed an easy method to enable the 
assembly of multiple linear fragments of DNA (Gibson, Young et al. 2009). Multiple 
overlapping fragments can be joined in a single isothermal reaction utilising the power of 
three different enzymes, T5 exonuclease, Phusion polymerase and Taq ligase. This can result 
in the creation of a fully ligated double stranded DNA molecule. It is primarily used by 
molecular biologists in the creation of synthetic plasmids and has rapidly overtaken more 
conventional cloning techniques due to its ease of use, ability to join almost any two 
fragments regardless of sequence (due to lack of restriction sites). There are no ‘scars’ 
between ligated sites and the technique has been shown to combine up to six fragments at a 
time in a single tube. A simple schematic of the system can be visualised in Figure 1.8. 
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Figure 1.8. Gibson Assembly. Gibson Assembly details a method for the easy assembly of multiple linear 
DNA fragments in a single isothermal reaction. By using overlapping primers, the enzymes T5 exonuclease, 
Phusion DNA polymerase and TAQ DNA ligase can form a fully ligated double-stranded DNA molecule. 
Image courtesy of Addgene (https://www.addgene.org/protocols/gibson-assembly/).  
 
Complementary termini of PCR products determine the order in which the fragments will be 
assembled and can be seen in Figure 1.9. In order for these PCR products to assemble, the 
three enzymes mentioned above play a pivotal role. 
T5 exonuclease creates single stranded 3’ overhangs by chewing back from the 5’ end. This 
allows the complementary DNA fragments to subsequently anneal to each other.  
Phusion DNA polymerase integrates new nucleotides to fill in the gaps in the annealed DNA 
fragments.  
Taq DNA ligase covalently links the newly annealed DNA fragments, removing any nicks 
and creating a continuous DNA fragment, thus eliminating any scars left in the construct. 
Upon designing primers with overlapping complimentary regions (see coloured regions in 
Figure 1.9), the PCR products are added to a Gibson Master Mix which contains the 3 
enzymes and dNTPs. This single tube is left at 50 °C for 15-60 minutes and the resulting 
plasmid is then to be transformed into a host bacteria. 
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1.9 Why Lactococcus lactis? 
 
Lactic acid bacteria (LAB) have a long history of safe use in humans, being used for 
hundreds of years in the food industry and more recently, use as probiotics in human health. 
Of late, there has been an increased effort to use LAB as microbial cell factories for the 
production of proteins of interest. So far, these bacteria have been used as vectors for the 
delivery of functional proteins to mucosal tissues amongst others shown in Table 1.2 (Cano-
Garrido, Seras-Franzoso et al. 2015).  L. lactis, amongst other LAB have GRAS (Generally 
Regarded As Safe) status by the US Food and Drug Administration (FDA) and fulfil criteria 
of the qualified presumption of safety (QPS) according to the European Food Safety 
Authority (EFSA) (Cano-Garrido, Seras-Franzoso et al. 2015). 
This bacteria was chosen as LAB are gram-positive, in contrast to gram negative bacteria 
such as E. coli, and therefore do not contain lipopolysaccharide (LPS). LPS is known to 
cause anaphylactic shock in humans and so the use of gram positive bacteria is of utmost 
importance when trying to create synergistic environments for mammalian cells and bacteria 
(Rueda, Cano-Garrido et al. 2014).  
Furthermore, this strain features a very low production of exopolysaccharide (EPS) (Le Loir, 
Azevedo et al. 2005), a mandatory requirement to ensure the interaction of the mammalian 
cell integrins with the exposed fibronectin fragment in the cell wall and allowing ease of 
secretion of BMP-2.  
Figure 1.9. Gibson Assembly primer overlap. By creating primers with overlapping regions (yellow, 
purple, green and orange regions), a fully ligated DNA molecule can be assembled in a single reaction vessel. 
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Another important characteristic of this strain is it has the ability to spontaneously develop 
biofilms (Mercier, Durrieu et al. 2002, Habimana, Le Goff et al. 2007). Despite its low EPS 
production, L. lactis has the potential to colonise a vast array of surfaces, including the 
widely used tissue culture substrates. These biofilms have been shown to remain stable for 
at least four weeks (Hay, Rodrigo-Navarro et al. 2016) and support MSC adhesion and 
differentiation.  
Lastly, L. lactis has been widely used and has been deeply characterised, being the first LAB 
to have its genome sequenced. In addition, it is an expression system that can be easily 
manipulated and has a vast array of commercial cloning and expression systems already in 
place. 
In this work we are using the pT1NX plasmid designed by Dr L Steidler which features the 
P1 lactococcal promoter and erythromycin resistance gene (Waterfield, Lepage et al. 1995, 
Steidler, Viaene et al. 1998). mRNA synthesis is controlled by the T7g10 terminator from 
phage T7 (Schotte, Steidler et al. 2000). The replicon is from the Enterococcus faecalis 
plasmid pAMβ1 origin and the plasmid also includes repD and repE. It has been used for the 
constitutive expression of both anchored and secreted proteins and is commercially available 
with the tools to accomplish these protein types. pT1NX has many features and the important 
sections will be will be discussed, a basic map can be seen in Figure 1.10.  
 
 
 
Figure 1.10. L. lactis plasmids. pT1NX and pNZ8123 vector maps showing the P1 lactococcal promoter 
(pT1NX), PnisA nisin A promoter (pNZ8123), usp45 secretion signal, spaX protein A anchor (pT1NX), the 
ermAM erythromycin resistance gene (pT1NX) and chloramphenicol resistance gene (pNZ123). 
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A further plasmid designed by Mobitec known as pNZ8123 also features in this work. This 
harbours the PnisA promoter which is under the control of the inducer nisin controlled by 
the terminator T. It also contains a chloramphenicol resistance gene as well as repC and repA 
and pSH71 origin of replication. A basic map can be seen in Figure 1.10. 
Table 1.2. Recombinant proteins produced by L. lactis for biomedical purposes (Cano-Garrido, 
Seras-Franzoso et al. 2015).  
 
 
Bacteria Application 
Recombinant 
protein 
Expression 
vector Protein display 
Lactococcus 
lactis 
Intestinal 
disease 
Anti TNF alpha 
antibodies pTREX Secreted 
Lactococcus 
lactis 
Intestinal 
disease Trefoil factors pTREX Secreted 
Lactococcus 
lactis 
Intestinal 
disease 
Low calcium 
response pNZYR Secreted 
Lactococcus 
lactis 
Intestinal 
disease 
Superoxide 
dismutase pSodA Secreted 
Lactococcus 
lactis 
Intestinal 
disease IL-10 
Chromosome 
integrated Secreted 
Lactococcus 
lactis 
Intestinal 
disease IL-27 pT1NX Secreted 
Lactococcus 
lactis 
Intestinal 
disease Murine IL-10 pLB263 Cytoplasmic 
Lactococcus 
lactis 
Colorectal 
cancer Catalase pSEC:KatE Secreted 
Lactococcus 
lactis 
Type 1 
diabetes Pro-insulin pT1NX Secreted/cytoplasmic 
Lactococcus 
lactis 
Type 1 
diabetes HSP65 pCYT:HSP65 Secreted 
Lactococcus 
lactis 
Type 1 
diabetes GAD65 pCYT:HSP66 Secreted 
Lactococcus 
lactis Diabetes 
Single chain 
insulin pNZPnisA Secreted 
Lactococcus 
lactis 
Type 2 
diabetes 
Glucagon like 
peptide 1 pUBGLP Secreted 
Lactococcus 
lactis Cancer 
HPV-16 E7 
antigen pLB263 Cytoplasmic 
Lactococcus 
lactis 
Cervical 
cancer HPV-16 E7 pMG36e Anchored 
Lactococcus 
lactis 
Cervical 
cancer HPV-16 E7 pMG36e Cytoplasmic 
Lactococcus 
lactis 
Cervical 
cancer HPV-16 E7 pMG36e Anchored 
Lactococcus 
lactis 
Staphylococal 
infection 
Staphylococal 
nuclease pLB263 Secreted 
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The genes found in pT1NX and pNZ8123 can be utilised in the creation of either cell wall 
bound or secreted proteins. Protein A (SpA) is a 42 kDa protein found in the cell wall of 
Staphylococcus aureus (known as spaX) (Steidler, Viaene et al. 1998). To allow anchorage, 
a C-terminal 35 residue sorting sequence is essential, which contains the conserved peptide 
LPXTG followed by a tail mainly composed of positively charged amino acids which 
prevents the full secretion of the protein. The C–terminal is cleaved by a signal peptidase 
which leads to the translocation of the protein. After translocation, a sortase with proteolytic 
activity (Mazmanian, Hung et al. 2001, Mercier, Durrieu et al. 2002) that modifies surface 
proteins by recognising the LPETF motif in the C-terminal cleaves between a threonine and 
glycine residue and leaves the C-terminal end anchored to the cell wall. The C-terminal of 
the threonine is covalently linked to the free amino groups of the peptidoglycan cross bridge 
via an amide bond which allows the final crosslinking to be completed. This mechanism is 
not always 100 % accurate and sometimes these molecules can be found in the extracellular 
space, mainly due to the physical turnover and release of peptidoglycan fragments linked 
with surface proteins. Figure 1.11 displays a schematic of the anchoring mechanism. 
 
The Usp45 signal peptide used is part of Usp45 (unknown secreted protein 45) found in 
many LAB (Vanasseldonk, Rutten et al. 1990). This protein has no known biological activity 
but can be exploited by biologists to allow the secretion of desired proteins. This secretion 
peptide comprises the first 27 residues of the native N-terminal region of Usp45 
(Vanasseldonk, Rutten et al. 1990). The largest protein known to be secreted using this 
protein is 160 kDa and therefore, will not affect the proteins planned to be secreted in this 
thesis.  
The use of the Usp45 secretion peptide is mandatory for both cell wall bound and secreted 
proteins as this protein tells the bacteria to transport the cargo to the outside of the cell, 
however, spaX is only necessary for cell wall bound expression. By utilising the powers of 
these proteins, we can tailor specific protein design and their localisation. 
 
25 
 
 
 
 
 
 
 
 
 
 
In contrast to the constitutive expression of pT1NX, many inducible plasmids have been 
constructed for effective secretion in L. lactis. pNZ8123 provides the Usp45 secretion 
peptide under control of the PnisA promoter. The most commonly used regulated expression 
system in L. lactis is the Nisin Controlled Gene Expression System (NICE) (deRuyter, 
Kuipers et al. 1996). This utilises sub-toxic amounts of the bacteriocin nisin (ng/mL) which 
is enough to fully activate the normally tightly controlled promoter (Kuipers, de Ruyter et 
al. 1998). Naturally, extracellular nisin can bind to the nisin receptor NisK, which activates 
NisR by phosphorylation. This in turn induces the nisin operon at the PnisA promoter. This 
system and operon have been exploited by synthetic biologists in order to create a gram 
positive inducible protein expression system. The genes of the receptor (NisK) and response 
regulator (NisR) have been isolated and placed on the chromosome of a suitable host strain 
(NZ9000 and NZ9020 in this work). In addition to this, PnisA has been isolated and placed 
on many plasmids, including pNZ8123. Upon downstream gene placement at PnisA, and 
insertion of this plasmid into a nisRK strain, expression of this protein can be controlled by 
the addition of nisin (deRuyter, Kuipers et al. 1996). Localisation of the protein is determined 
by the presence of Usp45 and spaX (discussed above). Figure 1.12 displays a schematic of 
the NICE system (Mierau, Olieman et al. 2005)  
Figure 1.11. L. lactis anchoring mechanism. Anchoring mechanism of the LPETG motif onto the 
peptidoglycan layer. A signal peptidase cleaves near the N-termini of the protein, which is translocated to 
the outer part of the cell wall. Then, a sortase cleaves the polypeptide chain between the threonine and 
glycine and anchors the threonine to the tetrapeptide motif that crosslinks the peptidoglycan layer. 
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1.10 L. lactis phylogeny 
 
LAB are classified using a variety of characteristics, which have evolved over time.  
Traditionally, mode of glucose metabolism, morphology, growth rates (both temperature, 
pH and salt concentrations), type of lactic acid produced, cell wall constituents and alkaline 
tolerance. However, due to the advent of DNA sequencing, the 16S and 23S ribosomal RNA 
(rRNA) as well as G + C content (percentage moles of guanosine and cytosine content in the 
genomic DNA) are used to classify the organism. Eubacteria are subdivided into gram 
negative and gram positive phyla. LAB can be found in the gram positive low G + C content 
tree of eubacteria.  
Based on 16S and 23S rRNA data, gram positive bacteria form two major lines of descent 
shown in Figure 1.13 (Schleifer and Ludwig 1996). One phylum consists of bacteria with a 
high G + C content (actinomyces) and one with a low G + C content (clostridium). LAB are 
considered as a super cluster, located between the facultative aerobic species staphylococci 
and bacilli and the anaerobic species clostridia. As such, Lactococcus has its own cluster 
within the clostridium branch. It is difficult to form an exact definition of what a typical 
LAB should be. However, they could be described as gram positive, catalase deficient (some 
have catalase activity), largely anaerobic (can tolerate oxygen), acid tolerant, no 
cytochromes, non-spore forming and having lactic acid as the end product of metabolism. 
Figure 1.12. L. lactis nisin-controlled gene expression system. After binding of nisin to the specific 
receptor NisK autophosphorylates and transfers the phosphate group to NisR. Activated NisR induces 
transcription from the target gene placed under the control of the promoter. Depending on the 
presence of the spaX anchor, proteins are either secreted or cell wall bound. 
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1.11 L. lactis metabolism 
 
L. lactis, as well as other bacteria in the LAB clade primarily metabolise glucose to lactic 
acid (Cocaign-Bousquet, Garrigues et al. 1996, Bolotin, Wincker et al. 2001, Rezaiki, 
Cesselin et al. 2004). This high carbohydrate fermentation coupled with substrate level 
phosphorylation activity is used for the synthesis of ATP. ATPase is membrane bound and 
utilises a H+ gradient to generate a proton motive force that drives the transport of ions and 
metabolites into the cell. L. lactis uses the glycolytic Embden-Meyerhor-Parnas pathway, 
which is also known as homolactic fermentation to produce ATP from glucose. This pathway 
is almost exclusively used and results in almost all of the glucose available to the bacteria 
transformed into L-(+)-lactic acid, through the formation of fructose 1,6-diphosphate, which 
is then converted into dihydroxyacetonephosphate and glyceraldehyde-3-phosphate which 
are then both further transformed into pyruvate. Under laboratory conditions, that is cell 
culture medium where oxygen access is restricted and glucose is in high excess, the pyruvate 
is reduced to lactic acid by a NAD+- lactate dehydrogenase, reoxidising the NADH to NAD+. 
Usually, the only product of this reaction is lactic acid, however, in some cases where more 
complex ingredients are found in the growth medium, the formation of other molecules such 
as acetic acid can be found (Stahl, Molin et al. 1990). Pyruvate can be utilised in many 
different ways by L. lactis. Pyruvate can be converted by pyruvate formate lyase, giving 
acetyl-CoA and formate. Pyruvate dehydrogenase can also produce acetyl-CoA, and results 
Figure 1.12. Phylogenetic tree of the lactic acid bacteria (LAB) clade. 
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in the production of NADH and CO2 when oxygen is present. Moreover, acetyl-CoA can 
either be converted into ethanol via alcohol dehydrogenase, resulting in the generation of two 
molecules of NAD+, or into acetate via phosphotransacetylase and acetylkinase with a net 
gain of one ATP molecule. These pathways are used less frequently but there are other routes 
for ATP genesis such as when pyruvate is converted into 2,3-butanediol. One ATP molecule 
and two CO2 molecules are formed from one 2,3-butanediol molecule. Although this pathway 
is very rarely used in normal laboratory conditions, improved production of 2,3-butanediol 
can be easily achieved by metabolic and genetic engineering strategies (Gaspar, Neves et al. 
2011). The production of 2,3-butanediol, acetate, ethanol and formate is called mixed-acid 
fermentation, mainly taking place under sub-optimal conditions of growth, which is not 
usually found in the high glucose rich laboratory growth conditions (Thomas, Ellwood et al. 
1979). L. lactis almost exclusively grows homofermentatively, meaning that most of the 
pyruvate formed in glycolysis is converted into lactate with recovery of NAD+.  Figure 1.14 
highlights the homolactic fermentation process in L. lactis. The glycolytic pathway can be 
explained best by carbon catabolite repression (CCR). When extracellular glucose is present, 
the uptake and metabolic pathways of less favoured sugars are downregulated (Warner and 
Lolkema 2003). CCR is caused by an array of proteins that systematically phosphorylate 
specific protein products. A complex of the proteins CcpA and HPr phosphorylate at its 
serine on position 46 (Gunnewijk and Poolman 2000, Bolotin, Wincker et al. 2001). This 
complex then binds to CcpA binding motifs (cre-sites) which are located upstream of many 
central metabolism genes (Zomer, Buist et al. 2007). The phosphorylation state of HPr is 
completely reliant on a phosphotransferase system which allows phosphorylation transfer 
between different enzymes (EI, EIIA, EIIB and HPr). A glycolytic intermediate molecule 
PEP donates its phosphoryl group to EI, transfers it to HPr, which phosphorylates EIIA and 
EIIB. EIIB then phosphorylates intracellular glucose, forming glucose-6-phosphate. At low 
extracellular glucose concentrations the cell accumulates phosphorylated EII and HPr His-
15 (Deutscher 2008). Conversely, at high glucose concentrations, HPr His-15P gets 
dephosphorylated and then HprK/P, HPr can be phosphorylated at Ser-46 (Reizer, Hoischen 
et al. 1998). HPr Ser46-P can form a complex with CcpA that results in CCR. Additionally, 
as well as acting as a repressor, CcpA-HPr Ser46-P is also capable of binding to cre-sites 
upstream of the las-operon, which results in the activation of thee highly important glycolytic 
enzymes, namely pfk, pyk and ldh (Luesink, van Herpen et al. 1998). 
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In addition to glucose, L. lactis can metabolise other sugars such as mannose, fructose and 
galactose. For mannose and fructose, a permease transport system allows these sugars to 
enter the cell cytoplasm. Galactose metabolism depends on the strain and the presence of a 
sugar phosphotransferase system (PTS). If the galactose PTS is present in the cell, galactose 
is converted into galactose-6-P entering the glycolytic pathway at the glyceraldehyde-3-P 
level (Figure 1.14 left) (White and Kennedy 1979). In the absence of such a system, galactose 
follows a different pathway, the Leloir pathway (Figure 1.14 right) (White and Kennedy 
1979).  
How L. lactis controls its carbohydrate metabolism has been a major driver of investigation 
into the bacterium due to its industrial applications and all the answers are still not present.  
Figure 1.14. Homolactic fermentation process in L. lactis. Glycolytic pathway of L. lactis, 
yielding lactate as final product. 
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1.12 Aims of the project 
 
Current strategies for controlled stem cell differentiation are limited and provide a major 
challenge to stem cell based regenerative medicine. In vivo, stem cells reside in an area 
defined as a niche, which is a specialised milieu of cells, ECM and growth factors that 
maintains stem cells in a quiescent state and also plays a role in their activation.  
One way of implementing existing technology to mimic this niche, is to use genetically 
modified, non-pathogenic bacteria to control cell behaviour. These bacteria can be tailored 
to synthesise proteins in a constitutive or inducible manner and thus, creating a living, 
dynamic interface for stem cell differentiation.  
It had been shown by this laboratory that FN null fibroblasts (FN -/-) adhered to our modified 
L. lactis monolayer displaying the FN fragment FNIII7-10 leads to the development of focal 
adhesions and promoted FAK based signaling (Rodrigo-Navarro, Rico et al. 2014). This 
FNIII7-10 fragment comprises the RGD adhesion motif (FNIII10) and the PHSRN synergy site 
(FNIII9). The RGD and PHSRN sequence are both essential to promote α5β1 integrin 
mediated adhesion as well as promiscuous integrin adhesion (Aumailley, Gurrath et al. 
1991). It has been shown that short RGD containing peptides can mimic a number of the 
properties of cell adhesive proteins and allow integrin attachment, therefore promoting 
adhesion of cells to the surface (Pierschbacher and Ruoslahti 1984, Dsouza, Ginsberg et al. 
1991).  
The goal of this thesis is to utilise this platform of bacteria harnessing the FNIII7-10 fragment 
to sustain long-term MSC adhesion, whilst simultaneously, the induced production of BMP-
2 can begin to initiate the differentiation of MSCs to osteoblasts. It has also been shown that 
α5β1 integrins and BMP-2 can act synergistically to create strong osteogenic differentiation 
(Salmeron-Sanchez and Dalby 2016).  
The specific aims have been broken down and are thus: 
1. Explore the effect of the FNIII7-10 fragment coupled with the addition of exogenous 
BMP-2 on MSCs. 
 
2. Engineer the secretion and cell wall bound expression of BMP-2 into L. lactis in a 
constitutive and inducible manner. 
 
3. Deduce MSC behaviour in response to bacterially expressed BMP-2 in vitro and in 
vivo. 
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2. Materials and methods 
 
This chapter details a general methods section with specific details highlighted in the 
individual results chapters.  
2.1 Bacterial culture 
 
L. lactis was cultured in M17 medium (Oxoid Microbiology Products) to allow growth in 
standing cultures. The composition of M17 is (Terzaghi and Sandine 1975):  
 Typtone (5 g/L) 
 Soya-peptone (5 g/L) 
 “Lab-lemco” (5 g/L) 
 Yeast extract (2.5 g/L) 
 Ascorbic acid (0.5 g/L) 
 Magnesium sulphate (250 mg/L) 
 Di-sodium glycerophosphate (19 g/L)  
When dissolved, the media has a pH of 6.9 ± 0.2 at 25 °C. The medium is bought as a powder 
that has to be reconstituted at 37.25 g/L in ultrapure water before sterilisation at 126 °C for 
20 minutes. Upon cooling, 0.5 % v/v sterile glucose and any appropriate antibiotic was 
added. This prevents the caramelisation of the glucose and degradation of the antibiotic. L. 
lactis was then grown at 30 °C in anaerobic conditions (unless stated otherwise) in standing 
cultures. The stationary phase of growth is usually met within 8 hours and the bacteria slowly 
begin to form a pellet at the bottom of the culture.  
To allow for unimpeded protein expression and characterisation, bacteria were grown in M9 
minimal medium. This again allows growth but does not include as many ingredients as M17 
and therefore allows much easier downstream experimentation. The composition of M9 is 
(Steidler, Wells et al. 1995):  
 25.6 g/L Na2H2PO4 
 6  g/L KH2PO4 
 1 g/L NaCl 
 2 g/L NH4Cl 
The following was added to complete the media for L. lactis: 
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 20 mM MgSO4 
 2 mM CaCl2 
 50 nM NaHCo3 / Na2CO3  
 0.5 % w/v glucose 
 
2.2 L. lactis biofilm production 
 
The method to develop an L. lactis biofilm was adapted from other authors (Burmolle, Webb 
et al. 2006). A frozen stock of L. lactis was kept at -80 °C and used to streak a fresh M17 1 
% agar plate supplemented with 0.5 % glucose and appropriate antibiotic. The plate was kept 
at 30 °C for 24 hours until 1-2 mm colonies had grown. A single colony was picked and 
inoculated in 10 mL fresh M17 with 0.5 % glucose v/v until an optical density of 0.3-0.5 at 
600 nm was measured. The bacterial culture was then poured over an appropriate surface in 
a multiwall plate and sealed with parafilm and grown at 30 °C for 24 hours.  
After 24 hours, the media was removed along with the planktonic phase, and the adhered 
portion of the bacteria were washed 3 times with sterile ultrapure water. These wash steps 
ensure that all planktonic phase bacteria are removed and the only bacteria that remain are 
those attached to the surface. This results in a bacterial monolayer adhered to the material 
surface and are ready for further experimentation.  
 
2.3 Sample preparation 
 
Glass coverslips were spin coated with 4% w/v poly (ethyl acrylate) (PEA) in toluene prior 
to coating with fibronectin (FN) or L. lactis. PEA sheets were dissolved in toluene to a final 
4 % w/v concentration. The solution was stirred for two days until all the polymer was 
properly dissolved, obtaining a viscous solution as a result. Spin-coating was performed over 
12 or 25 mm glass coverslips at 2000 rpm for 30 seconds. Samples were dried in vacuum at 
60 °C to remove solvent traces before biofilm preparation. For FN functionalisation, 200 µL 
of a solution of 20 µg/mL FN was used to coat the PEA surface for an hour at room 
temperature. The methods used to develop a biofilm on surfaces has been previously 
published (Burmolle, Webb et al. 2006, Zaidi, Bakkes et al. 2011). In these experiments L. 
lactis were grown as standing cultures in M17 broth with the appropriate antibiotic at 30 °C 
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for 24 hours. The cells were then harvested at 3000 g for 10 minutes and resuspended in 500 
µL of the same medium and streaked on M17 agar plates supplemented with 0.5 % w/v 
glucose and the appropriate antibiotic and left to grow at 30 °C overnight. Colonies were 
taken from the plates and transferred into sterile M17 broth until OD 660 was 0.3. 4.8 mL 
of suspension was used for the glass coverslips in the 6 well plates and 1 mL for 24 well 
plates. These were then sealed and left at 30 °C for 24 hours. After 24 hours the non-adherent 
planktonic phase bacteria were removed by shaking and washing. The wells were shaken by 
hand and the planktonic phase bacteria were removed via pipette followed by 3 washes with 
sterile water. 
PEA coated coverslips were only used for long term cell culture (more than 4 days) as it was 
found that the bacteria were able to adhere to this surface for longer periods than on glass 
alone.  
 
2.4 Mammalian cell culture 
 
Two cell types have been used in this work, human bone marrow-derived mesenchymal stem 
cells (MSCs) and murine C2C12 myoblasts. The first experiments were completed with the 
C2C12s as these are a well-documented model for osteogenic differentiation. These were 
used in preliminary studies to ensure both the interaction of the cells with the FNIII7-10 
subunit and the differentiation capabilities of BMP-2 in short term cultures. Finally, MSCs 
were used to assess the differentiation capabilities of BMP-2 in long term cultures.  
 
 
2.4.1 C2C12 murine myoblasts 
 
This is a murine myoblastic cell line that can be used a model system for osteoblastic 
differentiation. The cells were purchased from ATCC (USA) and a stock was created. Cells 
were used before passage 10. This cell type can differentiate into myotubes and under the 
correct circumstances, be induced down the osteogenic pathway. It is not advised to allow 
this cell type to reach confluence as the myoblastic population rapidly depletes due to 
paracrine interactions (Katagiri, Yamaguchi et al. 1995, Watt, Judson et al. 2010, Velica and 
Bunce 2011). These cells were grown in DMEM (Dulbecco’s modified eagle medium) with 
4.5 g/L glucose, 20 % FBS (foetal bovine serum) and 1 % P/S (penicillin-streptomycin).  
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2.4.2 Human bone marrow derived mesenchymal stem cells (MSCs) 
 
These cells were obtained from PromoCell and show great therapeutic potential due to their 
inherent differentiation capabilities. The PromoCells used in this thesis are harvested from 
normal human bone marrow and are vigorously tested for their ability to differentiate in vitro 
into adipocytes, chondrocytes, osteoblasts and neuronal cells (Pittenger, Mackay et al. 1999). 
These cells are verified through marker selection CD73+/CD90+/CD105+ and CD14-/CD19-
/CD34-/CD45-/HLA-DR- and adhere to the expression profile compiled by the International 
Society for Cellular Therapy (Dominici, Le Blanc et al. 2006). Under the right conditions, 
these cells can differentiate to osteoblasts, adipose cells, nerve cells and reticular sub types. 
These cells were grown in DMEM supplemented with 100 µM pyruvate (Sigma), 1.1 mM 
L-glutamine (Sigma), 10 % FBS and 1 % P/S.  
 
2.5 Immunofluorescence assays 
 
2.5.1 Cell adhesion 
 
Cell adhesion was either studied through vinculin or integrin immunostaining. After selected 
culture times (described in the results chapter), cells were washed with phosphate buffered 
saline (PBS, Invitrogen) and fixed in 4 % formaldehyde at 37 °C for 15 minutes. This fixative 
was washed 3 times with PBS before incubating the samples with permeabilisation buffer 
(10.3 g of sucrose, 0.292 g of NaCl, 0.06 g of MgCl2, 0.476 g of HEPES buffer in 100 ml of 
water, pH 7.2 followed by the addition of 0.5 ml Triton X) at 4 °C for 5 minutes. Then, the 
samples were incubated in 1 % bovine serum albumin (BSA) in PBS at room temperature 
for 30 minutes to block reactive sites and therefore decrease background fluorescence. For 
vinculin staining, samples were then treated with a mouse monoclonal anti-vinculin (Sigma, 
V9131, UK) diluted to 1:400 in 1 % BSA / PBS for 1 hour at room temperature. For integrin 
staining, samples were treated with monoclonal antibodies against α5 (Millipore, AB1928, 
USA, anti rabbit), β1 (BD Pharmingen, (EG7, USA, anti rat) and αVβ3 (Millipore, LM609, 
USA, anti mouse). These were then washed 3 times for 5 minutes (last wash on a shaker) in 
0.5 % Tween 20 / PBS. For vinculin detection, a Cy-3-conjugated polyclonal rabbit anti-
mouse secondary antibody (Jackson Immunoresearch, UK), diluted 1:200 in 1 % BSA / PBS, 
with 1:200 BODIPY FL-conjugated phallacidin (Invitrogen, UK) was added and incubated 
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for 1 hour at room temperature in the absence of light. For the integrins, secondary antibodies 
against rabbit for α5 (FITC 1:2000), rat for β1 (RFP 1:2000) and mouse for αVβ3 (Cy5 
1:2000) (Jackson Immunoresearch, UK) were used.  Samples were again washed 3 times for 
5 minutes in 0.5 % Tween 20 / PBS and mounted using Vectashield containing DAPI (Vector 
Laboratories, UK). Samples were then viewed under a fluorescence microscope (Zeiss 
AxioObserver- Z1). 
 
2.5.2 Osteogenic differentiation 
 
After 3 weeks, cells were fixed using 4 % formaldehyde in PBS at 37 °C for 15 minutes. 
Fixative was removed and washed with PBS before the addition of permeabilising buffer 
(10.3 g of sucrose, 0.292 g of NaCl, 0.06 g of MgCl2, 0.476 g of HEPES buffer in 100 ml 
of water, pH 7.2 followed by the addition of 0.5ml Triton X) for 5 minutes at 4 °C. 
Permeabilising buffer was removed and PBS/BSA 1 % was added for 5 minutes at 37 °C to 
block reactive sites. This was followed by the addition of the primary antibody (1:50 in 
PBS/BSA 1 %) osteocalcin (OCN, mouse monoclonal, sc-365797, UK) and osteopontin 
(OPN, mouse monoclonal, sc-21742, UK) (Santa Cruz Biotechnology, UK) for 1 and a half 
hours at 37 °C. 100 µL was added to ensure the coverslips were submerged.  The samples 
were next washed with 0.5 % Tween 20 in 100 mL PBS 3 times for 5 minutes. A secondary, 
biotin-conjugated antibody (1:50 in PBS/BSA, monoclonal horse antimouse (IgG), (Vector 
Laboratories) was added for 1 hour at 37 °C followed by washing with 0.5 % Tween 20 in 
100 mL PBS 3 times for 5 minutes.  Simultaneously, rhodamine-conjugated phalloidin was 
added for the duration of this incubation (1:50 in PBS/BSA 1 %, Life Technologies).  A 
FITC-conjugated streptavidin third layer was added (1:50 in PBS/BSA 1 %, Vector 
Laboratories) at 4 °C for 30 minutes, and given a final wash with 0.5 % Tween 20 in 100 
mL PBS 3 times for 5 minutes. The coverslips were then inverted onto glass slides with 
DAPI stain (Vector Laboratories, UK). Samples were then viewed under a fluorescence 
microscope (Zeiss AxioObserver- Z1). 
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Table 2.1. Antibodies and suppliers used in this thesis. 
 
 
 
 
 
 
 
 
 
 
2.6 von Kossa staining 
 
MSCs were seeded at 5,000 cells/cm2 and cultured on freshly prepared FN coated glass and 
L. lactis-FN biofilms for 28 days. Cells were fixed with 4 % formaldehyde in ultrapure water 
for 5 minutes and then a 5 % silver nitrate solution in H2O was added to ensure the coverslips 
were fully submerged and exposed to UV light for 30 minutes. After washing in deionised 
water, 5 % sodium thiosulphate was added to the samples for 10 minutes and then samples 
were washed with warm tap water for 10 minutes. After another wash with deionised water, 
the samples were counterstained with nuclear fast red for 10 minutes and washed again with 
deionised water. Finally the samples were rinsed with 70 % ethanol and observed in a phase-
contrast optical microscope (Zeiss Axio Observer-Z1). 
 
2.7 Bacterial viability 
 
To study viability of the bacteria, the BacLight LIVE/DEAD kit (Life Technologies, UK) 
was used. Biofilms were grown as mentioned previously and transferred to DMEM, DMEM 
was supplemented with either 1 % penicillin-streptomycin (P/S), DMEM with 10 µg/mL 
tetracycline (TC)  or DMEM with 5 and 10 µg/mL sulfamethoxazole and viability was tested 
at 1, 2, 3 and 4 weeks. The biofilm was washed once with sterile NaCl 0.85 % w/v solution 
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and incubated for 30 minutes using SYTO9 (5 µM) and propidium iodide (30 µM) in NaCl 
0.85 % w/v. After this, the samples were washed with PBS and mounted using Vectashield 
without DAPI (Vector Laboratories, UK) and imaged immediately on a Zeiss AxioObserver- 
Z1. The viability was determined as the ratio between the viable and total number of bacteria. 
ImageJ was used to analyse the pictures taken.  
 
 
2.8 Image analysis 
 
Image analysis was completed using the Fiji-ImageJ software (Schindelin, Arganda-Carreras 
et al. 2012). Images were acquired using a Zeiss AxioObserver Z1 (unless stated otherwise) 
fitted with an Andor camera. 10, 20, 40 and 63 x objectives were used and images were 
saved in 8-bit per channel RGB BMP format.  
2.9 Statistical analysis 
 
All statistical analysis was performed with GraphPad Prism 6. One way or two way 
ANOVAs (analysis of variance) were completed depending on the data present (two way 
ANOVAs were completed when grouped data was tested against two independent variables). 
A one way ANOVA was used when there were more than two independent groups (not 
grouped data). A two way ANOVA was used for group data as its purpose is to test if there 
is an interaction between the two independent variables on the dependent variable. Firstly, 
data was checked for normality to determine the type of post-hoc test used. If data were 
normally distributed, a Tukey post-hoc test was used. Conversely, for data that were not 
normally distributed, a Bonferroni post-hoc test was used. Statistical significance levels are 
indicated by a number of one to four asterisks that indicate the following levels of 
significance: *p < 0.05, **p < 0.01, ***P < 0.001 and ****p < 0.0001.  
38 
 
 
3. Cell-bacteria co-cultures and initial 
differentiation studies 
 
 
 
 
Summary 
This chapter focusses on the effect of the fibronectin (FN) fragment (FNIII7-10) on cell 
adhesion and the ability of the interface to sustain mesenchymal stem cell (MSC) 
differentiation in response to externally added bone morphogenetic protein-2 (BMP-2). 
C2C12 murine myoblasts and MSCs were cultured on FNIII7-10 and non-FN expressing 
bacteria (from here on denoted L. lactis-FN and L. lactis-empty respectively) and their 
behaviour was assessed. BMP-2 was added to the medium to induce osteogenic 
differentiation and compared to a control surface of FN coated glass. The results demonstrate 
that differentiation on the biofilm is approximately equal to that of a FN coated surface.  
 
 
 
*Results in this chapter are partially published in: Hay, J. J., Rodrigo-Navarro, A., Hassi, K., 
Moulisova, V., Dalby, M. J., & Salmeron-Sanchez, M. (2016). Living biointerfaces based 
on non-pathogenic bacteria support stem cell differentiation. Scientific reports, 6. 
10.1038/srep21809 
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3.1 Introduction 
 
The requirement for synthetic materials that mimic the characteristics of the extracellular 
matrix (ECM) is essential in biomedical engineering to comprehend the complex and 
dynamic behaviour of cells. Cells interact with different structures of the ECM, namely via 
physical interactions such as cell geometry and topography at the micro and nanoscale, these 
micro or nanoenvironments can be used to ultimately control cell behaviour or direct cell 
fate (Pittenger 2008, Guilak, Cohen et al. 2009). Previously, samples have been coated with 
a layer of adhesive proteins such as fibronectin (FN), peptides or growth factors as cells are 
incapable of direct interaction with biomaterials (Grinnell 1986, Dsouza, Ginsberg et al. 
1991, Aumailley and Gayraud 1998, Hench and Polak 2002, Shin, Jo et al. 2003). These 
surfaces are static and provide cells with only one behavioural cue, therefore engineering 
dynamic surfaces that allow controlled regulation is now at the forefront of biomedical 
engineering. These surfaces have the potential to provide spatiotemporal triggers that can 
recapitulate critical characteristics of the ECM and can therefore be used in myriad 
biomedical fields, ranging from tissue engineering to molecular biology. There have been 
many recent attempts at synthetic replication of the ECM, a large percentage of which use 
an extracellular trigger to alter the surrounding environment  which can direct cellular 
behaviour, these include light (Wirkner, Weis et al. 2011, Lee, Garcia et al. 2015), 
temperature (Ebara, Yamato et al. 2004) and enzymes (Todd, Scurr et al. 2009, Zelzer, Scurr 
et al. 2012). Significant efforts have been directed toward utilising the adhesive peptide 
arginine-glycine-aspartic acid (RGD), found in many extracellular matrix proteins such as 
FN, vitronectin and laminin allowing the user to control cell adhesion (Pierschbacher et al, 
1983). We hypothesise that biofilms formed by non-pathogenic bacteria can be utilised to 
accomplish a successful dynamic surface. They can be genetically modified to express or 
secrete different proteins which can be used to direct cell behaviour and ultimately control 
stem cell fate. In that case, bacterial cell to mammalian cell communication can be facilitated 
on the level of the bacterial biofilm interface due to bacterial capability to colonise many 
different biomaterials to form a monolayer.  
This chapter focuses on highlighting the dynamic interaction between bacterial and 
mammalian cells by using different microscopic techniques, such as scanning electron 
microscopy and immunofluorescence, compounded with molecular techniques. This chapter 
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also shows the ability of the interface to sustain mesenchymal stem cell (MSC) 
differentiation.  
We use the previously characterised L. lactis strain that constitutively expresses, via the P1 
lactococcal promoter, a fusion protein made of the FNIII7-10 fragment of the human 
fibronectin with GFP fused upstream, as a reporter protein (Saadeddin, Rodrigo-Navarro et 
al. 2013, Rodrigo-Navarro, Rico et al. 2014, Hay, Rodrigo-Navarro et al. 2016). This protein 
is efficiently located in the bacterial cell wall by using a secretion peptide and an anchoring 
signal. The expressed FNIII7-10 fragment contains the RGD adhesion motif on the III9 repeat 
and the PHSRN synergy motif on the III10 repeat. These two motifs interact with the α5β1 
integrin, amongst others (Giancotti and Ruoslahti 1999).  
 
In this chapter, we show C2C12 murine myoblast and MSC behaviour in response to the 
FNIII7-10 exposed on the bacterial cell wall shown in Figure 3.1A. In addition to the adhesive 
cue from the FNIII7-10 fragment, the osteogenic growth factor, bone morphogenetic protein 
2 (BMP-2) (mechanism shown in Figure 3.1B) can induce the differentiation of MSCs 
towards osteoblasts.  
 
BMP-2 binds to cells via BMPRs (bone morphogenetic protein receptors), of which there 
are many. BMP-2 signalling is initiated upon BMP-2 binding to BMPRI and the subsequent 
recruitment of other BMRPs is essential for proper signal propagation. Normally, two of 
each type of BMPRI and BMPRII are needed to form a ternary homocomplex which leads 
to the activation of SMADs. SMADs are a group of intracellular proteins that transduce 
extracellular signals into downstream gene activation. In terms of BMP-2, BMPR activation 
leads to the recruitment of the pathway restricted SMADs 1 5 and 8 which recruit the 
common mediator SMAD 4 (Itoh, Itoh et al. 2000, Moustakas, Souchelnytskyi et al. 2001, 
Derynck and Zhang 2003). This complex migrates to the nucleus and induces expression of 
osteogenic genes in the nucleus, represented in Figure 3.1 B (Hay, Rodrigo-Navarro et al. 
2016).   
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Figure 3.1. Conceptual overview of the system. (A) L. lactis biofilm expressing the III7–10 fragment of 
the human fibronectin on its cell wall, fused to green fluorescent protein (GFP) as a reporter, acting as a 
biointerface for bone marrow-derived human mesenchymal stem cells. (B) Recombinant human BMP-2 
(rhBMP-2) was added in the cell culture medium at 100 ng/mL to induce osteogenic differentiation. 
BMPR1/2 signalling through the Smad pathway leads to activation of the transcription factors Osterix, 
RunX2 and Dlx5 which induces expression of proteins involved in osteogenic differentiation (Hay, 
Rodrigo-Navarro et al. 2016). 
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3.2 Materials and methods 
 
3.2.1 Scanning electron microscopy (SEM) 
 
MSCs and C2C12s were seeded at 5,000 cells/cm2 and were fixed in either 2 % 
glutaraldehyde / 2 % paraformaldehyde / 0.15 M sodium cacodylate buffer / 0.15 % alcian 
blue for 2 hours at 4 °C or in 1.5% glutaraldehyde/0.1 M sodium cacodylate buffer fix for 1 
hour at 4 °C. After fixation, these were then washed with 0.15 M sodium cacodylate buffer 
5 times before 1 hour incubation in 1 % osmium tetroxide/0.1 M sodium cacodylate buffer. 
Samples were then washed 3 times in distilled water and stained with 0.5 % uranyl 
acetate/distilled water for 1 hour in the dark. Samples were washed again with distilled water 
before dehydration through an ethanol gradient (30 %, 50 %, 70 % and 90 % for 10 minutes 
each) with 100 % ethanol used 4 times 5 minutes to fully dry the sample. Samples were then 
loaded onto a POLARON E3000 Critical Point Dryer (Liquid CO2) for 1 hour 20 minutes 
and then given a gold/palladium coat using a POLARON SC515 SEM COATER and viewed 
on a JEOL6400 SEM running at 10 kilovolts. 
 
3.2.2 Quantitative real-time PCR (qPCR) 
 
qPCR protocol is split into 3 sections: 
1. RNA extraction 
A cell density of 20,000 cells/cm2 were used for qPCR experiments. Cells were grown for 
14 days in the same conditions as stated previously on fibronectin coated and L. lactis-FN 
coated PEA coverslips. RNA extraction was performed using the Qiagen RNA extraction 
kit, briefly: cells were lysed with RLT buffer and homogenised prior to the addition of 70 % 
ethanol. Samples were then transferred to an RNeasy MinElute spin column and centrifuged 
for 30 seconds at 8000 g and the flow through was discarded. Buffer RW1 was added to the 
column and centrifuged for 30 seconds at 8000 g and the flow through was discarded. DNase 
stock solution was added to buffer RDD and mixed. This was then added to the columns and 
left for 15 minutes at room temperature. Buffer RW1 was added to the columns and 
centrifuged for 30 seconds at 8000 g and the collection tube was discarded. A new collection 
tube was added and buffer RPE was added to the column and spun for 30 seconds at 8000 g 
and flow through was discarded. Next, 80 % ethanol was added and centrifuged for 2 minutes 
at 8000 g and collection tube discarded. A new collection tube was added and the column 
was spun at full speed for 5 minutes to dry the membrane and the collection tube was 
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discarded. A new collection tube was added and RNase free water was added to the column 
and centrifuged for 1 minute at 16,000 g and the collection tube was kept.  
 
2. Reverse transcription 
200 ng of template RNA (when possible) was added to a tube containing reverse 
transcriptase master mix (Qiagen) and incubated for 15 mins at 42 °C before raising the 
temperature to 92 °C for 3 minutes. 
 
3. Quantification 
qPCR was performed on an ABi7500 thermal cycler using the SYBR Green relative standard 
method. The SYBR Green master mix was bought from Applied Biosystems, which 
comprises SYBR Green I dye, AmpliTaq DNA polymerase, dNTPs with dUTP, and a PCR 
reaction buffer. SYBR Green I dye detects double-stranded DNA, AmpliTaq DNA 
polymerase synthesises new DNA, and the dUTP reduces carryover contamination. qPCR 
was started with the cDNAs for each sample and each sample was scaled down to its 
corresponding RNA concentration of 5 ng/µL. SYBR Green master mix, 2 µL of primer pair 
(forward and reverse primer) and 1 µL of cDNA sample were mixed up to a final volume of 
20 µL for each well (cells isolated from six well plate). Negative controls (samples without 
reverse transcriptase) and blanks (reactions without cDNA samples) were made to ensure 
the correct functionality through the monitoring of genomic DNA contamination and 
substrate fluorescence background respectively. Three technical replicates were run for each 
experiment. The samples were initially treated with heat activation for 5 minutes at 95 °C, 
that was followed by a 2 step cycle of 10 seconds at 95 °C and 30 seconds at 60 °C for 40 
cycles to allow for elongation. Gene expression was normalised against the house keeping 
gene, GAPDH (primers shown in Table 3.1).  
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Primers were synthesised using the Roche universal probe library assay design centre. 
 
 
      Table 3.2. Primers used in the qPCR gene expression analysis. 
Gene Pair Sequence (5' - 3') 
Alcam Forward ACG ATG AGG CAG AGA TAA CT 
Self Renewal Reverse CAG CAA GGA GAC CAA C 
CD63 Forward GCT GTG GGG CTG CTA ACT AC 
Self Renewal Reverse ATC CCA CAG CCC ACA GTA AC 
Osteocalcin Forward CAG CGA GGT AGT GAA GAG ACC 
Osteogenic Reverse TCT GGA GTT TAT TTG GGA GCA G 
Osteopontin Forward AGC TGG ATG ACC AGA GTG CT 
Osteogenic Reverse TGA AAT TCA TGG CTG TGG AA 
GAPDH Forward TCA AGG CTG AGA ACG GGA A 
Housekeeping Reverse TGG GTG GCA GTG ATG GCA 
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3.3 Results 
 
It is important to note that the strain of bacteria used in this chapter is the previously 
characterised MG1363. This strain and the FNIII7-10 have been characterised in previous 
publications (Saadeddin, Rodrigo-Navarro et al. 2013, Rodrigo-Navarro, Rico et al. 2014, 
Hay, Rodrigo-Navarro et al. 2016) and a thesis and have been used in this chapter to highlight 
MSC behavior at longer time points.  The future chapters highlight the use of different 
strains, namely NZ9000 and NZ9020.  
 
3.3.1 Bacterial viability and metabolism 
MSCs require four weeks for terminal differentiation to osteoblasts (Stein, Lian et al. 1990, 
Pittenger, Mackay et al. 1999, Agarwal, Gonzalez-Garcia et al. 2015) and thus it was 
imperative to deduce bacterial viability up to this time point as the stability of the biofilm 
modulates cell adhesion. Previous to this work, the biofilms were seeded over glass 
coverslips as the maximum culture time used was four days (Rodrigo-Navarro, Rico et al. 
2014). However, upon culturing the biofilm for longer time points, it became apparent that 
a new surface was needed as large areas of the biofilm began to detach from the surface after 
seven days. Glass is a hydrophilic surface, and whilst keeping viability values high (~60 %), 
the relatively weak adhesion was insufficient to allow long term biofilm formation.  
To overcome this obstacle, we used the synthetic polymer poly (ethyl acrylate) (PEA). This 
has previously been used in mammalian cell culture (Salmeron-Sanchez, Rico et al. 2011) 
and was found to be particularly well suited for bacterial adhesion (An and Friedman 1998, 
van Oss, Wu et al. 1998, Van Oss 2002). PEA is a hydrophobic, non-biodegradable polymer 
and thus, is a good choice for bacterial adhesion. The strain of L. lactis used in these 
experiments was MG1363, a derivative of L. lactis subsp. cremoris TIL672, which features 
a hydrophobic surface. The extended Derjaguin-Landau-Verwey-Overbeek model 
(XDLVO) (Bayoudh, Othmane et al. 2009) states that hydrophobicity plays an important 
role in surface interaction. This model explains the interaction in terms of surface free energy 
of the interacting surfaces, and considers the solid-bacteria, solid-liquid and bacteria-liquid 
interfaces when calculating the free energy. A practical explanation at the molecular level is 
that the interaction between two apolar moieties immersed in water is the consequence of 
hydrogen-bonding energy of cohesion of the water molecules surrounding them, and 
therefore, a hydrophobic surface is a stronger candidate for bacterial adhesion and biofilm 
creation, at least with this strain.  Nevertheless, L. lactis proliferate continuously if nutrients 
are available and convert any suitable carbon source into lactic acid (De Vuyst and 
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Vandamme 1992). The build-up of this organic acid unavoidably leads to a decrease in pH 
of the medium, which is detrimental to mammalian cell viability. It has been previously 
outlined that tetracycline (TC) used at 10 µg/mL is sufficient to impede bacterial metabolism 
without affecting mammalian cells for up to four days (Rodrigo-Navarro, Rico et al. 2014).  
TC is a bacteriostatic antibiotic that inhibits bacterial protein synthesis by binding to the 30S 
subunit of bacterial ribosomes, which hinders the attachment of charged aminoacyl tRNA 
(transfer Ribonucleic acid) to the A site (Geigenmuller and Nierhaus 1986). Due to the 
differentiation characteristics of MSCs, it was essential to increase this time course up to 
four weeks. To increase the efficiency of lactic acid retardation, a mixture of 
penicillin/streptomycin (P/S) at 100 U/mL was also tested.  P/S is a bactericidal antibiotic 
and interferes with the synthesis of the peptidoglycan cell wall, leading to cell lysis (Park 
and Strominger 1957). These approaches were chosen in an attempt to control the biofilm in 
a bacteriostatic manner by preventing initial cell death and avoiding acidification of the 
medium. Figure 3.2 shows L. lactis-FN viability at 1, 2, 3 and 4 weeks. 
 
 
 
 
Figure 3.2. L. lactis biofilm viability. Biofilms of L. lactis-FN were produced on a poly (ethyl acrylate) (PEA) 
surface and cultured for one to four weeks with DMEM, DMEM supplemented with 100 U/mL of 
penicillinstreptomycin (DMEM+ P/S) and DMEM supplemented with 10 μg/mL tetracycline (DMEM+ TC). (A) 
After the selected time points, biofilms were washed and their viability assessed using the commercial BacLight 
viability kit (Life Technologies). This kit stains viable cells in green and non-viable cells in red. Viability was 
calculated by analysing the total amount of cells stained in green versus the amount of cells stained in red and 
green. (B) After three weeks, viability values were found to be higher in biofilms cultured with DMEM or 
DMEM+ TC than in biofilms cultured with DMEM+ P/S. This result might be attributed to the fact that P/S is 
bacteriolytic in comparison to TC, which is bacteriostatic. There is an increase in viability values of the four week 
biofilms that can be attributed to the detachment of non-viable cells. Scale bar size is 50 μ m. 10 images were 
taken per condition from three technical replicates. Data is presented as mean ±  SD, and was analysed with a one 
way ANOVA test with a Tukey post-hoc test. Statistical significance levels are *p <  0.05 and ***p <  0.001. 
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 L. lactis-empty was not investigated as this strain has been proven to be unable to bind 
integrins and thus mammalian cells cannot attach due to the lack of adhesive cues from the 
FNIII7-10 fragment (Saadeddin, Rodrigo-Navarro et al. 2013, Rodrigo-Navarro, Rico et al. 
2014, Hay, Rodrigo-Navarro et al. 2016). L. lactis could be seen to have formed stable 
biofilms at all-time points on the material surface (Figure 3.2A). Figure 3.2B shows the 
percentage of living bacteria calculated by analysing the total number of living cells (green) 
versus the total cell number, stated as living cells (green) plus dead cells (red) from Figure 
3.2A. Bacterial viability was constant at approximately 50 % after one week with the highest 
viability value found in the antibiotic free samples. After two weeks, viability was again 
seen to be similar between the sample sets, and had increased to approximately 55 %. After 
three weeks the viability for DMEM + P/S (44 %) was found to be significantly lower than 
in DMEM (63 %) and DMEM + TC (63 %). This difference was further confirmed by the 
four week result, again, the viability for bacteria grown in DMEM + P/S (47 %) was 
significantly lower than both the DMEM (81 %) and DMEM + TC (85 %) conditions. The 
data shown in Figure 3.2 initially suggests that viability increases as a function of time. It is 
apparent from Figure 3.3 that as time increases, the surface density of the biofilm decreases.  
Figure 3.3 shows the surface coverage of the biofilm in colony forming units. These graphs 
confirm what can be inferred from Figure 3.2A. After two weeks of culture, large portions 
of the biofilm begin to detach from the surface. Non-viable cells would detach from the 
surface, and the presence of antibiotic prevents further proliferation of the populations, thus 
increasing the ratio of viable to non-viable bacteria. However, it can be seen that after four 
weeks, bacteria are still present on the substrate surface with a similar morphology to those 
observed at shorter time points.  
 
 
 
Figure 3.3. Biofilm coverage after one, two, three and four weeks. Biofilm coverage was calculated as the 
percentage of the surface covered by bacteria, expressed as cfu (colony forming units) per square milimeter. We 
found that a large proportion of the biofilm had detached as the culture time increased, explaining the rise in 
viability found in Figure 3.2. This results suggests that biofilms produced on PEA, a hydrophobic polymer, can 
serve as a substrate for long-term stem cell culture. 10 images were quantified per condition from three technical 
replicates. Data is presented as mean ±  SD, and was analysed with a one way ANOVA test with a Tukey post-
hoc test. Statistical significance levels are *p < 0.05, **p < 0.01  and ***p < 0.001.   
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3.3.2 Cell adhesion and morphology 
Cell adhesion was assessed through scanning electron microscopy (SEM) and vinculin 
immunostaining. Firstly, C2C12 murine myoblast cells were seeded over L. lactis-empty, L. 
lactis-FN and FN coated glass for three hours. These experiments were completed in the 
absence of FBS (unless stated otherwise), to rule out the presence of any FN deposition from 
serum influencing the material surface, except for that displayed by L. lactis-FN or the FN 
coat. Figure 3.4 shows SEM images of C2C12s seeded over L. lactis-empty biofilms after 
three hours. It can be seen from this that cells remain in a rounded morphology, and show 
no protrusions or lamellipodia to attach to the surface.  
 
 
Figure 3.5 shows SEM images of C2C12 cells seeded over L. lactis-FN biofilms. It is 
instantly apparent from Figure 3.5A that cell morphology is drastically affected by the 
presence of the FNIII7-10 fragment in the bacterial cell wall. Cells can be seen to spread and 
form filopodia. Figure 3.5B is a magnified portion of 3.5A shown by the red square and 
shows a cellular protrusion over four bacteria. Figure 3.5C and 3.5D clearly show a filopodia 
like projection from the cell straight to the cell wall of a bacteria. This evidence suggests 
that the FNIII7-10 fragment available in the bacterial cell wall is able to induce cell adhesion.  
Figure 3.6 shows SEM images of C2C12 cells seeded over a FN coated glass coverslip after 
three hours. Again, the difference in morphology between these cells and the cells on the L. 
lactis-empty is clear (Figure 3.4). Cell morphology is similar between the FN coat and L. 
lactis-FN. These results support the work completed previously (Saadeddin, Rodrigo-
Navarro et al. 2013, Rodrigo-Navarro, Rico et al. 2014). On the L. lactis-empty, no adhesion 
Figure 3.4. High magnification SEM images of C2C12 murine myoblasts seeded over L. lactis-empty after 
three hours. The mammalian cells can be seen as the larger spherical shapes, whereas the bacteria can be seen 
as clusters of smaller spheres. The mammalian cells can be seen as rounded forming no protrusions to the 
bacteria. Scale bar = 2 µm. 
49 
 
can occur as there are no proteins present that allow integrin interaction and thus the cells 
remain in a rounded morphology. On both the L. lactis-FN and FN coated surface, 
mammalian cell integrins can associate with the RGD domains of FN and spread.  
 
These images shown (Figures 3.4, 3.5 and 3.6) were taken after fixing the cells with 1.5 % 
glutaraldehyde/0.1 M sodium cacodylate buffer mix. It was noted that there was a major 
difference between these images and when the sample was viewed under the microscope 
before the fixation process, an extremely large proportion of bacteria had dissociated from 
the sample. The experiment was repeated and the fixation process was altered with the 
addition of 0.15 % alcian blue, a cationic fixative that allows for a higher degree of bacterial 
fixation (Erlandsen, Kristich et al. 2004). This allows us to have a more accurate 
representation of what was occurring on the coverslip. Figure 3.7 shows SEM images of 
C2C12 cells seeded over L. lactis-empty (A and B) and L. lactis-FN (C and D) after three 
hours. Figure 3.7A and 3.7C show low magnification images of the cellular interaction with 
Figure 3.5. Low (A and C) and high magnification (B and D)  SEM images of C2C12 murine 
myoblasts interacting with L. lactis-FN after three hours. (A). C2C12 cells are spread with a magnified 
region (red square) shown in B. This magnified image shows an extension of the cell on top of  four 
bacteria. (C). A region of a C2C12 cell with a filopodia like projection contacting the cell wall of a 
bacterial cell with a magnified region shown in D (red sqaure). These images confirm the presence of 
FNIII7-10 in the cell wall of the bacteria induce mammalian cell spreading and adhesion. Scale bar = 10 and 
2 µm for A and C respectively. 
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L. lactis-empty and L. lactis-FN respectively. Many more bacteria can be seen utilising this 
fixation method when compared with the previous method, even with the same seeding 
density. Figure 3.7B and 3.7D (larger image seen in Annex Figure 8.1) show high resolution 
images of the cellular interaction with L. lactis-empty and L. lactis-FN respectively. Figure 
3.7B shows four rounded C2C12 cells surrounded by bacteria, which is in stark contrast to 
the images shown in Figure 3.4. Figure 3.7D shows two spread C2C12 cells, again, 
surrounded by bacteria. The C2C12s fixed with this method can be seen to interact 
(highlighted with the red arrows, larger image found in Annex Fig 8.1) with many more 
bacteria than seen in Figure 3.5. Fixation with this method allows for a more representative 
image of what is occurring on the coverslip.  
MSCs ability to interact with L. lactis-FN compared to FN coated surface and L. lactis-empty 
were next assessed. MSC spreading after three hours was found to be directly related to the 
availability of FN to the MSCs. Figure 3.8 shows SEM images after three hours (without 
FBS) and 1 week (with FBS) of MSC culture. From these images, it became apparent that 
the FNIII7-10 fragment in the bacterial cell wall is essential to develop adhesion structures 
after three hours, since MSCs cultured on top of L. lactis-empty biofilms kept a rounded 
shape, with no sign of adhesion. The morphology of the MSCs on the FN coated surface and 
L. lactis-FN appear similar. It is clear that the initial cell interaction determines cell 
morphology and it is distinctly affected by the availability of the FNIII7-10 fragment on the 
bacterial cell wall. After one week, cell morphology on all surfaces becomes more similar. 
This is likely due to the addition of 1 % foetal bovine serum (FBS) to the culture media, 
which is necessary to ensure the viability of the MSCs in the long-term. 
Figure 3.6. Low magnification SEM images of C2C12 murine myoblasts seeded over FN coated glass 
after 3 hours. The cells can be seen to form a spread morphology, adhered to the surface. These cells 
strognly resemble the shape of the mammalian cells on the L. lactis-FN sample. Scale bar = 20 µm. 
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Figure 3.7. Low and high magnification SEM images of C2C12 murine myoblasts under alcian blue fixitive 
after 3 hours. Many more bacteria can be seen utilising this fixative when compared with the previous method 
giving a much more accurate representation of what is occuring on the coverslip. A and B represent cells on the L. 
lactis-empty(low and high magnification respectively) samples. C and D represent cells on the L. lactis-FN (low 
and high magnification respectively) samples. A larger picture of D can be seen in the Annex Figure 8.1. It can be 
seen in D that the cells have many more protrusion structures to bacteria (highlighted by the red arrows). Scale bar 
= 50 µm for A and C  and 10 µm for B and D. 
52 
 
 
 
After initial SEM studies, MSC adhesion was explored through vinculin immunostaining, a 
protein present in focal adhesion complexes (Humphries, Wang et al. 2007, del Rio, Perez-
Jimenez et al. 2009, Kanchanawong, Shtengel et al. 2010, Case, Baird et al. 2015). This 
experiment was completed to ascertain if there were any changes in focal adhesion 
complexes across the surfaces. Figure 3.9 shows vinculin staining on the surfaces after three 
hours and one day. After three hours, MSCs cultured on L. lactis-empty display a rounded 
morphology with no signs of adhesion, a result similar to SEM. Whereas MSCs cultured on 
the FN coated surface and L. lactis-FN display evidence of spreading and adhesion; the 
nascent focal adhesions could be seen at the edges of the cell lamellae (see arrows Figure 
3.9). After one day, cells on all surfaces have spread and adhered to the surfaces. The 
presence of vinculin on the L. lactis-empty is likely due to the addition of FBS to the media. 
FBS contains many proteins and molecules essential for long term cell culture such as, 
albumin, antichymotrpsin, apolipoproteins, biotin, and growth supporting factors, however, 
it also comprises many cell adhesive glycoproteins which become adsorbed to the sample 
surface (Hayman and Ruoslahti 1979, Zheng, Baker et al. 2006). Nevertheless, and more 
Figure 3.8. Morphological study of the hMSCs by SEM. MSC behaviour on the L. lactis-FN and L. 
lactis-empty biofilms, and FN-coated surface was assessed by scanning electron microscopy. Cells were 
cultured for three hours in absence of FBS and for one week with 1 % FBS, in this case to ensure cell 
viability. MSCs cultured for three hours on the L. lactis-empty biofilm kept a round shape, while in the 
L. lactis-FN and in the FN-coated surface showed adherence and spreading. On the other hand, in the 
one week cultures, due to the need to use FBS to ensure viability, cells showed an elongated shape with 
evidences of adhesion behaviour. Nevertheless, MSCs showed different features in the L. lactis-FN 
compared to the L. lactis-empty biofilm, this behaviour can be attributed to the presence of the III7–10  
fragment exposed on the L. lactis cell wall. Cells cultured on the FN-coated surface displayed higher 
proliferation ratios. Scale bar = 20 μm. 
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critically, MSCs cultured on the FN coat and L. lactis-FN displayed many more and more 
developed focal adhesions, which is highlighted by the larger dash morphology when 
compared against L. lactis-empty, where the adhesions are strictly punctate, dot shaped focal 
complexes.  
Focal adhesions were again explored after three and seven days (Figure 3.10A). All cells 
display adhesion complexes and a spread morphology, regardless of the sample surface. This 
may again be due to the presence of FN, amongst other adhesive proteins in the FBS (Taub 
1990). After cells become attached to a surface, they begin to secrete their own matrix, 
allowing other cells to migrate and grow. After three days, it can inferred from the graphs 
(Figure 3.10B) that the FBS, combined with the matrix secreted by the cells has allowed cell 
adhesion to become uniform across all sample sets. 
 
 
Figure 3.9. Adhesion assessment of hMSCs cultured on L. lactis-empty, L. lactis-FN and FN-coated 
surface. Cells were cultured for three hours in absence of FBS and one day with 1 % FBS with an initial 
density of 5,000 cells/ cm2. After selected times, cells were fixed and immunostained against vinculin (red) 
and DAPI (blue). MSCs cultured for three hours in the L. lactis-empty biofilm showed no sign of adhesion, 
keeping a round shape, while in the L. lactis-FN and FN surfaces there is evidence of spreading and 
adhesion, although focal adhesion complexes are not fully developed. After one day, there are focal 
adhesion (FA) complexes in the three different conditions; the presence of FA in cells cultured on L. lactis-
empty biofilm is most probably due to the presence of FBS in the medium. Cells cultured on the L. lactis-
FN biofilm and FN-coated surface displayed more developed FA complexes compared to L. lactis-empty 
biofilm, suggesting that the already present fibronectin in the surface (either on the L. lactis cell wall or 
grafted on the surface) enhances the development of this FA complexes. Scale bar = 50 μm. 
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Figure 3.10. Long term focal adhesion analysis. Image A shows focal adhesion analysis performed on 
MSCs after three and seven days of culture on L. lactis-empty, L. lactis-FN and FN coated glass. MSCs 
were cultured in DMEM supplemented with 10 µg/mL tetracycline and 1 % FBS and after the selected time 
points, fixed and immunostained for vinculin (red), while nuclei were stained with DAPI (blue). A 
minimum of 12 individual, isolated cells per condition were analysed to check area and number of focal 
adhesion complexes. The graphs in B show that there is no difference between focal adhesion distribution 
between time, nor surfaces, probably due to the fact that the FBS added to the cell culture medium is 
helping in the initial adhesion steps, via fibronectin, vitronectin and collagen present in the serum. After 
this initial adhesion, MSCs start to secrete their own ECM proteins, leading to a very similar behavioural 
profile across the sample sets. A minimum of 24 cells were used per condition from three technical 
replicates. Data was analysed with a one way ANOVA test with a Tukey post-hoc test. No statistical 
differences were seen.  Scale bar = 50 μm. 
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After vinculin staining, a more specific staining for integrins was completed. Figure 3.11 
shows integrin (α5, β1 and αvβ3) staining of MSCs on differently functionalised glass 
coverslips after 75 minutes. 75 minutes was chosen as a time point as after this time, the 
cells begin to secrete their own matrix and integrin binding begins to become more uniform 
(Sternlicht and Werb 2001). This experiment was set up to highlight if the FNIII7-10 
expressing strain engages α5β1 compared to αvβ3. This is due to the fact that our FNIII7-10 
fragment houses PHSRN and RGD, which is thought to be essential for α5β1 binding (Ebara, 
Yamato et al. 2008). 
As can be seen from Figure 3.11 the samples that display no FN (no FN coat and L. lactis-
empty) show rounded cells, indicative of no adhesion. Cells seeded upon coverslips 
functionalised with either a FN coat or FNIII7-10 expressing L. lactis are spread, with good 
integrin staining in all channels. It is apparent that αvβ3 staining is higher on the FN coat 
than in L. lactis-FN as can be seen in the graphs in Figure 3.12. The α5 and β1 channels on 
the L. lactis-FN confirm good co-localisation of these integrin subunits, which can be seen 
in the composite images. Focal adhesion structure can be seen to be distinctly different in 
the FN positive and negative samples. In the FN positive samples, integrin structures are 
seen to be much larger and more numerous as can be seen by the dashed morphology. 
Conversely, the samples without FN display structures that are dot shaped and more 
punctate. These results are highly similar to the three hour vinculin staining shown 
previously (Figures 3.9 and 3.10).  
The number of unique focal adhesions, integrin area per cell and average integrin cluster size 
in MSCs was calculated from the images analysing 16 cells per condition. The samples on 
surfaces with no FN are not shown for average integrin cluster size as upon quantifying the 
samples, it became apparent that the low number of focal adhesions relative to integrin area 
per cell resulted in an extremely high average integrin size per cell. As can be seen from 
Figure 3.12A, the number of unique focal adhesions per cell is greatly increased on the FN 
coated surfaces when compared against surfaces without FN. In the L. lactis-FN sample, α5 
shows the highest number of unique adhesion structures, whereas on the FN coat, αvβ3 
shows the highest number of adhesions. Figure 3.12B displays the average integrin area per 
cell and shows that cells on surfaces without FN have a much lower total integrin area than 
FN functionalised surfaces with α5 having the highest area per cell in L. lactis-FN. 
Conversely, integrin area is almost uniform across α5, β1 and αvβ3 on the FN coat. Most 
interestingly, L. lactis-FN displays a similar integrin area per cell for αvβ3 to the non-FN 
expressing cells. Figure 3.12C displays the average integrin size. It can be noted that average 
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integrin cluster size was highest on the FN coat. Integrin cluster size on the FN coat is fairly 
uniform with α5, β1 and αvβ3 all displaying similar areas with no statistically significantly 
different focal adhesion sizes. Contrariwise, on the L. lactis-FN samples, αvβ3 shows the 
smallest integrin size with α5 and β1 being roughly equivalent.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11. Immunofluorescent images of MSCs stained for integrin α5, β1 and αVβ3. Cells 
were fixed 75 minutes after seeding. Images were taken at 63x, from top to bottom, no FN coat, L. 
lactis empty, FN coat and L. lactis-FN and from left to right, composite image, α5, β1 and αVβ3. 
Cell spreading was seen in all FN samples. Scale bar = 50 µm. 
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The differences in integrin binding between the FN coat and L. lactis-FN may be explained 
by the structure of FN and how integrins interact with FN. L. lactis-FN only displays FNIII7-
10 which houses the RGD and PHSRN motifs whereas the FN coat displays the whole 
molecule. On the FN coat, average focal adhesion area is seen to be higher for all integrins 
than for L. lactis-FN showing that the natural protein is able to induce a better cell response. 
There is a statistically significant difference between αvβ3 and α5 on the L. lactis-FN 
whereas there is no difference on the FN coat. This difference in integrin binding on L. lactis-
FN could be due to the binding of α5β1 to RGD in the presence of PHSRN when there is an 
absence of the whole FN protein. This data describes a preferential binding of α5β1 over 
αvβ3 for MSCs seeded over L. lactis-FN. 
 
3.3.3 Mesenchymal stem cell differentiation 
 
Immunohistochemistry 
 
BMP-2 was used to determine the ability of the biofilm to sustain MSC differentiation 
towards an osteoblastic phenotype. The bone specific proteins osteocalcin (OCN), 
osteopontin (OPN) as well as phosphate deposition (von Kossa) as part of matrix 
mineralisation were used to determine the reaction of MSCs to the addition of 100 ng/mL 
BMP-2. Figure 3.13 shows OCN staining after 21 days. Cells were cultured on FN coated 
glass as a control, and L. lactis-FN. Samples treated with 100 ng/mL BMP-2 show 
statistically significantly more OCN than non-treated samples by factors of 7.6 and 3 on the 
Figure 3.12. Graphs detailing integrin adhesion after 75 minutes. Graphs were constructed from 16 
pictures per sample. A = Number of unique focal adhesions, B = integrin area per cell and C = Average 
integrin size. Cells seeded over non-FN samples show low adhesion number and integrin area, conversely, 
cells on FN samples show more and larger adhesion structures. Cells on L. lactis samples do not use αvβ3 as 
regularly as on a FN coated surface. A minimum of 16 cells were analysed per condition from three technical 
replicates. Data is presented as mean ± SD, and was analysed with a one way ANOVA test with a Tukey 
post-hoc test. * p < 0.05, ** p < 0.01 and **** p < 0.0001. 
 
58 
 
FN coated surface and the L. lactis-FN surfaces respectively as can be seen in Figure 3.13A.  
Moreover, both samples with added BMP-2 were found to be statistically similar (p < 0.05). 
Both samples with added BMP-2 showed high variance in the data as seen by the large error 
bars. Upon viewing the cells under fluorescence microscopy, it became apparent that some 
cells showed high amounts of OCN whereas some cells showed very little or no stain 
whatsoever (as shown in Figure 3.13A), this is the cause of the high standard deviation 
shown in Figure 3.13B. This could also be caused by undesired differentiation of the MSCs 
as well as ‘stemness’ retention as these cells would not produce any OCN. Standard 
deviation was low across the samples with no BMP-2 addition showing similar results were 
found in all replicates. These results demonstrate that the biofilm can sustain MSC 
differentiation.  Figure 3.13C shows the number of cells per coverslip. Samples without 
added BMP-2 showed higher cell numbers in both sample sets. The cell count on the biofilm 
was found to be higher than on the FN in both the BMP-2 positive (statistically significant 
p < 0.05) and negative media (p < 0.001). This is likely caused by cell cycle inhibition. In 
terminal somatic cell culture models, inhibition of the cell cycle is usually a requisite for 
differentiation, and vice versa (Lathrop, Thomas et al. 1985, Budirahardja and Gonczy 2009, 
Hindley and Philpott 2012). By adding a growth factor to the medium, we can pull the cells 
from the cell cycle and hence proliferation, and force them to enter terminal differentiation.  
Figure 3.14 shows OPN staining after 21 days. Cells were cultured on FN coated glass and 
L. lactis-FN, both with and without 100 ng/mL BMP-2. More OPN was found in the BMP-
2 positive samples on both substrates, by a factor of 1.6 (statistically significant p < 0.01) 
and 1.1 (not statistically significant) for the FN coated glass and L. lactis-FN respectively as 
can be seen in Figure 3.14B. The differences in expression of OPN compared to OCN are 
not as striking, but do give a positive result. The fact that all cells are seen to express OPN 
(green area surrounding the nucleus) shows that all cells have begun differentiation towards 
an osteoblastic phenotype, this may be a phenomenon of the surface characteristics, and 
stiffer surfaces favour osteoblastic differentiation (Engler, Sen et al. 2006). The fact that 
BMP-2 addition only increases differentiation levels leads us to the conclusion that the 
growth factor is indeed responsible for the additional differentiation. 
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Figure 3.13. Osteocalcin and cell count after three weeks of culture. A. Cells stained for osteocalcin 
(green), actin (red) and DNA (blue) from left to right: FN 0 ng/mL BMP-2, FN 100ng/mL BMP-2, L. 
lactis-FN 0 ng/mL BMP-2 and L. lactis-FN  100 ng/mL BMP-2. B. Graph shows OCN area per cell ± 
standard deviation of the sample sets (460, 269, 452 and 386 cells respectively). Total integrated density 
corresponding to the green channel (osteocalcin) was quantified using ImageJ. C. Graph shows MSCs 
per coverslip ± standard deviation of the sample sets (2226, 1684, 2639 and 2295 cells respectively) 
from three technical replicates. OCN expression was much higher on the samples with added BMP-2. 
Data is presented as mean ± SD and analysed with a one way ANOVA with a Tukey post-hoc test, * p < 
0.05, ** p < 0.01 and *** p < 0.001. Scale bar = 50 µm. 
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Figure 3.14. Osteopontin production by cells. A. Cells were grown for three weeks and stained for 
OPN (green), actin (red) and the nucleus (blue), the top row shows MSCs grown on FN coated PEA 
glass coverslips, the bottom row shows MSCs grown on L. lactis-FN PEA glass coverslips. The first 
column denotes 0 ng/mL BMP-2 and the second with 100 ng/mL BMP-2. B. Graph shows OPN area per 
cell ± standard deviation of the sample sets (572, 347, 562 and 402 cells respectively) from three 
technical replicates. OPN expression was roughly equivalent across sample sets, with the exception of 
FN + 100 ng/mL BMP-2 where more OPN was observed. Data is presented as mean ± SD and was 
analysed with a one way ANOVA test with a Tukey post-hoc test. Statistical significance levels are *p <  
0.05, **p < 0.01.  Scale bar = 100 µm. 
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In addition to differentiation, it was important to check whether the bacteria were still present 
after three weeks of co-culture. Figure 3.15 shows that the biofilm is still visible and marked 
as purple dots, with the MSC nuclei in blue. It is abundantly clear that the bacterial density 
is lower than at the beginning, where the coverage can be as high as 27%, but in this case in 
particular, where L. lactis is providing only the adhesion cue, the importance of the biofilm 
is less essential than the differentiation cues provided by the BMP-2 supplemented in the 
medium. Further to this, the sample preparation involved in immunohistochemistry staining 
washes out a large proportion of the bacteria.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Matrix mineralisation 
 
 
A third population of MSCs were grown for 28 days before analysing phosphate deposition 
shown in Figure 3.16. Matrix mineralisation was assessed via a von Kossa stain. Active 
osteoblasts deposit phosphate as a primary step of bone development and is therefore 
suggestive of terminal osteogenic differentiation. As can be seen from Figure 3.16, little 
phosphate deposition has been observed in the BMP-2 negative samples. In comparison, 
distinctly more phosphate (black deposits highlighted by red arrows) could be found in the 
BMP-2 positive samples thus showing that mineralisation of the ECM has occurred, a 
prerequisite for successful bone formation.  
Together, the results confirm the ability of the living interface to support long-term MSC 
viability and trigger functionality, including mature differentiation with deposition of 
mineralised matrix.  
 
 
Figure 3.15. Cell and bacterial coverage after 3 weeks. Reconstructed DAPI images from left to right, 
cells were cultured on a FN-coated surface with and without BMP-2 at 100 ng/mL and on L. lactis-FN 
biofilm, again with and without BMP-2 at 100 ng/mL. Mammalian cell nuclei are seen in blue and bacterial 
DNA are seen in purple. Mammalian cells can still be seen after 3 weeks in co-culture with bacterial cells.  
Scale bar = 50 µm. 
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Gene expression analysis 
A fourth population of MSCs were grown at 20,000 cells per cm2 for 14 days on FN and L. 
lactis-FN with and without 100 ng/mL BMP-2. Cells were grown in the same medium as 
previous experiments; however, the number of cells was increased to aid in the harvesting 
of enough RNA for qPCR analysis.  The gene expression profiles of MSCs after two weeks 
of culture are shown in Figure 3.17 (normalised to glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH)). The most notable difference can be seen between the BMP-2 
A B 
C D 
Figure 3.16. Extracellular matrix mineralisation. Mineralisation (phosphate deposition) was 
assessed with a von Kossa stain. MSCs were cultured for 28 days on a surface coated with FN (top 
row) and on L. lactis-FN biofilms (bottom row). After staining, cells were imaged in a Zeiss 
AxioObserver Z1 microscope using phase contrast. Cultures treated with BMP-2 showed black areas 
corresponding to phosphate deposits produced by the MSCs, while in the untreated cultures there is no 
evidence of mineralization. Scale bar size is 300 μm. 
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positive and BMP-2 negative samples in which the expression of the ‘stemness’ markers 
ALCAM and CD63 are down-regulated in comparison with the BMP-2 negative samples. 
This illustrates the reduction in the expression of ‘stemness’ related mRNA and thus a 
decrease in protein expression therefore altering the cells behaviour and consequently, 
phenotype.  
However, the expression of the osteogenic markers OPN and OCN display a similar 
expression level. After two weeks of culture, these markers are expected to be upregulated 
in an osteogenic culture (Yang, McNamara et al. 2014). Lian and Stein et al. described 
different markers of osteogenesis at differing time points, and OCN and OPN are shown as 
later markers (three or four weeks as opposed to two used in the experiment) (Stein, Lian et 
al. 1990). However, compounded with the previous histological and matrix mineralisation 
results, showing a large increase in OCN levels after three weeks and phosphate deposition 
after four weeks under the same conditions, it seems sensible to assume osteogenic 
differentiation has occurred. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17. Gene expression analysis of MSCs after 14 days. From left to right, cells were cultured on 
a FN-coated surface with and without BMP-2 at 100 ng/mL and on L. lactis-FN biofilm, again with and 
without BMP-2 at 100 ng/mL. The gene expression has been normalised to glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH).The most notable difference can be seen in the self-renewal genes, ALCAM 
and CD63 where their expression is downregulated in the BMP-2 positive samples. Three technical 
replicates were used per condition. Data is presented as mean ± SD and was analysed with a two way 
ANOVA with a Tukey post-hoc test. No statistical differences were found. 
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3.4 Discussion 
 
In vivo, adult stem cells survive within a specialised environment known as the niche (Yin 
and Li 2006, Li and Clevers 2010). The niche is made up of both cellular and non-cellular 
components, including resident stem cells, support cells, and the ECM that, together, 
regulate stem cell self-renewal (Engelhardt 2001, Yin and Li 2006, Xie 2008, Li and Clevers 
2010, Mendez-Ferrer, Michurina et al. 2010). Once these cells are removed from their 
natural environment and placed on tissue culture plastics, which are distinctly different from 
the in vivo niche, MSCs begin to spontaneously differentiate into a heterogeneous population 
of mainly fibroblasts (Papadimitropoulos, Piccinini et al. 2014). This is undesirable for tissue 
engineering and provides a large obstacle in regenerative medicine.  
Previous attempts at synthesising a dynamic niche for MSC proliferation and differentiation 
include the functionalisation of material surfaces with cell adhesive motifs, or incorporating 
protease degradable fragments in polymer hydrogels that allow changes in the material 
structure as cells secrete proteases to remodel the ECM (Garcia, Vega et al. 1999, Todd, 
Scurr et al. 2009, Khetan, Guvendiren et al. 2013). Dynamic surfaces have also been 
engineered to present cell adhesive RGD domains on demand (Todd, Scurr et al. 2009, 
Zelzer, Scurr et al. 2012, Weis, Lee et al. 2013, Roberts, Sahoo et al. 2016). In addition to 
adhesion, the dynamic release of growth factors in a controlled way to support cell 
differentiation have been tested (Lutolf and Hubbell 2005, Ma 2008, Makarenkova, Hoffman 
et al. 2009, Moon, Hahn et al. 2009, Silva, Richard et al. 2009, Phelps, Landazuri et al. 
2010).  
As seen in previous publications (Rodrigo-Navarro, Rico et al. 2014, Hay, Rodrigo-Navarro 
et al. 2016), a system has been proposed where mammalian cells can survive and 
differentiate on engineered non-pathogenic bacteria. This genetically engineered strain of L. 
lactis, a food grade, gram-positive bacterium with very low production of lipopolysaccharide 
(LPS) has been modified to present a fibronectin fragment (III7-10) tethered to its 
peptidoglycan layer by the Staphylococcus aureus protein A, making it available for 
mammalian cell integrins. This fragment houses the RGD and PHSRN synergy sequences 
which promotes cell adhesion and differentiation (Aumailley, Gurrath et al. 1991, Dsouza, 
Ginsberg et al. 1991, Salmeron-Sanchez and Dalby 2016). We have shown that this FNIII7-
10 fragment can induce adhesion in a variety of cell lines including NIH3T3, C2C12 and 
MSCs, and that the intracellular cascades activated are the same as when the cells are seeded 
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over FN coated glass (Saadeddin, Rodrigo-Navarro et al. 2013, Rodrigo-Navarro, Rico et al. 
2014).  
The FNIII7-10 fragment contains the RGD adhesion and the PHSRN synergy motifs. RGD 
interacts with a wide variety of integrins, however, when combined with the synergy motif, 
a specific interaction with integrin α5β1 is able to occur. Signalling initiated with this 
specific integrin has been linked to enhanced osteogenic differentiation in MSCs (Agarwal, 
Gonzalez-Garcia et al. 2015). In addition to FNIII7-10, the known osteoinducer BMP-2 has 
also been used. The combination of FNIII7-10 expressed in the bacterial cell wall and BMP-
2 added to the culture media has proven an effective means of inducing osteoblastic 
differentiation in MSCs.  
This bacterial strain produces stable biofilms that allow us to co-culture mammalian cells. 
The formation of the biofilm begins when individual bacteria begin to adhere to the surface. 
This process is governed by weak non-specific forces such as Van der Waals and polar Lewis 
acid-base interactions (Nishiyama, Sugiyama et al. 2016). This is an initial adherence, and 
can easily be reversed. Bacterial cells can increase their adherence through the use of cell-
wall anchored proteins (CWAPs), these are also known as adhesins. L. lactis has several 
prominent anchor proteins, the most notable being CluA (Godon, Jury et al. 1994, Stentz, 
Jury et al. 2004) sex factor and the PrtP and NisP proteinases (Godon, Jury et al. 1994, 
Habimana, Le Goff et al. 2007, Giaouris, Chapot-Chartier et al. 2009). The required force to 
detach the bacteria from the surface is increased and allows for more bacteria to co-aggregate 
to the existing ones. The adhesins act by actively remodelling the bacterial surface and lead 
to the irreversible attachment to the surface. A bacterial community is now established and 
the bacteria can proliferate and develop the biofilm. L. lactis is a bacterial species that 
produces a low amount of exopolysaccharide and therefore their biofilms usually show a 
monolayered morphology, lacking the stratified structure found in many other species 
(Gulot, Georges et al. 2002, Habimana, Meyrand et al. 2009, Saadeddin, Rodrigo-Navarro 
et al. 2013). 
Previously, L. lactis biofilms were developed on glass, a hydrophilic surface, and were found 
to be stable for at least four days in co-culture with mammalian cells (Pittenger 2008). As 
our experiments were running for four weeks (28 days), it was essential to select an 
appropriate surface to allow stable bacterial attachment for the time course. A stronger 
interaction was needed between the biofilm and the underlying surface. To allow for this, a 
change in material was needed. Surface hydrophobicity plays a role, as is explained by the 
XDLVO theory (Bayoudh, Othmane et al. 2009) and therefore a switch to a more 
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hydrophobic surface was chosen, more specifically,  poly (ethyl acrylate) (PEA), spin coated 
onto glass coverslips to form a thin layer. PEA is a hydrophobic, non-biodegradable 
synthetic polymer that showed excellent adhesive properties for L. lactis. Glass covered with 
this polymer were found to support good bacterial viability, similar to those found on glass 
at shorter time points. Moreover, these biofilms were found to be stable for at least 28 days, 
even in the presence of the bacteriostatic antibiotic TC. TC was used to impede bacterial 
metabolism and prevent acidification of the medium, enabling survival of the mammalian 
cells. The basis of using PEA as an alternative to glass is due to the interaction between the 
bacterial cell wall and the surface. Our L. lactis strain MG1363 and NZ9000 are derivatives 
of the subspecies cremoris TIL672 which feature hydrophobic surfaces (Giaouris, Chapot-
Chartier et al. 2009). Observations had been made on many occasions, that when this strain 
is grown in M17 media, they tend to aggregate together to form chains, indicative of its 
hydrophobicity. The XDLVO theory describes the interaction in terms of free energy of the 
interacting surfaces (Bayoudh, Othmane et al. 2009). The interaction is not distant dependent 
and hydrophobic surfaces interact better together than hydrophobic-hydrophilic. A practical 
explanation at the molecular level is that the interaction between two apolar moieties 
immersed in water is the consequence of the hydrogen bonding energy of cohesion of the 
water molecules surrounding them. Therefore, the use of a hydrophobic surface is better 
suited to support biofilm development, at least with this strain. For other strains, an 
evaluation of their hydrophobicity should be completed to optimise and improve biofilm 
development.  
The combination of these factors, that is, improved biofilm stability, the bacterially 
expressed FNIII7-10 compounded by its integrin related signalling and BMP-2 induced 
phenotypical change lead to improved osteogenic differentiation in MSCs when compared 
to FNIII7-10 signalling alone.  
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3.5 Conclusion 
 
This chapter has shown that engineered bacteria can be used as an interface between a 
synthetic surface and mammalian cells to control adhesion and sustain differentiation. 
Firstly, conditions were optimised to maintain stable biofilms for up to four weeks to allow 
terminal MSC differentiation. More specifically, there is very little difference between a 
fibronectin coated surface and our modified bacteria in terms of adhesion and differentiation 
and that the bacteria holds an advantage over a simple fibronectin coat, in that it can be 
further modified to produce a superfluity of proteins or growth factors that can be used to 
alter and direct cell fate. This is advantageous over current systems in that the bacteria can 
be controlled to express proteins in a spatiotemporal manner; something that is currently 
unavailable in the literature. We aim to control the interface to allow MSC self-renewal and 
differentiation, which can then be applied to aid in many strategies to promote tissue repair 
and regeneration.  
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4. Lactococcus lactis cloning and 
characterisation 
 
 
 
 
Summary 
This chapter focusses on the cloning of bone morphogenetic protein 2 (BMP-2) into the 
relevant plasmids and their transformation into Lactococcus lactis.  Both constitutive and 
inducible expression of BMP-2 was completed and characterised by fusing the biologically 
active protein to GFP or a hexahistidine tag. The well characterised nisin controlled gene 
expression system was used to control temporal induction of BMP-2 and FNIII7-10 fragments. 
The results demonstrate that the new L. lactis is viable and can display BMP-2 and FNIII7-
10 in an inducible fashion. 
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4.1 Introduction 
 
Microbes are ever present in the surrounding environment and are postulated to have been 
present on earth for 2 billion years before any other living organism (Corliss 1975). They 
are as such, ubiquitous and have colonised a vast array of environments including the living 
bodies of most, if not all living organisms (Sagan 1967), have formed colonies on land and 
in the deepest oceans, can be found in arctic ice and hot springs, and even in the stratosphere 
(Ferris, Muyzer et al. 1996, Huston, Krieger-Brockett et al. 2000, Wainwright, 
Wickramasinghe et al. 2004, Hazen, Dubinsky et al. 2010). Bacteria were first witnessed by 
Anton van Leeuwenhoek in the mid-17th century and since, have become extensively studied 
(Lane 2015).  
Since their discovery, it has been proven that microbes play a significant role in the lifestyle 
and industry of humans. Some cause disease in humans and animals, initiating an economic 
burden as well as affecting health. On the contrary, some bacteria have proved very useful 
in industry, particularly in the petroleum, agriculture and food industries. These ‘useful’ 
bacteria, that is, the ones that are not pathogenic, can be exploited to provide beneficial 
outcomes, both in health and in industry. This idea of exploitation is not new, some of the 
earliest biotechnology used prokaryotes in the production of cheese, bread and yoghurt. 
Cheese production is thought to have originated sometime between 4000-7000 years ago, 
and thus biotechnology was being used long before the term was coined (Campbellplatt 
1994).  
The arrival of molecular and synthetic biology has rapidly revolutionised microbiology, 
through the use of recombinant strains and has opened new possibilities for industry and 
medicine. The first documented experiments using foreign DNA was in 1944, where DNA 
from the bacterium Streptococcus pneumonia was found to transfer to a genetically different 
bacterium and its subsequent recombination into the host-cell genome (Avery, Macleod et 
al. 1944). Ensuing studies substantiated that genetic alteration of a recipient cell can be due 
to the uptake of exogenous extrachromosomal DNA such as plasmids.  
Plasmids are defined as extrachromosomal genetic elements capable of stable autonomous 
replication in a cell and were first introduced by the molecular biologist Joshua Lederberg 
in 1952 (Lederberg and Lederberg 1952). Usually, bacterial plasmids are initially recognised 
by the phenotypic properties they confer on a cell, for example, the ability to promote genetic 
transfer by conjugation, resistance to drugs and some metal ions, and production of antibiotic 
proteins and toxins. They are typically smaller in size compared to the genome, but a 
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bacterium can contain hundreds or thousands of copies of the plasmid (copy number). Many 
beneficial characteristics have been engineered into plasmids, which allow the user to 
convey wanted phenotypes to the cell (Debruijn and Lupski 1984). Microbiologists can 
insert genes, operons or cassettes that give a selective advantage to the host bacterium, often 
an antibiotic resistance, which allows the selection of the bacterium harbouring the 
favourable plasmid against the wild type species (Laddy and Weiner 2006). Many positive 
uses of bacteria have originated through plasmid engineering, such as lactose fermentation 
(Efstathiou and McKay 1977), proteinase activity (Efstathiou and Mckay 1976) and 
bacteriophage resistance (Labrie, Samson et al. 2010), amongst many others. Conversely, 
numerous pathogenic and toxin producing strains harbour their virulence factors on plasmids 
(Evans, Silver et al. 1975). Scientists can exploit the genetic machinery of bacteria as 
plasmid vectors allow the delivery of foreign DNA into a cell, to be replicated and 
maintained in the new host. As such, recombinant DNA technology relies on the alteration 
of plasmids. We can design plasmids that produce therapeutically advantageous or 
industrially relevant proteins to combat their associated problems.  
More specifically, lactic acid bacteria (LAB), such as Lactococcus lactis have a long history 
of benevolent use by humans. They have been used in food production and as probiotics 
agents to promote human wellbeing (Cano-Garrido, Seras-Franzoso et al. 2015). Some 
species of LAB, including L. lactis are generally regarded as safe (GRAS) by the US Food 
and Drug Administration (FDA) and fulfil criteria of the qualified presumption of safety 
(QPS) according to the European Food Safety Authority (EFSA). Besides their characteristic 
safety, a great effort has been put toward developing effective molecular tools to use LAB 
as cell factories for the production of proteins of interest. The lack of effective approaches 
for regenerative medicine has driven the way for LAB to become an appealing option for 
biologists to deliver therapeutic molecules to sites of interest. These bacteria have already 
been used as vectors for delivering functionally active proteins to mucosal tissues for the 
treatment of gastrointestinal diseases, diabetes, cancer and viral infections (Steidler, Wells 
et al. 1995, Steidler, Viaene et al. 1998, Schotte, Steidler et al. 2000). A distinctive advantage 
of LAB over current technologies is the significant decrease in the cost of treatment. These 
are living organisms and as such would be able to autonomously replicate and synthesise the 
proteins of interest at the site of delivery.  
A novel system has been created where mammalian cells directly interact with L. lactis 
through a fragment of fibronectin (FNIII7-10) (Saadeddin, Rodrigo-Navarro et al. 2013, 
Rodrigo-Navarro, Rico et al. 2014, Hay, Rodrigo-Navarro et al. 2016). Further to this, these 
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bacteria can be further modified to allow the production of a potent osteogenic growth factor, 
bone morphogenetic protein 2 (BMP-2) in a variety of forms. The direct contact of 
mesenchymal stem cells (MSCs) with L. lactis through the FNIII7-10 fragment will allow the 
precise delivery of BMP-2 directly to the cells. This combination of cell adhesion and growth 
factor delivery is hypothesised to allow a currently unmet differentiation platform for MSCs. 
This, compounded by the presence of inducible plasmids allows the user to control the exact 
amount of growth factor delivery and adhesion to tailor exact MSC differentiation.  
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4.2 Materials and Methods 
 
4.2.1 Cloning 
 
A summary of the cloning procedure is as follows: 
The plasmid pGEM-T-BMP2, shown in Figure 4.1 was purchased from Sino Biological and 
transformed into E. coli. The biologically active part of the BMP-2 preprotein was isolated 
and amplified by PCR from the plasmid after miniprep and cloned into pT1NX, between the 
usp45 secretion peptide and spaX anchor protein. Depending on whether we wanted cell wall 
bound or secreted expression, the spaX was either made part of the open reading frame or a 
stop codon was placed before the spaX gene. The plasmids were created using Gibson 
Assembly and were transformed into electrocompetent L. lactis with exact methods 
described below.  
The primers used to isolate the biologically active form of BMP-2 from pGEM-T-BMP2 
(Figure 4.1) are shown below:  
 
Table 4.1. Isolation of BMP-2 from pGEM-T-BMP2. 
 
 
 
 
 
 
 
Primer Sequence 5’-3’ 3’ Annealing 
Temperature 
BMP-2 Forward ‘GTCAGGTGTTTACGCCCAAGCCAAACACAAA
CAGC’ 
 62.4 °C 
BMP-2 Reverse ‘TCTTCCTCTTTTGGATCCTAGCGACACCCACA
ACC’ 
 62.4 °C 
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4.2.2 Transformation of chemically competent Escherichia coli (E.coli) 
 
Firstly, agar plates and media were prepared for E.coli from Luria-Bertani (LB) media which 
contains: 10 g/L tryptone, 10 g/L NaCl and 5 g/L yeast extract, for plates, 1.5 % agar was 
added (Sambrook 2001). After sterilisation by autoclaving, 100 µg/mL ampicillin for 
pGEM-T (Sino Biological) was added. 100 ng of the plasmid pGEM-T-BMP2 was 
transferred into NEB 5-alpha competent E. coli (high efficiency) cells and incubated on ice 
for 30 minutes. These were then heat shocked at 42 °C for 30 seconds then placed on ice for 
5 minutes. 950 µL of Super Optimal broth with Catabolite repression (SOC) was added and 
the cells were incubated at 37 °C for 1 hour at 250 rpm before being spread on agar plates 
and incubated overnight at 37 °C. These transformed cells were then inoculated in LB media 
and left to grow overnight at 37 °C.  A glycerinate was prepared by adding 15% v/v of sterile 
glycerol to the bacterial culture and then stored at -80 °C for further work.  
Figure 4.1. Schematic representation of the commercially available pGEM-T-BMP-2 used in this 
thesis. 
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4.2.3 E. coli culture 
 
Escherichia coli is a gram-negative aerobic strain which grows in Luria Broth, composed of 
10 g/L tryptone, 5 g/L NaCl and 10 g/L yeast extract. This media is then sterilised at 126 °C 
for 30 minutes. E. coli has an optimal growth temperature of 37 °C with shaking, in aerobic 
conditions (open container). The agar plates were prepared by adding 1 % w/v of agar, 
sterilising at 126 °C for 20 minutes and pouring into Petri dishes supplemented with the 
appropriate amounts of antibiotic when needed. Freshly prepared LB agar plates can be 
stored at 4 °C for several weeks in closed containers. 
 
4.2.4 Plasmid isolation from E.coli 
 
Bacteria were lysed using the manufacturer’s guidelines (GenElute HP Five-Minute Plasmid 
Miniprep Kit, Sigma Aldrich). Briefly, 40 µL lysis reagent was added to 400 µL of overnight 
culture in a collection tube and mixed thoroughly before a 2 minute incubation at room 
temperature. 500 µL of column preparation solution were centrifuged at maximum speed for 
15 seconds to prepare the columns, discarding the flow-through. 400 µL of binding solution 
was added to the lysate and mixed by inverting at least 15 times. This mixture was then 
transferred to a prewashed binding column and centrifuged for 20 seconds, the flow through 
was discarded. The column was twice washed using 700 and 200 µL of washing buffer and 
centrifuged for 20 and 30 seconds respectively, also discarding the flow-through. Finally, 40 
µL of water was used to recover the plasmid DNA, by centrifugation at maximum speed for 
30 seconds and the plasmid was stored at -20 °C. All centrifugation steps were completed at 
maximum speed, usually 20,000 g.  
4.2.5 Plasmid purification 
 
Post miniprep and PCR, plasmid purification is necessary to remove salts and left over 
nucleotides and leave pure plasmid for downstream experiments. The PureLink Quick Gel 
Extraction and PCR Purification Combo Kit from ThermoFisher was used following the 
manufacturer’s guidelines.  Briefly, columns were prepared by incubating 500 µL 10 % HCl 
for 5 minutes before 3 washes with 650 µL of nuclease-free water being centrifuged through 
the column at 16,000 g for 30 seconds. Four volumes of binding buffer was added to the 
PCR mix and loaded into the spin columns and centrifuged for 1 minute at 10,000 g. The 
flow through was discarded and 650 µL of wash buffer was added to the column before 
spinning for 1 minute at 10,000 g. The flow through was discarded and the column was then 
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centrifuged at maximum speed for 3 minutes. The column was then placed in a new 
collection tube and 40 µL of nuclease-free water was added to the column and left to incubate 
for 2 minutes. This was then centrifuged at maximum speed for 1 minute and the DNA 
product collected and stored at -20 °C until use.  
4.2.6 Preparation of L. lactis electrocompetent cells 
 
2 mL culture of L. lactis was grown overnight in M17 medium supplemented with 1 % 
glycine and inoculated into 200 mL of fresh M17 with 1 % glycine and grown at 30 °C. Once 
the culture had reached an optical density (OD) of 0.6-0.8 at 660 nm the cells were harvested 
by centrifugation at 3000 g for 10 minutes at 4 °C. This pellet was then washed 3 times in a 
sterile ice-cold solution of 10 % v/v glycerol and 0.5 M sucrose in ultrapure water. The cells 
were then resuspended in 1 % of the same wash solution and aliquoted at volumes of 50 µL, 
flash-frozen in liquid nitrogen and stored at -80 °C. Cells stored at this temperature are able 
to keep their electrocompetency for approximately 6 months.  
4.2.7 Polymerase chain reaction (PCR)  
 
PCR reactions were carried out on a ThermoFisher ProFlex PCR System (ThermoFisher) 
using Q5 High-Fidelity DNA Polymerase (New England Biolabs). 
PCR programs were set up as shown: 
1. 1st denaturation step: 2 minutes at 95 °C 
2. 35 amplification steps: 
Denaturation, 30 seconds at 95 °C 
Annealing, 30 seconds at the annealing temperature of each pair of primers 
Extension, 30 seconds per kilobase of DNA at 72 °C 
3. Final extension step: 72 °C for 2 minutes 
Specific primers are annealing temperatures are shown below:  
Primers were designed using New England Biolab’s NEBuilder assembly tool and purchased 
from ThermoFisher. 
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Table 4.2. Primers for constitutively secreted biologically active BMP-2 (Usp45-BMP-2). 
 
Table 4.3. Primers for constitutively secreted BMP-2-GFP (Usp45-BMP-2-GFP). 
 
Table 4.4. Primers for constitutively cell wall bound BMP-2 (Usp45-BMP-2-spaX). 
 
 
 
 
 
 
Primer Sequence 5’-3’ 3’ Annealing 
Temperature 
Forward BMP-2  ‘GTCAGGTGTTTACGCCCAAGCCAAACACAAA
CAGCG’ 
66.4 °C 
Reverse BMP-2  ‘TCTTCCTCTTTTGGATCTTAGCGACACCCACA
ACCCTC’ 
66.4 °C 
pT1NX Forward ‘TAAGATCCAAAAGAGGAAGACAAC’ 61.6 °C 
pT1NX Reverse ‘TGATCCACCTCCACCTGATCCTCCACCACCGG
CGTAAACACCTGACAAC’ 
61.6 °C 
Primer Sequence 5’-3’ 3’ Annealing 
Temperature 
Forward GFP ‘CGTTGTCAGGTGTTTACGCCATGGGTAAAGG
AGAAGAAC’ 
59 °C 
Reverse GFP ‘CTCCACCACCGTATAGTTCATCCATGCCATG’ 59 °C 
pT1NX Forward ‘CTAGTAGATCCGGCTGCTAAC’ 64.7 °C 
pT1NX Reverse ‘GGCGTAAACACCTGACAAC’ 64.7 °C 
Linker-BMP-2 
Forward 
‘TGAACTATACGGTGGTGGAGGATCAGGT’ 65.8 °C 
Linker-BMP-2 
Reverse 
‘TTAGCAGCCGGATCTACTAGTTAGCGACACC
CACAACC’ 
65.8 °C 
Primer Sequence 5’-3’ 3’ Annealing 
Temperature 
Forward BMP-2  ‘GTCAGGTGTTTACGCCCAAGCCAAACACAAA
CAGCG’ 
66.4 °C 
Reverse BMP-2  ‘TCTTCCTCTTTTGGATCGCGACACCCACAACC
CTC’ 
66.4 °C 
pT1NX Forward ‘ GATCCAAAAGAGGAAGACAATAAC’ 62.1 °C 
pT1NX Reverse ‘ GGCGTAAACACCTGACAAC’ 62.1 °C 
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Table 4.5. Primers for constitutively cell wall bound BMP-2-GFP (Usp45-GFP-BMP-2-spaX). 
 
Table 4.6. Primers for inducible secreted bound BMP-2-6xHis (Usp45-6xHis-BMP-2). 
 
Table 4.7. Primers for inducible cell wall bound BMP-2-6xHis (Usp45-6xHis-BMP-2-spaX). 
 
 
Primer Sequence 5’-3’ 3’ Annealing 
Temperature 
Forward GFP ‘CGTTGTCAGGTGTTTACGCCATGGGTAAAGG
AGAAGAAC’ 
59 °C 
Reverse GFP ‘CGCTGTTTGTGTTTGGCTTGGTATAGTTCATC
CATGCCATG’ 
59 °C 
pT1NX -BMP-
2-spaX Forward 
‘CAAGCCAAACACAAACAG’ 64.7 °C 
pT1NX-BMP-2-
spaX Reverse 
‘GGCGTAAACACCTGACAAC’ 64.7 °C 
Primer Sequence 5’-3’ 3’ Annealing 
Temperature 
Forward BMP-2 ‘CGTTGTCAGGTGTTTACGCCCATCACCATCA
CCACCATCAAGCCAAACACAAACAGCG’ 
66 °C 
Reverse BMP-2 ‘GCAGTACCCATGGCCGTGCCTTAGCGACACC
CACAACCCTC’ 
66 °C 
pNZ8123-BMP-
2- Forward 
‘TAAGGCACGGCCATGGGTACT’ 
 
70 °C 
pNZ8123-BMP-
2- Reverse 
‘ATGGTGGTGATGGTGATGGGCGTAAACACC
TGACAAC’ 
 
70 °C 
Primer Sequence 5’-3’ 3’ Annealing 
Temperature 
Forward BMP-2 ‘CGTTGTCAGGTGTTTACGCCCATCACCATCA
CCACCATCAAGCCAAACACAAACAG’ 
 
60 °C 
Reverse BMP-2 ‘GCAGTACCCATGGCCGTGCCTTATAGTTCGC
GACGACG’ 
 
60 °C 
pNZ8123 -
BMP-2-spaX 
Forward 
‘’GGCACGGCCATGGGTACT’ 
 
 
65 °C 
pNz8123-BMP-
2-spaX Reverse 
‘ATGGTGGTGATGGTGATGGGCGTAAACACC
TGACAAC’ 
 
65 °C 
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Table 4.8. Primers for inducible cell wall FNIII7-10-GFP (Usp45-GFP-FNIII7-10-spaX). 
 
Table 4.9. Primers for inserting chloramphenicol into pT1NX for the creation of pT2NX. 
 
4.2.8 Gibson Assembly 
 
To join PCR products together to form new plasmids, the Gibson Assembly Master Mix 
(New England Biolabs) was used. The workflow for a reaction is as follows: 
The fragment and vector were mixed in a 2:1 ratio (between 0.03 – 0.2 pmol) in a 0.2 mL 
microtube before adding the equivalent volume of Gibson Master Mix. This was then 
incubated for 15 minutes at 50 °C before diluting the volume four times with water. The 
assembled construct was then transformed into electrocompetent L. lactis. 
 
 
Primer Sequence 5’-3’ 3’ Annealing 
Temperature 
Forward GFP ‘CGTTGTCAGGTGTTTACGCCATGGGTAAAGG
AGAAGAACTTTT’ 
62 °C 
Reverse GFP ‘GCAGTACCCATGGCCGTGCCTTATAGTTCGC
GACGACG’ 
62 °C 
pNZ8123 -FN-
spaX Forward 
‘GGCACGGCCATGGGTACT’ 
 
 
70 °C 
pNZ8123-FN-
spaX Reverse 
‘GGCGTAAACACCTGACAACGG’ 
 
 
70 °C 
Primer Sequence 5’-3’ 3’ Annealing 
Temperature 
Forward 
chloramphenicol 
‘TTCTATGAGTCGCTTTTG’ 56.9 °C 
Reverse 
chloramphenicol 
‘GTAATCACTCCTTCTTAATTACAAATTTTTA
G’ 
56.9 °C 
pT1NX Forward ‘AATTAAGAAGGAGTGATTACATGAACTTTA
ATAAAATTGATTTAGACAATTG’ 
 
57.3 °C 
pT1NX Reverse ‘TACAAAAGCGACTCATAGAATTATAAAAGC
CAGTCATTAGG’ 
 
57.3 °C 
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4.2.9 Electroporation of L. lactis 
 
50 µL of frozen competent L. lactis and sterile electroporation cuvettes (VWR) were chilled 
on ice for 10 minutes. Then, 1 µL (100-500 ng) of the Gibson reaction product was added to 
the competent cells. This solution was added to pre-chilled electroporation cuvettes and 
electroporated at 2000 V (Eppendorf Eporator). The cells were then immediately transferred 
to a recovery medium of 5 mL M17 + 0.5 % glucose + 20 mM MgCl2 + 2 mM CaCl2 and 
incubated at 30 °C for 2 hours. The cells were then harvested at 3000 g for 10 minutes and 
resuspended in 50 µL of the same medium and streaked on M17 agar plates supplemented 
with 0.5 % w/v glucose and erythromycin at 10 µg/mL and left to grow at 30 °C overnight.  
4.2.10 Plasmid isolation from L. lactis 
 
Plasmid isolation was carried out using a combination  of an alkaline lysis protocol 
(O'Sullivan D and Klaenhammer 1993) and the GenElute five minute plasmid miniprep kit 
(Sigma). To lyse the bacteria, they were grown until the stationary phase in M17 media 
supplemented with 0.5 % v/v glucose and appropriate antibiotic and harvested by 
centrifugation at 3000 g for 10 minutes. The pellet was then resuspended in 200 µL 25 % 
sucrose containing 1 mg/mL RNase and 30 mg/mL lysozyme and incubated at 37 °C for 15 
minutes. Then 400 µL of 0.2 N NaOH and 3 % sodium dodecyl sulphate (SDS) solution was 
added followed by immediate mixing by inversion and left for 7 minutes. Then, 300 µL of 
ice cold 3 M sodium acetate (pH 4.8) was added and the solution was vortexed. This solution 
was then centrifuged at 18,000 g for 15 minutes at 4 °C. The supernatant was recovered and 
the plasmid was isolated using the GenElute miniprep kit detailed above. 
4.2.11 Sequencing 
 
Samples were sent to Source Bioscience using the SpeedREADTM service. 100 ng/µL of 
plasmid DNA and 3.2 pmol/µL of primers were sent to the service and these were sequenced 
using standard Sanger sequencing. The chromatograms were analysed using the SnapGene 
software.  
The primers used for sequencing are shown below: 
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Table 4.10. Primers for sequencing. 
 
4.2.12 Agarose gel preparation 
 
0.8 % agarose gels were used to visualise plasmids. Briefly 1 µg of plasmid was added to 
the agarose gel stained with SYBR safe. 2-Log DNA Ladder (0.1-10 KB) (New England 
Biolabs) was added as a marker and gels were run until the bands of the ladder could be seen 
separately. Prior to running the gel, plasmids were linearised using either EcoRI or NgoMIV. 
4.2.13 Preparation of the nisin stock 
 
Nisin was purchased from Sigma (N5764) and a stock of 1 mg/mL in 0.05 % acetic acid was 
prepared. The nisin was left to dissolve for 10 minutes at room temperature before 
centrifugation at 20,000 RPM for 1 minute to pellet the insoluble material. The supernatant 
was removed and stored at -20 °C. This stock was diluted to the desired concentration in 
water prior to use as less concentrated solutions of nisin are unstable (Mierau and 
Kleerebezem 2005).  
4.2.14 GFP Assay 
 
Bacteria were grown in GM17 with appropriate antibiotic in standing cultures for 24 hours 
before harvesting at 7000 g for 5 minutes and washing with M9 before resuspension in GM9 
for 24 hours. The cells were then harvested at 7000 g for 5 minutes before the supernatant 
was neutralised with NaOH and left for 1 hour. The supernatant was then transferred to a 
black 96 well plate for fluorescence reading. The excitation wavelength was set to 395 nm 
and emission was set to 508 nm using an Infinite 200 PRO NanoQuant Plate Reader from 
Tecan.  
Primer  Sequence 5’-3’ 
pT1NX  ‘AGTTCTTGTGGTTACGTGGT’ 
BMP-2 ‘CGGAAACGCCTTAAGTCCA’ 
GFP ‘ACGTGCTGAAGTCAAGTTTGA’ 
pNZ8123 Forward ‘CGAGCATAATAAACGGCTCTG’ 
pNZ8123 Reverse ‘CTATCAATCAAACGAACACGTGC’ 
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4.2.15 Western blot 
 
 Constitutive cell wall expression 
1 mL of standing culture was taken and lysed with the addition of 200 µL of 25% sucrose 
and 30 mg/mL lysozyme for 30 minutes at 37 °C. Then, 400 µL of 3 % SDS was added and 
incubated for 7 minutes at room temperature and then immediately placed on ice. 60 µL of 
the lysate was mixed with 20 µL of 4x Laemmli buffer and boiled at 95 °C for 5 minutes 
and then 30 µL was loaded into a 4-20 % gel (New England Biolabs).  
The gels were then run at 50 V for 2 hours. The proteins were then transferred to a 0.45 µm 
pore size polyvinylidene fluoride (PVDF) membrane at 25 V for 45 minutes. The membrane 
was then blocked with 5 % milk in PBS for 1 hour on a shaker. The primary antibody (anti 
GFP (Clonetech) 1:7500 in 5 % milk-TBS-0.1 % Tween-20) was then added and left 
overnight at 4 °C. The sample was then washed 4 times for 5 minutes each in PBS-0.5 % 
Tween. The secondary antibody (Rabbit antimouse 1:20,000 with HRP in 2 % milk with 
PBS-0.5 % Tween, General Electric Healthcare) was then added for 1 hour on a shaker. The 
sample was then washed 6 times for 5 minutes with TBS-0.1 % Tween. The substrate ECL 
Prime WB Detection Agent (GE Healthcare) was then added and incubated for 5 minutes. 
Chemiluminescence was then imaged using the Syngene PXi 5 gel documentation system.  
Inducible cell wall expression.  
Cultures were grown in GM17 overnight before a 1 % inoculation into fresh GM17. After 1 
hour, nisin was added at desired concentrations (see results section) and left for 5 hours 
before lysis and western blotting using the method described above.   The primary antibodies 
(anti 6x HisTag (His.H8, ThermoFisher, UK) 1:2500 in 5 % milk-TBS-0.1 % Tween-20 for 
BMP-2W and HFN7.1 (Developmental Studies Hybridoma Bank, University of Iowa, USA) 
1:1000 in 5 % milk-TBS-0.1 % Tween-20. 
4.2.16 Enzyme Linked Immunosorbent Assay (ELISA) 
 
Bacteria were grown overnight before fresh GM17 was inoculated with 1 % bacterial culture. 
After 1 hour, nisin was added at desired concentrations (0, 0.1, 0.5, 1 and 10 ng/mL) and left 
for 5 hours. A competitive ELISA (His-Tag Protein ELISA Kit, Cell Biolabs Inc, UK) was 
completed. Briefly, the plate was coated with polyhistidine and left overnight and samples 
and standards were added for 10 minutes on an orbital shaker. Standards were obtained from 
the kit. Anti-6xHis antibody was added to the wells for 2 hours before washing with wash 
buffer 5 times. Secondary antibody was added for 1 hour on an orbital shaker before washing 
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5 times. Then, substrate solution was added for 8 minutes before stopping and absorbance 
was read on an Infinite 200 PRO NanoQuant Plate Reader from Tecan at 450 nm.  
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4.3 Results 
 
In order to utilise the power of L. lactis inducible systems, we had to change strain from 
MG1363 (used in the previous chapter) to NZ9000 and its derivatives. This is due to the fact 
that MG1363 does not harbour the nisin receptor needed for intracellular signalling and 
promoter activation. This chapter will focus on the cloning procedures and basic mammalian 
cellular response to these new clones.  
 
4.3.1 NZ9000 FNIII7-10-GFP and BMP-2 strains 
 
As there are no commercially available kits for the detection and quantification of bacterially 
expressed BMP-2, the synthesised proteins were tagged with either GFP or a 6x HisTag. The 
epitope of antibodies against BMP-2 bind to the glycosylated region of BMP-2 (information 
obtained from PeproTech). Bacteria do not possess the machinery to complete the same post-
translational modifications as mammalian cells (Caina, Solis et al. 2014) and therefore a tag 
was needed.  
For the constitutive clones, GFP was cloned into both cell wall and secreted clones for 
detection. This allowed the direct measurement of GFP by both western blot and 
fluorescence to detect the protein. Four clones were completed, cell wall expressing BMP-2 
with and without GFP and secreted BMP-2 with and without GFP. 
For the inducible clones, FNIII7-10-GFP and BMP-2 with a 6x HisTag were used. This 
allowed the direct measurement by western blot and ELISA. Two clones were completed, 
cell wall bound BMP-2 and secreted BMP-2.  
To quantify FNIII7-10 production, either antiGFP (constitutive) or antiFN (inducible) 
antibodies were used. 
Constitutive expression 
Cell wall expressing BMP-2 in NZ9000 
Expression and localisation of cell wall bound BMP-2 was confirmed utilising a variety of 
methods. Firstly, sequencing an isolated plasmid from the clones highlighted an in-frame 
insertion of a 1.7 kb fragment, corresponding to GFP-BMP-2 and an insertion of 1 kb for 
BMP-2 without GFP. 
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Further confirmation was ascertained by western blot as shown in Figure 4.2. As described 
in the Materials and Methods section, L. lactis was lysed and the lysate was run on a gel and 
transferred for western blotting. The blot displayed bands at 60 kDa which is equivalent to 
that of GFP-BMP-2-SpA whereas control GFP which has a molecular weight of 26.9 kDa 
was found at 27 kDa. The bacterially expressed GFP band was found to be at a higher 
molecular weight as it is also fused to spaX and BMP-2. GFP was also used to make a 
standard curve to determine the concentration of BMP-2 per bacteria. Band densitometry 
analysis was used, finding a linear relationship between band density and protein amount. 
Based on this, it was determined that 37.5 and 18.7 µL of standing culture contains 
approximately 1.2 ± 0.2 and 0.44 ± 0.04 µg of GFP-BMP-2 respectively. Using these 
estimations, the approximate density of BMP-2 molecules that a mammalian cell can interact 
with is roughly 55,000 per bacterial cell, assuming a molecular weight of 60 kDa and fully 
saturated media containing 2.2 x 109 bacteria per mL. This is equal to 6.65 ng/cm2 of cell 
wall bound BMP-2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Western blot against constitutive NZ9000 cell wall bound GFP-BMP-2. From left to 
right colour prestained protein ladder (NEB), GFP standards at 100, 80, 60, 40 and 20 ng and 37.5 
and 18.75 µL cell wall fractions of standing culture and colour prestained protein ladder (NEB). 
GFP has a molecular weight of 26.9 kDa and can be seen at approximately 28 kDa and GFP-BMP-
2-spaX has a molecular weight of 60 kDa and can be seen at 60 kDa. Three western blots were 
completed to allow quantification. 
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These results suggest that the anchoring of the protein by spaX and the fusion of BMP-2 and 
GFP can be easily expressed and are not detrimental to bacterial viability. L. lactis-BMP-2 
cell wall and L. lactis-BMP-2 fused to GFP cell wall will now be known as L. lactis-BMP-
2W and L. lactis-BMP-2WGFP respectively.  
 
Expression of secreted BMP-2 in NZ9000 
Expression of secreted BMP-2 was confirmed in a different manner to cell wall expression. 
Again, sequencing the isolated plasmid from bacterial cells revealed the inclusion of an in-
frame 1.7 kb fragment comprising GFP and BMP-2 with a stop codon between BMP-2 and 
spaX, preventing the synthesis of the spaX anchor, allowing protein secretion and another 1 
kb insertion for BMP-2 without GFP. 
A fluorescence assay was used to verify the presence of GFP from the clones. GFP shows 
fluorescence when it is excited with light at 395 nm and emits at 508 nm. Bacterial 
supernatant was loaded into 96 well plates and the fluorescence was measured. Figure 4.3A 
shows the GFP fluorescence of the bacterial supernatant under differing conditions. It has 
been proven that increasing the pH of the solution over 10 further increases the fluorescence 
which would further support the presence of GFP. In addition to pH, the presence of oxygen 
is essential for the maturation of the chromophore, and therefore, the bacteria had to be 
grown aerobically (Landete, Langa et al. 2015). As can be seen from Figure 4.3A, GFP 
fluorescence is statistically significantly higher in the aerobically grown samples, and the 
highest in the pH 12 samples. A standard curve was created using GFP at known 
concentrations allowing us to ascertain the amount of GFP in the L. lactis samples shown in 
Figure 4.3B. As GFP and BMP-2 are at a 1:1 ratio the total amount of GFP will be the same 
as BMP-2. Using the standard curve, it was found that we had 970 ng/mL of BMP-2 
monomers, to be biologically active, BMP-2 needs to dimerise, and therefore we 
theoretically have 485 ng/mL of BMP-2 in a fully saturated culture of L. lactis after 1 day.  
L. lactis-BMP-2 secreted and L. lactis-BMP-2 fused to GFP secreted will now be known as 
L. lactis-BMP-2S and L. lactis-BMP-2SGFP respectively.  
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Figure 4.3. GFP fluorescence assay to confirm the presence of constitutive BMP-2-GFP 
from NZ9000. (A) GFP fluoresce is higher at higher pH so fluorescence at pH 7 and 12 were 
tested. (B) GFP at known concentrations was used for linear regression analysis in the 
quantification of L. lactis-BMP-2-GFP. Significance levels are *p < 0.05 and ****p < 0.0001. 
Three technical replicates were completed to allow quantification. Data is presented as the 
mean ± SD and analysed with a one way ANOVA with a Tukey post-hoc test. 
 
A 
B 
87 
 
FNIII7-10 fragment expression in NZ9000 
The FNIII7-10 expressing plasmid from MG1363 was purified and transformed into 
electrocompetent NZ9000 using methods described previously. This was again isolated and 
sent for sequencing. The sequencing data showed an insert corresponding to FNIII7-10-GFP 
of 2.3 kb. Further to sequencing, a western blot shown in Figure 4.4 was completed showing 
the presence of GFP at approximately 85 kDa. GFP-FNIII7-10-SpA has a molecular weight 
of 87.4 kDa and therefore the weight is slightly off.  However, the sequence data shows the 
correct insertion and the presence of GFP is confirmed. GFP was used as a standard to create 
a standard curve for the accurate quantification of GFP in the bacterial cell wall fragments 
and it was found that there were approximately 6.36 ng/cm2 of FNIII7-10 for mammalian cells 
to interact with.  
 
 
 
 
 
 
 
 
 
 
Inducible expression 
Cell wall expressing BMP-2 in NZ9000 
Plasmids were isolated and sent for sequencing. An insertion of 999 bp was found 
corresponding to Usp45, 6x HisTag, BMP-2 and spaX. Further to sequencing, a western blot 
against the HisTag was completed. Nisin was added at differing concentrations (0, 0.5, 1, 5 
and 10 ng/mL) one hour after fresh M17 was inoculated with 1 % of saturated bacterial 
culture and left to grow for five hours before a western blot was completed against the 6x 
Histag sequence. FNIII7-10-Histag was used to make a standard curve and band densitometry 
analysis was used to calculate protein expression. Figure 4.5A shows that upon increasing 
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Figure 4.4. Western Blot against constitutive NZ9000 cell wall bound FNIII7-10-GFP. From left 
to right colour prestained protein ladder (NEB), GFP standards at 20, 40, 60, 80 and 100 ng and  20 
µL cell wall fractions of standing culture. GFP has a molecular weight of 26.9 kDa and can be seen 
at approximately 28 kDa and GFP-FNIII7-10-spaX has a molecular weight of 87 kDa and can be 
seen at 80 kDa. Three western blots were completed to allow quantification. 
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amounts of nisin, more BMP-2W was found in the blot. Figure 4.5B highlights that 
production of protein increases as a function of nisin addition. At 10 ng/mL of nisin, BMP-
2W was found at 8.79ng/cm2. The dotted line on the graph represents the amount of BMP-
2W-GFP present in the constitutive clone (6.65 ng/cm2). The blot also shows that the nisA 
promoter is not leaky as there is no protein found in the 0 ng/mL channel. Protein expression 
was seen to be highest in the 10 ng/mL sample, being marginally higher than protein 
expression in the constitutive samples. 
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Figure 4.5. Western blot against inducible NZ9000 cell wall bound BMP-2. (A) From left to right colour 
prestained protein ladder (NEB), FN standards at 5, 10, 20 and 30 ng and  20 µL cell wall fractions of standing 
culture under different nisin induction profiles. FN standard has a molecular weight of 44 kDa and can be seen at 
approximately 46 kDa and BMP-2W-spaX has a molecular weight of 32 kDa and but can be seen above 32 kDa. (B) 
A plot of BMP-2W concentration at different levels of inducer shows protein expression at 10 ng/mL is slightly 
higher than in the constitutive clone. The plotted line follows the equation Y = Bmax*X/(Kd + X), R2 = 0.9765. The 
dotted line represents protein expression in the constitutive clone. Three western blots were completed to allow 
quantification. 
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Secreted expression of BMP-2 in NZ9000 
Plasmids were isolated and sequenced in the same manner as described previously. An 
inframe insertion of 442 bp corresponding to Usp45, 6x HisTag, BMP-2 followed by a stop 
codon was found. Further to sequencing, an ELISA for the 6x HisTag was completed (Figure 
4.6). Nisin was added at differing concentrations (0, 0.1, 0.5, 1 and 10 ng/mL) one hour after 
fresh M17 was inoculated with 1 % of saturated bacterial culture and left to grow for five 
hours before completing a competitive ELISA. It was found that at 10 ng/mL (plateau 
reached at approximately 2 ng/mL of nisin) BMP-2 was secreted at 18.6 µg/mL, a value 46 
times greater than that from the constitutive clone. 
 
 
 
 
 
 
 
 
 
 
 
 
 
FNIII7-10 fragment expression in NZ9000 
Sequencing the isolated plasmid revealed an insert corresponding to FNIII7-10-GFP of 2.3 
kb. A western blot against FNIII7-10 was completed to further ascertain protein expression. 
Nisin was added at differing concentrations (0, 0.1, 0.5, 1 and 10 ng/mL) one hour after fresh 
M17 was inoculated with 1 % of saturated bacterial culture and left to grow for five hours. 
Figure 4.6. ELISA data for inducible NZ9000 secreted BMP-2. Protein production 
was seen to increase upon additive amounts of nisin up to 2 ng/mL where a plateau in 
protein production was seen. Maximal expression was found to be 18.6 µg/mL. The 
plotted line follows the equation Y = Bmax*X/(Kd + X), R2 = 0.8389. Three technical 
replicates were completed to allow quantification. 
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Figure 4.7A shows a western blot against FNIII7-10 and the corresponding amounts of FNIII7-
10-GFP produced. Figure 4.7B illustrates a plateau of FNIII7-10-GFP production at 
approximately 2 ng/mL of nisin in the media. The dotted line on the graph represents the 
amount of FNIII7-10 present in the constitutive clone. This shows that when the nisA promoter 
of pNZ8123 is activated, it is roughly 120 (853 ng/cm2 vs 6.36ng/cm2) times stronger than 
the P1 promoter found in pT1NX, at least for FNIII7-10 production. The blot also shows no 
induction in the 0 ng/mL channel showing that the promoter is not leaky. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. Western blot against inducible NZ9000 cell wall bound FNIII7-10-GFP under different 
concentrations of nisin. (A) From left to right colour prestained protein ladder (NEB), FN standards at 10, 
40, 70 and 100 ng, FNIII7-10-GFP at 0, 0.1, 0.5, 1 and 10 ng/mL nisin. FNIII7-10-HisTag standard has a 
molecular weight of 44 kDa and can be seen at approximately 46 kDa and GFP-FN-spaX has a molecular 
weight of 87 kDa and can be seen at a this approximate molecular weight. (B) Below, a plot of FNIII7-10 
concentration at different levels of inducer shows a plateau of production at approximately 2 ng/mL. The 
plotted line follows the equation Y = Bmax*X/(Kd + X), R2 = 0.9998. The dotted line represents protein 
expression in the constitutive clone. One replicate was used to quantify protein expression. 
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4.3.2 Bacterial viability 
 
As discussed in the previous chapter, MSCs must be cultured for 3-4 weeks before late 
markers of osteogenesis are expressed. Therefore, bacterial viability up to this time point 
must also be studied to allow for continuous ligand (FNIII7-10) and growth factor delivery 
(BMP-2). The use of antibiotic is also essential to prevent overgrowth of bacteria. 
Previously, the use of tetracycline (TC) was used as it is bacteriostatic in its nature and 
retards the metabolism of the biofilm. We found that adding TC at 10 µg/mL was sufficient 
to prevent bacterial cell growth but not potent enough to kill the bacteria (Saadeddin, 
Rodrigo-Navarro et al. 2013, Rodrigo-Navarro, Rico et al. 2014, Hay, Rodrigo-Navarro et 
al. 2016). However, as TC acts by blocking protein synthesis (Geigenmuller and Nierhaus 
1986), a new antibiotic needed to be chosen. The use of TC would block the synthesis of 
BMP-2 and thus prevent osteogenesis of MSCs. Sulfamethoxazole (SMX) acts as an 
analogue to a prime precursor in the folate synthesis pathway in both gram positive and 
negative bacteria. Folate is an essential metabolite for bacterial growth and replication as it 
is used for both DNA synthesis of thymidylate and purine bases and amino acid synthesis. 
Therefore, blocking folate production leads to the obstruction of bacterial cell growth and 
therefore SMX is considered a bacteriostatic antibiotic (Burchall 1973, Hitchings 1973). 
SMX’s capability to impede bacterial cell growth was tested at different concentrations and 
can be seen in Figure 4.8A. It can be seen that bacterial viability in DMEM without antibiotic 
is good, as was shown in the previous chapter. Two different concentrations of SMX were 
studied, 5 and 10 µg/mL. Bacteria in the 10 µg/mL samples were seen to be less viable than 
in the 5 µg/mL samples. Moreover, the 5 µg/mL samples also managed to impede bacterial 
cell growth. This can also be seen in the graphs seen in Figure 4.8B. For future experiments, 
the use of 5 µg/mL SMX was chosen as it is concentrated enough to prevent bacterial growth 
whilst also keeping the biofilm healthy. This is essential as the preservation of the biofilm is 
of utmost importance for the continuous signalling of the FNIII7-10 fragment and BMP-2. 
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4.3.3 Mammalian cell viability on NZ9000 
 
Cell viability was explored using the constitutive expression clones only. MSCs were seeded 
over different BMP-2 clones with L. lactis-FN, L. lactis-empty and FN-coated samples as 
controls for 4 weeks as this is the time required for terminal MSC differentiation.  
As can be seen in Figure 4.9, MSC viability on all bacterial samples is seen to decrease over 
four weeks. MSCs seeded onto the FN coat show approximately 100 % viability at all time 
points. After one day, MSCs on all surfaces, have 100 % viability, but after this time point, 
cell viability begins to decrease. MSCs on the L. lactis-BMP-2S bacteria began to die after 
one day as is seen by the steep decrease on the chart after one day. There were no cells left 
on the samples after four days. Conversely, MSCs on all other bacterial types showed good 
viability up to day 14, but were severely diminished by day 21. 
  
Figure 4.8. Bacterial viability. (A) Biofilms of L. lactis-FN were produced on a poly (ethyl acrylate) (PEA) 
surface and cultured for 1 to 4 weeks with DMEM, DMEM supplemented with 5 µg/mL sulfamethoxazole 
(DMEM + SMX 5). After selected time points, biofilms were washed and their viability assessed using the 
commercial BacLight viability kit (Life Technologies). This kit stains viable cells in green and non-viable cells 
in red. Viability was calculated by analysing the total amount of cells stained in green versus the amount of 
cells stained in red and green. Scale bar is 100 µm. (B) Bacteria were seen to be less viable on DMEM SMX 
10 µg/mL at all time points. Viability results were similar between DMEM and DMEM SMX 5 µg/mL. 10 
images were taken from three technical replicates. Data is presented as mean ± SD and was analysed by a one 
way ANOVA test with a Tukey post-hoc test. Significance levels are *p < 0.05, **p < 0.01 and ***p < 0.001. 
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This decrease in cell viability may be due to the acidification of the medium, even in the 
presence of tetracycline, as the DMEM was seen to become yellow in colour. NZ9000 is a 
much more metabolically active strain than MG1363 (used in the previous chapter) and thus 
produces lactic acid at much higher rates. Loss of viability may also be compounded by the 
fact that the media had to be changed at least once a day due to the acidification of the media, 
and therefore, any growth factors secreted by the cells would be removed, thus altering their 
behaviour further. The most striking result from this experiment is the complete death of 
cells after one day on the L. lactis-BMP-2S clones. The L. lactis-BMP-2S-GFP did not 
display this result. MSC death may be due to a toxic concentration of BMP-2 in the media. 
However, upon searching the literature, there were no reports of BMP-2 toxicity to MSCs at 
this concentration.  
To deduce L. lactis derived BMP-2 toxicity to the cells, co-cultures of L. lactis-FN and L. 
lactis-BMP-2S clones were made, therefore, theoretically halving the amount of BMP-2 that 
the cells can interact with. Figure 4.10 shows MSC and C2C12 viability after five days on 
L. lactis-FN, L. lactis-BMP-2S and 50:50 co-cultures of L. lactis-FN and L. lactis-BMP-2S. 
As is seen in Figure 4.10, cell viability is drastically decreased in the L. lactis-BMP-2S 
samples, albeit, not complete cell death after four days as was shown in Figure 4.9. 
Interestingly, cell death is seen to be statistically significantly higher in MSCs when 
compared against C2C12s on L. lactis-BMP-2S. Cell viability in both MSCs and C2C12s on 
Figure 4.9. Mesenchymal stem cell viability on NZ9000 L. lactis clones. MSC viability was seen to 
decrease over 4 weeks on all NZ9000 L. lactis clones whilst viability on the FN coat was seen to stay high. 
10 images were taken per condition from three technical replicates. 
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L. lactis-FN was seen to be close to 100 % whilst the co-cultures of L. lactis-FN and L. 
lactis-BMP-2S display an intermediate cell viability, approximately 77 % for both MSCs 
and C2C12s. This result demonstrates that either the presence of the FNIII7-10 fragment in 
the L. lactis cell wall or the decreased amount of BMP-2 produced by decreasing the amount 
of L. lactis-BMP-2S bacteria positively affects cell viability. 
 
 
 
It was thus decided to use a metabolically different strain of NZ9000, NZ9020. In NZ9020, 
both known lactate dehydrogenase genes are knocked out and it is therefore unable to 
produce as much lactate as a fermentation end product, therefore decreasing the acidity of 
the media, keeping the pH neutral (Bongers, Hoefnagel et al. 2003). The lactate 
dehydrogenase genes were replaced with an erythromycin and tetracycline resistance and 
therefore the clones could be screened for. If NZ9020 is grown under aerobic conditions, it 
displays an almost complete loss of lactate production, and acetoin is found to be the main 
end product of fermentation, complete data can be found in Table 4.11. The presence of O2 
allows the cells to maintain their redox balance through the activity of endogenous NADH 
Figure 4.10. MSC and C2C12 viability on L. lactis. Viability values of co-cultures are seen to be 
higher than L. lactis-BMP-2S in both MSCs and C2C12s after 5 days. 10 images were taken per 
condition from three technical replicates. Data is presented as mean ± SD and analysed with a two 
way ANOVA test with a Tueky post-hoc test. Significance levels are *p < 0.05, ***p < 0.001 and 
****p < 0.0001. 
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oxidase. This sustains sugar fermentation without the production of lactic acid. However, 
under aerobic conditions, the rate of sugar fermentation is decreased, and the metabolic end 
products are also shifted to ethanol. This suggests that these pathways are using ethanol as 
an alternative electron sink, since the enzymatic conversions involved include reducing steps 
that use NADH as a cofactor. To combat the use of ethanol as an electron sink, many authors 
have described the use of heme in L. lactis aerobic respiration (Sijpesteijn 1970, Ritchey and 
Seely 1976, Arioli, Zambelli et al. 2013). By inhibiting fermentative metabolism (anaerobic 
respiration) under respiration permissive conditions (heme plus oxygen), oxidation of 
NADH is shifted toward the electron transport chain via cytochrome bd oxidase. This would 
enable the successful culture of L. lactis without the inevitable decrease in pH that is so 
detrimental to mammalian cell culture. Figure 4.11 highlights the use of hemin in aerobic 
respiration in L. lactis. 
 Figure 4.12 shows the final pH of bacterial cell supernatant using different strains. As can 
be seen, the pH in NZ9020 cell supernatant is higher than NZ9000 due to the lack of lactic 
acid being produced. The use of hemin further increases the pH. These results suggest that 
using NZ9020 aerobically with hemin at 5 µg/mL will be best for mammalian cell culture. 
All long term mammalian cell co-culture with NZ9020 used hemin from hereon.  
 
Table 4.11. L. lactis metabolism under different conditions (Bongers, Hoefnagel et al. 2003). 
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Figure 4.12. pH of M17 after 1 day of L. lactis growth. The pH of cultures after 1 day of growth were 
measured in both NZ9000 and NZ9020 when grown aerobically and anaerobically. In addition, NZ9020 
grown aerobically with 5 µg/mL hemin was also tested. The dotted line represents pH 7.4, the closest 
growth conditions to that preferred by mammalian cells. The closest L. lactis to this was reached by 
aerobic NZ9020 with the use of hemin at 5 µg/mL. Three technical replicates were completed per 
sample and data is presented as mean ± SD.  
Figure 4.11. Simplified representation of glycolysis, homolactic, and mixed-acid fermentations and heme-
dependent respiration in L. lactis. 
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4.3.4 NZ9020 FNIII7-10 fragment and BMP-2 expressing bacteria 
 
As discussed, NZ9020 is a less metabolically active strain of NZ9000 designed by Bongers 
et al.(Bongers, Hoefnagel et al. 2003) at Nizo Food Research in the Netherlands. It has had 
both its known lactate dehydrogenase enzymes removed and therefore its metabolism has 
been disrupted. This leads to a general decrease in growth and protein expression when 
compared with NZ9000. Further to this, in order to be able to screen for successful lactate 
dehydrogenase knockouts, the genes were replaced with tetracycline and erythromycin 
resistances. This posed problems for the constitutive clones as pT1NX has an erythromycin 
resistance gene.  Therefore screening successful clones with erythromycin would be 
impossible, so pT1NX had to be altered. The chloramphenicol resistance gene from 
pNZ8123 was isolated and used to replace the erythromycin resistance gene in pT1NX, 
effectively creating a new plasmid that could be screened for. This new plasmid has been 
denoted pT2NX, and it has been used for all the constitutive protein production in NZ9020. 
This section shows the characterisation of constitutive and inducible expression of cell wall 
anchored FNIII7-10 and both cell wall bound and secreted versions of BMP-2. 
Constitutive expression 
Cell wall expressing BMP-2 in NZ9020 
Again, sequencing an isolated plasmid from the transformed bacteria highlighted an inframe 
insertion of a 1.7 kb fragment, corresponding to GFP-BMP-2 and an insertion of 1 kb for 
BMP-2 without GFP. 
Further confirmation was ascertained by western blot as shown in Figure 4.13. Cell wall 
fragments were isolated as before and were run on a gel and transferred for western blotting. 
The blot displayed bands in the cell wall fraction at 60 kDa which is equal to that of GFP-
BMP-2-SpaX. GFP was again added as a control and standard and was found at 27 kDa; 
GFP has a molecular weight of 26.9 kDa. The GFP standard curve was used to determine 
the concentration of BMP-2 per bacteria. Band densitometry analysis found a linear 
relationship between band density and protein amount. Based on this, it was determined that 
20 µL of standing culture contains approximately 0.8 ± 0.14 µg of GFP-BMP-2. Using these 
estimations, the approximate density of BMP-2 molecules that a mammalian cell can interact 
with is approximately 40,000 per bacterial cell, assuming a molecular weight of 60 kDa and 
fully saturated media containing 2.2 x 109 bacteria per mL. This is equivalent to 4.84 ng/cm2 
of cell wall bound BMP-2. This is a lower amount of BMP-2W than was found for NZ9000 
but this is expected due to the lower metabolic activity of NZ9020.  
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These results also suggest that the presence of BMP-2W and BMP-2W-GFP are not 
detrimental for bacterial viability of the NZ9020 strain.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Secreted expression of BMP-2 in NZ9020 
Expression of constitutive secreted BMP-2 in NZ9020 was completed in the same manner 
as for NZ9000. Plasmids were isolated and sequenced, the plasmid revealed the inclusion of 
an inframe 1.7 kb fragment comprising GFP and BMP-2 with a stop codon between BMP-2 
and spaX allowing protein secretion. A fluorescence assay was again completed showing the 
presence of GFP in the bacterial supernatant shown in Figure 4.14A. As was seen with 
NZ9000, GFP fluorescence was seen to be highest in the aerobically grown L. lactis BMP-
2S-GFP samples. A standard curve shown in Figure 4.14B was made and highlighted that 
NZ9020 secretes 598 ng/mL of BMP-2S-GFP, which due to the need for dimerisation 
translates to a working concentration of 299 ng/mL of biologically active BMP-2. This is 
again, lower than the amount found from NZ9000. 
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Figure 4.13. Western blot against constitutive NZ9020 cell wall bound GFP-BMP-2. From left to right 
colour prestained protein ladder (NEB), GFP standards at 100, 80, 60, 40 and 20 ng and 20 µL cell wall 
fractions of standing culture and colour prestained protein ladder (NEB). GFP has a molecular weight of 26.9 
kDa and can be seen at approximately 28 kDa and GFP-BMP-2-spaX has a molecular weight of 60 kDa and 
can be seen at 60 kDa. Three western blots were completed to allow quantification. 
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Figure 4.14. GFP fluorescence assay to confirm the presence of constitutive NZ9020 BMP-2-
GFP. (A) GFP at known concentrations was used for linear regression analysis (B) in the 
quantification of L. lactis-BMP-2-GFP. Data is presented as mean ± SD and was analysed by a one 
way ANOVA test with a Tukey post-hoc test. Significance levels are *p < 0.05 and ****p < 0.0001. 
Three technical replicates were used for quantification. 
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FNIII7-10 fragment expression in NZ9020 
Insertion of the gene was again seen via sequencing data showing an insert of 2.3 kb, 
corresponding to Usp45, GFP, FNIII7-10 and the spaX anchor. Figure 4.15 shows a western 
blot against GFP for quantitation of FNIII7-10. GFP was once again used to make a standard 
curve to ascertain the concentration of FNIII7-10 per bacteria. Band densitometry analysis 
was used, finding a linear relationship between band density and protein amount. Based on 
this, the approximate density of FNIII7-10 in 1 mL of saturated culture contained 5.84 ng/cm
2 
of protein, a similar result to that found for FNIII7-10 when synthesised in MG1363 and 
NZ9000 (6.36 ng) (Saadeddin, Rodrigo-Navarro et al. 2013).  
 
 
 
 
 
 
 
 
 
 
 
 
Inducible expression 
Cell wall expressing BMP-2 in NZ9020 
Plasmids were isolated and sent for sequencing. An insertion of 999 bp was found 
corresponding to Usp45, 6x HisTag, BMP-2 and spaX. Further to sequencing, a western blot 
against the HisTag was completed. Nisin was added at differing concentrations (0, 0.5, 1, 5 
and 10 ng/mL) one hour after fresh M17 was inoculated with 1 % of saturated bacterial 
culture and left to grow for five hours before a western blot (Figure 4.16A) was completed 
against the 6x Histag sequence. FNIII7-10-Histag was used to make a standard curve and band 
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Figure 4.15. Western blot against constitutive NZ9020 cell wall bound FNIII7-10-GFP. From left to 
right colour prestained protein ladder (NEB), GFP standards at 5, 10, 50 and 100 ng and  20 µL cell wall 
fractions of standing culture. GFP has a molecular weight of 26.9 kDa and can be seen at approximately 
28 kDa and GFP-FNIII7-10-spaX has a molecular weight of 87 kDa and but can be seen above 100 kDa. 
Three western blots were completed to allow quantification. 
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densitometry analysis was used to calculate protein expression. It is apparent from Figure 
4.16A that nisin induction at different concentrations induces different protein expression, 
which has been quantified in Figure 4.16B. Interestingly, protein expression is seen to be 
higher in NZ9020 than in NZ9000 (Figure 4.5), however, this is only at the 10 ng/mL sample. 
NZ9000 protein expression was seen to be higher at the other nisin induction concentrations. 
The dotted line represents the amount of BMP-2W-GFP synthesised in the constitutive 
samples. Protein expression under the nisA promoter (pNZ8123) is seen to be much higher 
than under the P1 promoter (pT1/2NX). No protein expression was found in the 0 ng/mL 
nisin sample showing that the promoter is not leaky. 
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Figure 4.16. Western blot against inducible NZ9020 cell wall bound BMP-2. (A) From left to right 
colour prestained protein ladder (NEB), FN standards at 5, 10, 20 and 30 ng and  20 µL cell wall fractions 
of standing culture under different nisin induction profiles. FN standard has a molecular weight of 44 kDa 
and can be seen at approximately 46 kDa and BMP-2W-spaX has a molecular weight of 32 kDa and but can 
be seen above 32 kDa. (B) A plot of BMP-2W concentration at different levels of inducer shows protein 
expression at 10 ng/mL is approximately double to that found in the constitutive clone. The dotted line 
represents protein expression in the constitutive clone. The plotted line follows the equation 
Y = Bmax*X/(Kd + X), R2 = 0.9475. Three western blots were completed to allow quantification. 
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Secreted expression of BMP-2 in NZ9020 
Plasmids were isolated and sequenced. An inframe addition 442 bp corresponding to Usp45, 
6x HisTag, BMP-2 followed by a stop codon was found. An ELISA for 6x HisTag was also 
completed (Figure 4.17) to deduce BMP-2 concentration. Nisin was added at differing 
concentrations (0, 0.1, 0.5, 1 and 10 ng/mL) one hour after fresh M17 was inoculated with 1 
% of saturated bacterial culture and left to grow for five hours before completing a 
competitive ELISA. It was found that protein expression was highest at 10 ng/mL of nisin 
(plateau was reached at approximately 2 ng/mL nisin) at 183 ng/mL, a value that is less than 
that observed in the constitutive clone (299 ng/mL).  
 
 
 
 
 
 
 
 
 
 
 
 
FNIII7-10 fragment expression in NZ9020 
Sequencing isolated plasmid revealed an insert corresponding to FNIII7-10-GFP of 2.3 kb. A 
western blot against FNIII7-10 was also completed to ascertain protein expression. Nisin was 
added at differing concentrations (0.1, 1, 5 and 10 ng/mL) one hour after fresh M17 was 
inoculated with 1 % of saturated bacterial culture and left to grow for five hours. Figure 
4.18A shows a western blot against GFP and the corresponding amounts of FNIII7-10 
produced. Figure 4.18B shows a graphical representation of FNIII7-10 production under nisin 
and shows a different result to that of NZ9000, there is less protein expression in NZ9020 
Figure 4.17. ELISA data for inducible NZ9020 secreted BMP-2. Protein production 
was seen to increase upon additive amounts of nisin up to 2 ng/mL where a plateau in 
protein production was seen. Maximal expression was found to be 183 ng/mL. The 
plotted line follows the equation Y = Bmax*X/(Kd + X), R2 = -3.958.Three technical 
replicates were used to quantify BMP-2 secretion. 
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(359 ng/cm2 against 853 ng/cm2).  The dotted line represents the amount of FNIII7-10 found 
in the NZ9020 constitutive plasmid, protein expression under the nisin promoter is 62 times 
higher than under P1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18. Western blot against inducible NZ9020 cell wall bound FNIII7-10-GFP under different 
concentrations of inducer. (A) From left to right colour prestained protein ladder (NEB), FN standards at 
10, 40, 70 and 100 ng, FNIII7-10-GFP at 0, 0.1, 0.6, 1 and 10 ng/mL nisin. FN standard has a molecular weight 
of 44 kDa and can be seen at approximately 46 kDa and GFP-FNIII7-10-spaX has a molecular weight of 87 
kDa and can be seen at this approximate weight. (B) A plot of FNIII7-10 concentration at different levels of 
inducer shows a plateau of production, at approximately 2 ng/mL. The dotted line represents protein 
expression in the constitutive clone. The plotted line follows the equation Y = Bmax*X/(Kd + X), R2 = 
0.9942.One replicate was used to quantify protein expression. 
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4.3.5 Mammalian cell viability on NZ9020 
 
As can be seen from Figure 4.19, mammalian cell viability on NZ9020 grown with hemin is 
drastically different compared to NZ9000 (Figure 4.9). MSCs are seen to be at 99 % viability 
up until 21 days on all sample substrates. Unlike NZ9000, there is no rapid viability decrease 
on L. lactis-BMP-2S after one day, and there is also no slight viability decrease on the other 
L. lactis samples after 14 days. This is due to the lack of lactic acid production in NZ9020 
when compared with NZ9000. Also, the presence of hemin allows this bacterium to utilise 
aerobic respiration more effectively. Viability on the FN coat is seen to be 99 % for the 
whole four weeks with no statistical differences at any time point, whereas, viability drops 
to approximately 95 % after 21 days on all bacterial substrates. The exact reason for this is 
not known, but the small increase in acetoin in the medium may cause the small increase in 
cell death. Overall, mammalian cells cultured over NZ9020 show a much higher cell viability 
than on NZ9000 (Figure 4.9).  
 
  
Figure 4.19. Mesenchymal stem cell viability on NZ9020 L. lactis clones. MSC viability was seen to be more 
stable on all NZ9020 L. lactis clones. Viability on the FN coat was also seen to stay high. 10 images were taken per 
condition from three technical replicates. 
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4.4 Discussion 
 
L. lactis is a gram positive lactic acid bacterium that has been used for centuries in food 
fermentation. However, within the last 35 years, great progress has been made in using this 
organism in genetic engineering for the therapeutic delivery of proteins. More specifically, 
the HPV-16 E7 antigen was cloned and synthesised in a secreted form to aid in the fight 
against cancer (Benbouziane, Ribelles et al. 2013). Interleukin 27 has also been engineered 
to be secreted using the same plasmid used in this thesis (pT1NX) to alleviate the symptoms 
of colitis in mice (Hanson, Hixon et al. 2014). This organism can be used to produce proteins 
in a constitutive and inducible fashion which has been described in this chapter. The use of 
gram positive bacteria for heterologous protein production proves to be a useful choice due 
to easy protein secretion.  
Furthermore, the gold standard for bacterially produced recombinant proteins has been E. 
coli. However, the most commonly used production strategies for E. coli utilise intracellular 
or periplasmic expression and involve expensive and potentially problematic downstream 
purification processes. Moreover, LPS should be removed from proteins needed to be 
administered to humans. The presence of LPS makes protein use in humans impossible. 
Moreover, expressed proteins are likely to be hidden in a mesh of bacterial ECM (Froon, 
Dentener et al. 1995, Maestroni 2001).  
In addition to previous publications where FNIII7-10 was produced in L. lactis MG1363 
(Saadeddin, Rodrigo-Navarro et al. 2013, Rodrigo-Navarro, Rico et al. 2014, Hay, Rodrigo-
Navarro et al. 2016), we have demonstrated the completion of BMP-2 expressing L. lactis 
NZ9000 and NZ9020. This known osteoinducer has the capability to induce the 
differentiation of MSCs to osteoblasts as was shown in the previous chapter.  
The genetic modification of this strain has been completed using the versatile Gibson 
assembly technique (Gibson, Young et al. 2009) whereby primer overlaps are designed to 
allow the quick and efficient annealing of multiple fragments. With the correct primer 
design, facilitated by easy design software and commercial availability, Gibson assembly 
has fast become an extremely powerful and highly used technique. Overlaps can be designed 
in a single primer and PCR allows the elongation of large plasmid backbones which can be 
modified with the addition of other DNA sequences by the overhanging primers. 
The data has demonstrated that FNIII7-10 can be produced in both NZ9000 and NZ9020 with 
both pT1NX for constitutive expression and pNZ8123 for inducible expression and that 
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protein production under the nisin promoter is directly controlled by nisin concentration in 
the media.  
Furthermore, it can be concluded from the results that BMP-2 has been synthesised in both 
cell wall bound and secreted forms by the inducible and secreted plasmids. This was 
confirmed by the addition of a fusion GFP or His-tag reporter protein. GFP is a widely used 
expression reporter originally cloned from the jellyfish Aequorea Victoria and displays a 
bright green fluorescence when illuminated under ultraviolet light (Tsien 1998).   
Another widely used reporter protein is the polyhistidine tag (Hochuli, Bannwarth et al. 
1988). Histidine clusters of a minimum of four repeats interact with divalent cations that, 
when immobilised with metal ion matrices, electron donor groups on the histidine imidazole 
ring readily form coordination bonds with the immobilised transition metal (Block, Maertens 
et al. 2009). Peptides containing sequences of consecutive histidine residues are efficiently 
retained on immobilised metal-affinity chromatography (IMAC) columns. Following 
washing of the matrix material, peptides containing polyhistidine sequences can be easily 
eluted by either adjusting the pH of the column buffer or by adding free imidazole (Terpe 
2003, Block, Maertens et al. 2009). The proteins were expressed with the Usp45 secretion 
peptide and SpaX anchoring protein allowing either cell wall bound or secreted expression. 
Western blots, ELISAs and fluorescence assays were used to ascertain protein production 
levels in NZ9000 and NZ9020. 
Interestingly, it was mostly found that protein production was slightly higher in NZ9000 
than NZ9020 due to the discrepancies in the metabolic activity of the strains. For all proteins 
except BMP-2W, NZ9000 was found to synthesise more protein than NZ9020.  
A large disparity in protein concertation under the nisin promoter was found between FNIII7-
10 and BMP-2W. Under the P1 promoter, protein expression was seen to be highly similar 
for BMP-2W and FNIII7-10 in both NZ9000 and NZ9020. However, under nisin expression, 
FNIII7-10 was seen to be expressed at much higher amounts. Reasons for this could vary from 
simple steric hindrance (FNIII7-10 fragment is much further from the bacterial cell wall and 
can therefore be more easily accessed) to codon optimisation (Gold 1988, deRuyter, Kuipers 
et al. 1996). Further to this, the size and conformation of the protein can often have an effect 
on the efficiency of synthesis (Francis and Page 2010, Sabate, de Groot et al. 2010, Bonde, 
Pedersen et al. 2016). BMP-2S under the nisin promoter was also seen to have a large protein 
expression increase compared to P1 in NZ9000. However, BMP-2S under the nisin promoter 
in NZ9020 was seen to decrease in protein expression compared to P1. The increase in 
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NZ9000 BMP-2S under the nisin promoter compared to P1 and decrease in BMP-2S 
expression in NZ9020 under the same conditions is difficult to explain. It is well known that 
the nisin promoter is stronger than P1 (deRuyter, Kuipers et al. 1996) and this explains why 
expression is higher in the inducible plasmid for most cases. It is important to note that the 
constitutive bacteria for BMP-2S were grown in M9 media, not M17 and this could have an 
effect on protein expression. We do not have a satisfactory explanation, and this would have 
to be tested further to ascertain a firmer conclusion. It is apparent from the results that the 
protein is present, and at high enough levels (>100 ng/mL) to induce the differentiation of 
MSCs. Table 4.12 shows the amount of protein expression for all L. lactis clones. 
  Table 4.12. Quantitation of L. lactis protein expression  
 
 
 
 
 
 
 
 
 
The use of the NZ9020 strain was due to the high metabolic activity of NZ9000 as it was 
found that the high production of lactic acid resulted in the death of MSCs in the co-culture. 
To overcome this, the double lactate dehydrogenase knockout NZ9020 was genetically 
engineered and MSCs were seeded onto these bacteria instead. It was found that MSC 
viability was found to stay high, similar to that of a FN coated glass coverslip.  
 
The creation of genetically engineered L. lactis NZ9020 expressing BMP-2 and FNIII7-10 
fragments has been shown to keep MSCs viable and that these proteins are expressed at high 
levels in both constitutive and inducible fashions.  
 NZ9000 NZ9020 
Constitutive 
FNIII7-10 6.36 ng/cm2 5.84 ng/cm2 
Inducible 
FNIII7-10 853 ng/cm2 359 ng/cm2 
Constitutive 
BMP-2W 6.65 ng/cm2 4.84 ng/cm2 
Inducible 
BMP-2W 8.79 ng/cm2 11.16 ng/cm2 
Constitutive 
BMP-2S 485 ng/mL 299 ng/mL 
Inducible 
BMP-2S 18.6 µg/mL 183 ng/mL 
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4.5 Conclusion 
 
This chapter has shown that L. lactis NZ9000 and NZ9020 can be engineered to display and 
express FNIII7-10 and BMP-2. Furthermore, the use of SMX at 5 µg/mL has a similar effect 
to that of TC at 10µg/mL in terms of bacterial viability. SMX however, does not prevent 
bacterial protein expression like TC and can therefore be used in conjunction with BMP-2 
expressing clones.  
Regrettably, the use of NZ9000 was deemed detrimental to mammalian cell viability and a 
lactate dehydrogenase knockout was used to combat this problem. This NZ9020 has had 
both its known lactate dehydrogenase genes knocked out and has therefore had its 
metabolism sufficiently altered to produce less lactic acid and allow for longer term cell 
culture. However, the use of this bacteria leads to a general decrease in protein expression 
when compared with NZ9000.  
Most interestingly, the system was transformed to allow for the inducible expression of 
proteins through the well characterised NICE system (Kuipers, de Ruyter et al. 1998, Mierau 
and Kleerebezem 2005, Mierau, Olieman et al. 2005). It was found that protein production 
was reliant on nisin addition to the media and that the amount of protein production was 
concentration dependent. Furthermore, the promoter in not leaky, which is demonstrated by 
the absence of protein in cultures where no nisin was added.  
We aim to establish a surface whereby MSCs are adhered to the surface by the FNIII7-10 
fragment and the expression of BMP-2, either cell wall bound or secreted can induce the 
differentiation of these cells into osteoblasts.  
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5. Cell-bacteria interaction dynamics 
 
 
 
 
Summary 
This chapter focusses on how L. lactis and mammalian cells interact with one another and 
how this co-culture can affect bacterial and mammalian cell behaviour. Basic cell attachment 
to constitutive and inducible L. lactis was investigated for the FNIII7-10 expressing bacteria. 
Proliferation of MSCs on FNIII7-10 and BMP-2 expressing clones was also investigated to 
ascertain the health and differentiation capabilities of the bacterial strains in the short term. 
Lastly, bacterial internalisation by mammalian cells was explored as previous studies 
showed potential for the mammalian cells to engulf the bacteria. The results in this chapter 
demonstrate that L. lactis NZ9000 and NZ9020 can sustain cell adhesion on both the 
constitutive and inducible clones and that cell size is proportional to the amount of inducer. 
Also, mammalian cells are able to proliferate on all clones of L. lactis and proliferation is 
lowest on the BMP-2 secreting clones. Murine C2C12 cells as well as murine RAW 
macrophages are also able to engulf all strains of L. lactis but rate of uptake is limited by the 
presence of a protein in the bacterial cell wall.  
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5.1 Introduction 
 
It is thought that mitochondria are the progeny of bacteria, initially kept by higher cells in 
symbiosis due to their capacity to consume atmospheric oxygen and produce energy (Sagan 
1967, Margulis and Bermudes 1985). If this is true, this shows a long standing interaction 
between bacteria and eukaryotic cells. However, not all prokaryotic-eukaryotic interactions 
end so well. Some bacteria are pathogenic and can cause a disease state in their host. 
Similarly, some eukaryotic cells prey on prokaryotic cells. Microbial phagocytic defence 
may have evolved in response to these pathogenic bacteria. However, the usual outcome 
between a microbe and its host does not lead to a disease state. To test bacterial-mammalian 
cell dynamics, an internalisation assay was developed to establish whether C2C12 cells were 
able to engulf bacteria. RAW macrophage-like cells were also included to test whether the 
internalisation of bacteria was unique to immune cells only.  
We can exploit these non-pathogenic bacteria to become cell factories for the production of 
probiotics, through cell adhesion and differentiation.  
Cell adhesion is crucial for the survival, proliferation and differentiation of cells to form 
higher structures such as tissues and organs. The architecture of organs is therefore 
modulated by cell adhesion and adhesion systems should be regarded as mechanisms that 
translate basic genetic information into complex phenotypes. Upon attachment to a 
functionalised surface, cells begin to proliferate. There is evidence that signals arising from 
focal adhesions directly communicate with pathways that regulate proliferation (Giancotti 
and Ruoslahti 1999).  
However, proliferation and differentiation are closely coupled, and are intricately linked. 
Self-renewal and differentiation are associated with the cell-cycle and this enables tissue 
specification, organ homeostasis and potentially tumourigenesis. Tissue differentiation and 
maintenance is guided by the coordination between differentiation and proliferation of 
specific progenitor cells. The importance of these mechanisms has been displayed by many 
authors for many different organs such as the brain, gut and skin (Fuchs 2009, Lange and 
Calegari 2010, Li and Clevers 2010).  
In the established model of mammalian cell cycle control, the retinoblastoma protein 
functions to direct cell fate. The retinoblastoma protein functions to restrict cells from 
entering S phase by binding and sequestering the E2f activators E2f1, E2f2 and E2f3. These 
are largely regarded as the ultimate effectors that commit cells to enter and progress through 
111 
 
S phase towards self-renewal. In differentiating cells, such as MSCs, E2f1-3 function as a 
complex with retinoblastoma proteins allowing the silencing of E2f targets and assist in the 
exit from the cell cycle (Chong, Wenzel et al. 2009). The E2f1 transcription factor acts a 
molecular switch between proliferation and differentiation and can bind to phosphorylated 
retinoblastoma protein. Unbound, E2f1 promotes G1 to S phase transition. However, upon 
complex formation between retinoblastoma protein and E2f1, G1 to S phase is inhibited 
(Johnson, Schwarz et al. 1993). Accumulation of phosphorylated retinoblastoma protein 
allows the switch from proliferation to differentiation as it has been reported to interact with 
transcription factors that are specific to osteogenesis and adipogenesis (RUNX2 and PPARγ) 
(Docheva, Padula et al. 2008). Figure 5.1 shows a schematic detailing the stages of MSC 
differentiation and proliferation.  
 
 
 
 
 
 
 
  
Figure 5.1. MSC cell cycle schematic. Quiescent MSCs in G0 phase can either self-renew or 
differentiate. 
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5.2 Materials and methods 
 
5.2.1 Nisin induction for cell adhesion 
 
Biofilm production and cell seeding was the same as detailed for previous cell adhesion 
experiments. However, nisin was added to the cultures at the same time as the mammalian 
cells at 0, 0.5, 5 and 10 ng/mL. Cells were left to attach for five hours and stained for actin, 
vinculin and nuclei using antibodies and methods detailed previously.  
 
5.2.2 Cell proliferation 
 
MSCs were seeded over L. lactis clones at 5,000 cells/cm2 for one and three days to measure 
cell proliferation at these time points. 6 hours prior to fixation, 1 mM BrdU (5-bromo-2-
deoxyuridine) was added to each well in DMEM. Cells were fixed and permeabilised using 
standard methods described previously. These were then blocked with 1 % BSA in PBS at 
37 °C for 10 minutes. The GE Healthcare Cell Proliferation Kit was used from this point to 
stain the cells. The mouse monoclonal anti BrdU was added with DNase to ensure the 
primary antibody was able to reach the DNA and incubated at 37 °C for 2 hours. Samples 
were washed using the standard protocol and the addition of phallacidin (Life Technologies, 
UK) and a Cy3 conjugated anti mouse secondary antibody (Jackson Immunoresearch, UK) 
was added for 1 hour at 37 °C. Cells were washed and mounted using Vectashield with Dapi 
(Vector Laboratories, UK) and viewed under a Zeiss AxioObserver.Z1 fluorescence 
microscope. 
 
5.2.3 Bacterial internalisation 
 
Biofilms were established using the methods as described previously. Both C2C12 and RAW 
macrophages were seeded over the biofilms at 5,000 cells/cm2 and left to grow for 16 hours. 
The cells were trypsinised for five minutes at 37 °C before centrifugation at 1300 RPM for 
five minutes. This addition of trypsinisation for five minutes was found to remove most 
mammalian cells but left a majority of bacterial cells attached to the coverslip. To further 
separate the cell types, the centrifugation step allowed the pellet of the mammalian cells 
whilst leaving the bacteria in the supernatant to be discarded. This cell pellet was 
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resuspended and seeded over FN coated coverslips (using the same methods as described 
previously) for five hours to allow cell attachment. Any bacteria present should either be 
inside or stuck to the outside of the bacteria. A Nikon Eclipse Ti Confocal microscope fitted 
with a Scmos camera using the Volocity software (Piltti, Haus et al. 2011) was used to 
visualise the samples. To establish the localisation of the bacteria, the co-localisation plugin 
was used whereby the software can evaluate the overlap of two dyes and thus be highly 
specific to bacteria that are inside the mammalian cells. 
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5.3 Results 
 
5.3.1 Cell adhesion 
 
Cell adhesion to constitutive and inducible FNIII7-10 in NZ9000 and NZ9020 was tested 
using different amounts of nisin, ranging through 0, 0.5, 5 and 10 ng/mL which can be seen 
in Figure 5.2. NZ9000 was used as well as NZ9020 as the short time point used is not 
detrimental to cell viability and gives us insight into how protein expression differs between 
the strains. It can be seen in the constitutive samples that the presence of the FNIII7-10 
fragment in both NZ9000 and NZ9020 L. lactis induces cell spreading, similar to the FN 
coated sample with very comparable values; NZ9000 and NZ9020 both show cell areas of 
2527 and 2672 µm2 respectively. The cells on the FN coat show cell areas of 3125 µm2 
which is higher than either NZ9000 or NZ9020 under the constitutive promoter. These 
results have been demonstrated before using a different strain of L. lactis known as MG1363 
(see Chapter 3).  
Most interestingly, the nisin controlled FNIII7-10 protein expression samples show striking 
results. Upon additive amounts of nisin, cell spreading increases.  These results have been 
quantified and can be seen in Figure 5.3  
The empty samples, that is, the ones displaying no FN, show the smallest cell area being 
comparable between sample sets, all the cells found on these surfaces show similar cell areas. 
Cells seeded onto the constitutive FNIII7-10 samples show similar results to that of a FN coat 
and are higher than their respective empty samples. Interestingly, cell area is seen to increase 
in both the NZ9000 and NZ9020 samples upon higher amounts of nisin added to the system. 
This also agrees with the results from the western blot, as more nisin is added, more GFP-
FNIII7-10 is found (see Chapter 4, Figures 4.7 and 4.17). This increased amount of FNIII7-10 
presented to the mammalian cells would allow for more cell spreading. Further to this, cell 
spreading on NZ9020 is seen to be lower than in NZ9000. This is likely due to the fact that 
this strain is much more metabolically slower than NZ9000 and therefore the five hours may 
not be enough time for the bacteria to synthesise enough FNIII7-10 to give a similar response 
to that seen in NZ9000. It can be seen that cell spreading on NZ9000 FNIII7-10 expressing 
clones when stimulated with 10 ng/mL of nisin is the highest, albeit, only slightly higher 
than the FN coated surface. It is most likely higher than the constitutive expression as the 
nisA promoter is stronger than P1; and therefore, more FNIII7-10 can be produced.  
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Figure 5.2. MSC adhesion to inducibly expressed FNIII7-10 from L. lactis. Top images show cell 
adhesion in response to FNIII7-10 production under nisin induction in inducible L. lactis-FN clones for both 
NZ9000 (top) and NZ9020 (bottom). Middle images show cell adhesion to L. lactis-FN constitutive clones 
for both NZ9000 (top) and NZ9020 (bottom). Bottom images show cell adhesion to FN coated and non-FN 
coated glass. All images taken after five hours. Upon increasing nisin addition, cell area is seen to increase. 
This is due to more FNIII7-10 being available in the bacterial cell wall. Green is actin, blue is DNA. Scale 
bar = 100 µm. 
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5.3.2 Cell proliferation 
 
Cell proliferation was studied on NZ9020 only as the long-term cultures will only be 
completed on this strain due to detrimental effect NZ9000 has on the long-term cell viability 
of MSCs. Figure 5.4 shows the percentage of new cells formed within six hours after the 
addition of 5-bromo-2’-deoxyuridine (BrdU) after one day (orange) and three days (blue) on 
constitutively expressed protein. BrdU is a brominated analogue of thymidine and is 
incorporated into cell DNA at the S phase of the cell cycle. Upon addition to the media, 
BrdU can replace thymidine in the cell’s DNA and be stained for with an anti-BrdU antibody 
Figure 5.3. Graphical representation of cell area after nisin induction. Increasing amounts 
of nisin are seen to lead to an increase in cell area in both NZ9000 and NZ9020 (statistically 
significant). Cell area in NZ9000 with 5 and 10 ng of nisin shows higher cell area than on 
constitutive clones. Conversely, cell area on NZ9020is lower than the constitutive clones, likely 
due to the slower metabolism rates. A minimum of 27 cells were used. Data is displayed as 
mean ± SD and was analysed with a one way ANOVA test with a Tukey post-hoc test. 
Statistical significance levels are *p < 0.05, **p < 0.01  and ***p < 0.001.   
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(Zhang, Zhi et al. 2010). MSCs were seeded over different L. lactis strains and the percentage 
of BrdU positive cells was calculated. At day one, cell proliferation on glass, FN coat, L. 
lactis-BMP-2W, L. lactis-BMP-2WGFP and L. lactis-BMP-2SGFP are all roughly 
equivalent. Proliferation on L. lactis-empty and L. lactis-FN are much higher with 20 % of 
the total cell count being BrdU positive. Conversely, cell proliferation was seen to be lowest 
on the FN coat with 100 ng/mL of BMP-2 added and L. lactis-BMP-2S with less than 5 % 
of cells being BrdU positive. A similar trend was seen for the three day experiment. Again, 
the lowest cell proliferation was seen on the FN coat with 100 ng/mL of BMP-2 added and 
L. lactis-BMP-2S at about 3 % of total cells being BrdU positive. All other samples show 
similar values with approximately 10 % of cells being BrdU positive. At three days L. lactis-
empty and L. lactis-FN show similar results to the other samples as opposed to being higher 
at one day.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4. Cell proliferation on differing constitutive L. lactis clones. The cells were culutred 
for one and three days and quantified according to BrdU incorporation into the nucleus.. Cell 
proliferation on most samples is approximately 10 % new cells over a six hour period where as 
cells culutred in the BMP-2 positive control and L. lactis-BMP-2S show much lower proliferation 
rates. A minimum of five images were analysed from three technical eplicates. Data are reported 
as the mean ± SD and was analysed by a two way ANOVA with a  Bonferroni post-hoc test (data 
not normally distributed). Statistical significance levels are *p < 0.05, **p < 0.01. 
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Figure 5.5 shows cell proliferation in response to the inducible clones. In this experiment, 
only L. lactis-BMP-2S and L. lactis-FN were used as the L. lactis-BMP-2W and both BMP-
2-GFP expressing clones showed no change in cell proliferation compared to on the FN coat. 
Further to this, a co-culture of L. lactis-FN and L. lactis-BMP-2S was also tested. Nisin was 
added at 10 ng/mL to allow maximal protein synthesis. A similar trend to that observed on 
the constitutive clones can be seen where the lowest cell proliferation was found on the FN 
coat with 100 ng/mL BMP-2 and the L. lactis-BMP-2S at both day one and day three. Cell 
proliferation on the FN coat, L. lactis-empty and L. lactis-FN are also very similar to those 
seen on the constitutive clones at around 10 % on day one with lower proliferation rates by 
day three. The co-culture of L. lactis-FN and L. lactis-BMP-2S shows an intermediate 
proliferation rate, between that of single L. lactis-FN and L. lactis-BMP-2S. This result, 
although not statistically significantly different from either single clone culture could be due 
to the lower levels of BMP-2 secreted; due to there being half the amount of L. lactis-BMP-
2S. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5. Cell proliferation on inducible L. lactis clones.. Nisin was used at 10 ng/mL in 
all samples. Results are similar to those of the constituve clones whereby L. lactis-BMP-2S 
shows similar results to that of the FN coat + BMP-2. A minimum of six images were 
analysed with three technical replicates per sample.  Data is reported as the mean ± SD and 
analysed with a two way ANOVA using a Bonferroni post-hoc test (data not normally 
distributed). Statistical significance levels are *p < 0.05, **p < 0.01. 
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The difference in cell proliferation could be explained by cell cycle dynamics. As described 
in the introduction of this chapter, differentiating cells must make a choice whether to self-
renew or differentiate. Self-renewing cells will proceed through G1 to S phase, dictated by 
E2f proteins. On the contrary, differentiating cells will not leave G1as retinoblastoma protein 
phosphorylation blocks S phase entry. Therefore, differentiating cells are unable to 
proliferate which may explain the lower proliferation rate on the FN-coated surface with 100 
ng/mL BMP-2 added. L. lactis-BMP-2S also demonstrates a low proliferation rate, similar 
to that of the FN coat with added BMP-2. This could be due to the BMP-2 secreted by the 
bacteria effecting the mammalian cell population (Wen, Miyake et al. 2004, Xu, Peck et al. 
2005).  
5.3.3 Cell-bacteria dynamics 
 
The ability of a microbe to establish a niche within its host is an important parameter of its 
pathogenesis. Some pathogens can enter normally non-phagocytic host cells as this may be 
a requirement for their replication. Indeed, L. lactis are not pathogenic and therefore do not 
possess the mechanisms for invasion into non-phagocytic mammalian cells such as C2C12s 
and MSCs. However, the internalisation of particles is a constitutive property of most, if not 
all mammalian cells (Poussard, Decossas et al. 2015). Therefore, the potential of mammalian 
cells to internalise bacterial cells was studied. We postulated that the presence of FNIII7-10 
would lead to the internalisation of the bacteria due to the integrin endocytosis-exocytosis 
cycle. Integrins holding the cell to the surface will move rearwards as the cell migrates over 
a matrix. This means that the leading edge of the cell requires new receptors to anchor the 
cell to the surface; this is achieved by cycling integrins from the rear regions of the cell, and 
their subsequent transport in vesicular form to the leading edge of the cell for re-use 
(Bretscher 1984, Bretscher 1992).  
To assess the localisation of bacteria, it was necessary to use a confocal microscope as this 
allows the user to isolate specific z-planes through a 3D structure. As the density of bacteria 
on normal co-cultured surfaces was high and made analysis of internalised bacteria 
extremely difficult, a new method to study internalisation was developed. Mammalian cells 
were first cultured on L. lactis using the same methods as reported previously, before 
trypsinisation and centrifugation; and then reseeding onto FN coated glass coverslips. The 
trypsinisation followed by centrifugation resulted in the removal of the bacteria from the 
mammalian cells. Reseeding these cells on a FN coat ensures that any bacteria present would 
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either be inside or stuck to the outside of the mammalian cell. The presence and localisation 
of these bacteria was determined by confocal microscopy.  
Figure 5.6 highlights C2C12 cells imaged after being seeded on L. lactis-empty, FNIII7-10, 
BMP-2W and BMP-2S bacterial biofilms. To deduce their localisation, the co-localisation 
plugin on Volocity was used. Graphs detailing localisation can be seen in Figure 5.8. 
A complementary experiment with macrophages was also set up using the same method as 
described above. Figure 5.7 shows that all strains of bacteria were also engulfed. This is 
unsurprising as it is macrophages primary role in the body to engulf any foreign particles, 
including bacteria. Graphs detailing localisation can be seen in Figure 5.8. 
Figure 5.6. Bacterial internalisation by C2C12 murine myoblasts. All mammalian cells were seen to 
engulf bacterial cells. L. lactis displaying a cell wall bound protein show a higher uptake than empty and 
secreted protein clones. Red = actin, blue = mammalian nuclei and green = bacterial cells. Scale bar is 100 
µm. 
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Figure 5.8 shows quantitative data for the internalisation study. A direct trend can be 
observed whereby bacteria with cell wall bound proteins are internalised at higher rates. This 
trend can be seen in both the C2C12s (Figure 5.8 A) and macrophages (Figure 5.8 C). L. 
lactis-BMP-2W seem to be engulfed at a higher rate than that of L. lactis-FN. Furthermore, 
bacteria without cell wall bound proteins are still internalised, but at a much lower frequency. 
The number of bacteria internalised per cell in C2C12s is lower than that observed in 
macrophages. Additionally, all macrophages observed had internalised bacteria (Figure 
5.8D) whereas C2C12s were seen to engulf bacteria with varying success rates. C2C12s 
were most likely to internalise L. lactis-BMP-2W, followed by L. lactis-FN at as they were 
found in 75 % and 53 % of cells respectively. L. lactis-empty and L. lactis-BMP-2S showed 
very similar results to that of L. lactis-FN as 51 % of cells were found with bacteria 
internalised. However, the total number of L. lactis-FN and L. lactis-BMP-2S found in 
Figure 5.7. Bacterial internalisation by RAW macrophages. All mammalian cells were seen to engulf 
bacterial cells. Red = actin, blue = nuclei and green = bacterial cells. Scale bar is 50 µm. 
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C2C12 cells is drastically different with 20 and eight bacteria per cell respectively. This 
parameter explains that although the total amount of C2C12s with at least one bacteria is 
very similar, L. lactis-FN is more likely to be engulfed at higher rates. L. lactis-empty was 
found in the least amount of cells at 45 %.  
Figure 5.8. Graphs detailing bacterial internalisation. Graphs were constructed from 20 pictures per 
sample. A = number of bacterial cells internalised per C2C12, B = number of bacterial cells internalised per 
macrophage, C = the percentage of C2C12 cells with internalised bacteria and D = the percentage of 
macrophage cells with internalised bacteria. More bacteria were internalised in macrophages than C2C12s 
with bacteria displaying a cell wall bound protein being more likely to be internalised. All macrophages 
imaged had internalised bacteria whereas C2C12s displayed differing results. A minimum of 15 cells were 
tested and quantified per sample with three technical replicates completed. Data is presented as the mean ± 
SD and analysed with a one way ANOVA using a Bonferroni post-hoc test (data not normally distributed). 
Statistical significance levels are *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001. 
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5.4 Discussion 
 
Cell adhesion and proliferation is essential for the construction of organs in vitro. Usually, a 
scaffold is functionalised with proteins to allow cell attachment which can direct cellular 
behaviour (Lendlein 2011, Ebara, Kotsuchibashi et al. 2014, Murphy, McDevitt et al. 2014). 
This material-cell interface is designed by the user and can be used to alter cells phenotype 
(Friess 1998, Hench and Polak 2002, Rosso, Marino et al. 2006, Oh, Brammer et al. 2009, 
Lendlein 2011). For example, the scaffolds used in our experiments are glass coverslips that 
are functionalised with genetically engineered bacteria expressing FNIII7-10 and BMP-2 to 
control cell adhesion and differentiation.  
It was found that this surface of L. lactis comprising the strains NZ9000 and NZ9020 can 
induce cell attachment through the FNIII7-10 fragment in both a constitutive and inducible 
manner. Further to this, cell area is proportional to the amount of available protein which 
can be altered by the addition of different concentrations of inducer.  
In terms of the BMP-2 clones, for both constitutive and inducible BMP-2, L. lactis-BMP-2S 
seems to show similar results to that of a FN-coated surface with 100 ng/mL BMP-2 added 
to the culture. Cell proliferation was studied in response to the addition of differentiation 
factors as differentiating cells do not proliferate at the same rate as those on normal FN coats 
(Wen, Miyake et al. 2004, Xu, Peck et al. 2005). The data shows that L. lactis-BMP-2S in 
both the constitutive and inducible forms inhibits higher cell proliferation rates showing that 
the BMP-2 from L. lactis could potentially be used as a long term successful dynamic 
differentiation platform for MSCs.  
In addition to basic cell response, bacteria-mammalian cell dynamics were also evaluated. 
Mammalian cells have the machinery to internalise particles and is an inherent property of 
most, if not all mammalian cell types (Vannhieu and Isberg 1993, Poussard, Decossas et al. 
2015). We found that C2C12 cells, as well as RAW macrophages internalise all forms of L. 
lactis. However, the rate of uptake is determined by whether the bacteria is displaying a cell 
wall bound protein. Interestingly, L. lactis-BMP-2W was internalised at higher rates than L. 
lactis-FN. We hypothesised that L. lactis-FN would be internalised at the highest rates due 
to the integrin endocytosis-exocytosis cycle. Furthermore, although L. lactis-BMP-2W was 
internalised at a higher rate, it does not alter the cells ability to proliferate like L. lactis-BMP-
2S. This shows that although the cells are clearly interacting with L. lactis-BMP-2W, the 
BMP-2 does not stimulate the same cell response as L. lactis-BMP-2S.  
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The proteins displayed and expressed by L. lactis show biological function. L. lactis-FN can 
induce cell attachment whereas L. lactis-BMP-2S shows biological activity by preventing 
MSC proliferation at early time points (one and three days).  
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5.5 Conclusion 
 
This chapter assessed the short-term interaction dynamics between constitutive and 
inducible L. lactis clones and mammalian cells. The results of this chapter suggest that the 
inducible system for both L. lactis-FN and L. lactis-BMP-2S are biologically active. This is 
in agreement with the western blot and fluorescence data shown in Chapter 4. In terms of 
the FNIII7-10 expressing clones, the amount of nisin added to the system directly affects 
protein expression and that this in turn effects cell area. This is likely due to the fact that 
more RGD is available to the cells in the higher nisin cultures, and that this protein 
availability allows the cells to stretch further.  
In terms of the BMP-2 expressing clones, L. lactis-BMP-2S shows osteogenic activity 
whereas L. lactis-BMP-2W seems to show no activity. Longer term cell differentiation 
studies will be shown in the next chapter.  
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6. Mammalian cell differentiation on 
BMP-2 expressing bacteria 
 
 
 
Summary 
This chapter focusses on L. lactis clones and their ability to induce differentiation of MSCs. 
Mid (ALP activity) and long (OCN and von Kossa) term osteogenic markers were evaluated 
to ascertain the differentiation dynamics of different L. lactis clones. Both constitutive and 
inducible BMP-2 expressing clones were investigated in vitro. Lastly, constitutive NZ9000 
BMP-2 producing clones were used in an in vivo mouse model to explore bone growth. L. 
lactis were incorporated into collagen sponges and the clone demonstrating the best 
osteogenic results in vitro were chosen for further experimentation in vivo. The results in 
this chapter demonstrate that L. lactis-BMP-2S can induce the differentiation of MSCs in 
vitro in both a constitutive and inducible fashion.  
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6.1 Introduction 
 
MSCs are able to differentiate along the stromal lineages to give rise to osteoblasts, 
chondrocytes and adipocytes, typically through the application of chemical and physical 
cues (Pittenger, Mackay et al. 1999). More specifically, MSCs are sensitive to stiffness 
(Engler, Sen et al. 2006), cell tension through mechanotransduction (McBeath, Pirone et al. 
2004), surface topography (Dalby, Gadegaard et al. 2007) and dimensionality (2D or 3D) 
(Oh, Brammer et al. 2009), these physical characteristics have the power to direct cellular 
fate. On the other hand, chemical stimuli, such as that of BMP-2 also have the ability to 
induce differentiation (Rahman, Akhtar et al. 2015).  
Bone is a specialised form of connective tissue and is the main element of the skeletal 
system. The formation of bone is highly complex and a finely orchestrated process involving 
many of the physical and chemical stimuli mentioned above. BMPs play a major role in the 
regulation of osteoblast lineage specific differentiation, which later translates to bone 
formation. Since the discovery of BMPs in 1965, many authors have sought to find the 
importance of BMPs in vivo using transgenic animals. These loss-of-function experiments 
demonstrated a variety of bone related abnormalities during development (Urist 1997, 
Lechleider, Ryan et al. 2001, Zhao 2003). BMPs are therefore hugely important in vivo and 
demonstrate great therapeutic potential in vitro (Tamaki, Souchelnytskyi et al. 1998, Itoh, 
Itoh et al. 2000, Guicheux, Lemonnier et al. 2003, Afzal, Pratap et al. 2005, Ryoo, Lee et al. 
2006, Bessa, Casal et al. 2008, Ulsamer, Ortuno et al. 2008).  
The bone microenvironment mainly comprises MSCs, derived osteoblasts, osteoclasts, 
mineralised bone matrix and osteocytes (Chen, Deng et al. 2012). Osteogenesis can be 
separated into three distinct stages, migration and mitosis of MSCs, differentiation of MSCs 
and lastly, deposition of matrix (Gilbert 2000, Hoshiba, Kawazoe et al. 2009). During the 
differentiation stage, MSCs are the target of BMPs (Rahman, Akhtar et al. 2015). MSCs are 
therefore an important source of bone in vivo and show the greatest potential for recreating 
the bone microenvironment in vitro.  
MSCs have been used for decades in the attempt to imitate the bone microenvironment with 
varying success (Osdoby and Caplan 1981, Sparks and Scott 1986, Anderson, Sahoo et al. 
2016, Llopis-Hernandez, Cantini et al. 2016). It is currently postulated that the use of 
dynamic surfaces show the greatest potential to overcome problems with MSC culture 
(Ebara, Yamato et al. 2004, Todd, Scurr et al. 2009, Wirkner, Weis et al. 2011, Weis, Lee et 
al. 2013, Murphy, McDevitt et al. 2014, Roberts, Sahoo et al. 2016). The bone 
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microenvironment is constantly changing; therefore any synthetic material aiming to 
recapitulate this niche would need to be able to display a variety of behavioural cues. In 
terms of biochemical induced differentiation, the specific addition of supplements in a 
particular sequence is needed; the same will be needed for exact material control. We can 
expect to see a material that can be altered upon user defined conditions that relates material 
properties to gene activation, and thus has the power to control phenotype.  
This work aims to demonstrate that bacterial biofilms formed by non-pathogenic L. lactis 
can be exploited to create an effective dynamic surface. They have the potential to be 
modified with a superfluity of proteins, displaying them either through cell wall bound or 
secreted expression that can influence cell behaviour. The use of constitutive and inducible 
plasmids with differing strength promoters allows for a variety of clones to be easily 
synthesised and tested. The user can tailor these microbial factories to express their protein 
of interest at desired concentrations in a spatiotemporal manner. 
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6.2 Materials and Methods 
 
6.2.1 Collagen sponges 
 
Collagen sponges with a 5 mm diameter were sterilised overnight in ethylene oxide and used 
in 96 well plates. Bacteria were grown on these using the same method as described for glass 
coverslips (section 2.2). MSCs were then seeded at 5000 cells/cm2 under the same conditions 
used on glass coverslips (Section 2.5) and left to culture until the desired time point (one day 
for cell adhesion, 10 and 15 for ALP activity). For the positive control (100 ng BMP-2), 
BMP-2 was added after one day.  
6.2.2 Cell adhesion to collagen sponges 
 
Sponges were fixed with 4 % formaldehyde for 15 minutes at 37 °C and then stained for 
actin with phalloidin (Invitrogen, UK) for one hour at 37 °C before mounting with DAPI 
(Vectashield, UK). These were viewed under a Nikon Eclipse Ti Confocal microscope fitted 
with a Scmos camera. 
6.2.3 Alkaline phosphatase (ALP) assay 
 
Firstly, protein had to be extracted from the samples, cells were lysed by the addition of 50 
mM Tris-HCl and sonicated for 20 seconds at 5 watts. To obtain protein content, a 
bicinchoninic acid (BCA) (Life Technologies, UK) was completed. For ALP activity, 
MUP (4-methylumbelliferyl phosphate) substrate was added. MUP substrate comprises: 
500 µL 1M NaHCO3, 2 mL 5x Diethenolamine buffer, 7.5 mL water and 24 µL MUP 
stock. 5x diethenolamine buffer is 50 mM diethanolamine, 2.5 mg MgCl2 in water, pH 9.5 
and MUP stock is 83.3 mM MUP in 1x diethanolamine buffer.  
 
The BCA was completed using the manufacturer’s guidelines. Briefly, samples were 
incubated with the BCA working reagent at 37 °C for one hour. Then, the absorbance of the 
samples was measured at 562 nm using Infinite 200 PRO NanoQuant Plate Reader from 
Tecan. ALP concentration was measured through MUP fluorescence. Fluorescent readings 
were obtained by exciting the fluorophore at 360 nm and recording the fluorescence at 465 
nm. mU ALP/mg protein was obtained by dividing ALP mU/µL by the protein content 
obtained in the BCA.  
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6.2.4 Animals 
 
10 male mice (species Balb/c from Jackson Labs, USA) were used in the study, with two 
implants per mouse, to minimise animal usage. They were maintained in plastic cages in a 
room with a 12 h-day/night cycle and an ambient temperature of 21 °C, and were allowed 
ad libitum access to water and standard laboratory pellets. Animal selection and 
management, surgical protocol, and preparation followed the routines approved by the 
Georgia Tech Institutional Animal Care and Use Committee (IACUC).  
6.2.5 Surgical protocol 
 
The animals were generally anaesthetised with isoflurane anaesthesia. The surgical site was 
shaved and scrubbed with iodine. A vertical incision was made in the skin of the back. After 
flap reflection, a subcutaneous pocket was prepared by blunt dissection. Samples were 
implanted subcutaneously mid torso at the level of the panniculus carnosus. The incisions 
were closed with wound clips and mice were monitored daily until the wound clips were 
removed. 
6.2.6 Sponge implantation 
 
8 mm diameter sponges were sterilised in ethylene oxide overnight before the addition of 
bacteria. Bacteria were grown using the same method as used on glass coverslips. These 
were washed 2x in PBS before being implanted into the backs of mice. A small incision was 
made in the skin of the mice and the sponges, 1 on the left and 1 on the right were implanted 
subcutaneously, between the skin and muscle.  
 
6.2.7 Micro computed tomography (μCT) 
 
For μCT scanning, the region of implantation was scanned in anesthetised, live mice using 
a VivaCT system (Scanco Medical, Wayne, PA, USA) at 145 mA intensity, 55 kVp energy, 
376 ms integration time, and 12.5 μm resolution). Bone structure was evaluated by 
contouring 2D slices to include only the collagen sponge. 3D μCT reconstructions were 
rendered and the ratio of bone volume to total volume was computed. 
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6.2.8 Implant removal and histology 
 
The implants were used for histological analysis. Sponges were removed from the mice after 
CO2 asphyxiation and fixed in 4 % formalin overnight.  All samples were then decalcified 
in 10 % (vol/vol) formic acid for two days, embedded in paraffin, and sectioned transversely 
at the top, middle and bottom of the sponge at a thickness of 5 µm. These were then 
rehydrated through a graded series of alcohol solutions. The sections were then stained with 
haematoxylin and eosin.  
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6.3 Results 
 
6.3.1 Mesenchymal stem cell differentiation 
 
Alkaline phosphatase activity 
Alkaline phosphatase (ALP) catalyses the hydrolysis of phosphate esters (Sabokbar, Millett 
et al. 1994). Changes in ALP level and activity are associated with many biological states, 
including osteoblast activity. The precise mechanism of function is not understood, although 
it is believed to play a role in skeletal mineralisation and is therefore a marker of bone 
development (Siffert 1951, Orimo 2010). 
Figures 6.1 and 6.2 show ALP activity of MSCs after 10 and 12 days respectively. High 
ALP activity can be seen in the positive controls (FN coat + osteogenic media and FN coat 
+ 100 ng/mL BMP-2) when compared with the negative control (FN coat). ALP activity, 
was interestingly mostly equivalent to the FN coat in all L. lactis samples except L. lactis-
BMP-2S, which was seen to be higher than the FN coat, with results very similar to that of 
a FN coat with the addition of BMP-2 at 100 ng/mL. This is true at both time points.  
 
  
Figure 6.1. ALP activity of MSCs after 10 days. Cells were seeded over different L. 
lactis clones. ALP activity is highest in L. lactis-BMP-2S when compared with controls. 
Three technical replicates were completed per sample. Data is presented as the mean ± 
SD and analysed with a one way ANOVA with a Tukey post hoc test. Statistical 
significance levels are *p < 0.05, **p < 0.01, ***p < 0.001 and **** p < 0.0001. 
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This higher ALP activity could be due to the osteogenic potential of the secreted BMP-2 
from L. lactis-BMP-2S. These results, compounded by the BrdU results from the previous 
chapter (Figures 5.4 and 5.5), show that out of our L. lactis clones, L. lactis-BMP-2S displays 
the highest potential for MSC osteoblastic differentiation. 
For the long term experiments, only the differentiation characteristics of L. lactis-BMP-2S 
were explored as the other clones seem to show no osteoblastic potential.  
Three different nisin induction profiles were designed to test the effectiveness of the 
inducible L. lactis-BMP-2S at different strengths. Figure 6.3A highlights the daily addition 
of nisin to the cultures and when the OCN and von Kossa experiments were completed. 
Figure 6.3B shows the amount of BMP-2 produced by NZ9020 in response to the nisin added 
shown in Figure 6.3A. 
 
 
 
Figure 6.2. ALP activity of MSCs after 12 days. Cells were seeded over different L. lactis clones. 
ALP activity is highest in L. lactis-BMP-2S when compared with controls. Three technical 
replicates were completed per sample. Data is presented as the mean ± SD and analysed with a one 
way ANOVA with a Tukey post-hoc test. Statistical significance levels are **** p < 0.0001. 
 
134 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Osteocalcin expression 
The bone specific ECM protein OCN was used to determine MSC response to BMP-2 after 
21 days. OCN is regularly used as a positive indicator of the onset of osteogenic commitment 
as it is expressed post-proliferatively by osteoblasts (Lian, Stewart et al. 1989, Rickard, 
Figure 6.3. Nisin and BMP-2 induction profiles. (A) The inducible cultures were tailored 
to express BMP-2 and FNIII7-10 at different rates throughout the course of the experiment to 
test the longevity and time dependency of BMP-2 towards osteogenic differentiation. Nisin 
was added daily to the cultures. (B) BMP-2 production in NZ9020 in response to nisin 
addition. Graph was completed using data taken from the ELISA (Figure 4.16). A 
continuous (green), high to low (red) and low to high (blue) induction profile was chosen to 
test BMP-2s osteogenic activity. 
A 
B 
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Kassem et al. 1996, Malaval, Liu et al. 1999, Kim, Yoo et al. 2005). OCN expression was 
seen to be present in all samples as shown in Figure 6.4, albeit, with varying amounts at day 
21. Quantification of OCN (Figure 6.5) determined that their expression was higher in BMP-
2 positive samples (added at 100 ng/mL and in the L. lactis-BMP-2S samples). OCN levels 
are consistently high between the FN coat +100 ng/mL BMP-2, constitutive L. lactis-BMP-
2S and inducible L. lactis-BMP-2S at constant and high to low addition of nisin whilst OCN 
levels on the FN coat and constitutive L. lactis-FN are low.  
Importantly, OCN expression was seen to be similar between the constitutive and inducible 
clones when nisin was added at a constant and high to low amount.  
The results of OCN quantitation show clear differences in expression between a number of 
samples. For example, L. lactis-BMP-2S, in both its constitutive and inducible form shows 
a higher OCN expression than constitutive L. lactis-FN.    
 
 
Figure 6.4. Osteogenic differentiation of MSCs through osteocalcin. MSCs were cultured for 21 days and 
immunostained for actin (red), osteocalcin (green) and nuclei (blue). The top row represents MSCs seeded on 
FN coats, the second row shows constitutive L. lactis clones. The third and fourth row represent MSCs seeded 
on L. lactis-BMP-2S with differing amounts of inducer and MSCs seeded over co-cultures of L. lactis-FN and 
L. lactis-BMP-2S with differing amounts of inducer respectively. Scale bar is 100 μm. 
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von Kossa staining 
Osteoblasts deposit phosphate as a primary step of bone development and therefore this 
process is suggestive of terminal osteogenic differentiation. As can be seen from Figure 
6.6A, phosphate deposition is distinctly higher (black deposits) in the samples with BMP-2 
when compared to the negative control samples. Figure 6.6B shows a full coverslip as an 
example of the stain (L. latis-BMP-2S high to low).  
Quantification of phosphate deposition shown in Figure 6.7 again showed higher osteogenic 
markers in the BMP-2 positive samples. The positive control showed the highest 
differentiation with very comparable results between the BMP-2 positive sample sets. These 
results are complementary to the OCN results demonstrated above (Figures 6.4 and 6.5) with 
high OCN and von Kossa staining in the same samples.  
 
Figure 6.5. Osteocalcin quantitation. Graph shows integrated density corresponding to osteocalcin. 
OCN was found to be significantly higher in the samples with BMP-2 than in the samples without 
BMP-2. For the inducible clones, osteocalcin was seen to be higher in the sample sets where the 
inducer was highest at the start of the culture. A minimum of 400 cells from three technical replicates 
were used to analyse the samples. Data is presented at the mean ± SD and analysed with a one way 
ANOVA with a Tukey post-hoc test. Significance levels are **p < 0.01 and ***p < 0.001. 
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A 
B 
Figure 6.6. Osteogenic differentiation of MSCs through von Kossa. (A) Mineralisation (phosphate 
deposition) was assessed with a von Kossa staining on MSCs cultured after 28 days. Samples with BMP-2 
showed much higher phosphate deposition than without BMP-2, as can be seen by the black deposits. The 
top row represents MSCs seeded on FN coats, the second row shows constitutive L. lactis clones. The third 
and fourth row represent MSCs seeded on L. lactis-BMP-2S with differing amounts of inducer and MSCs 
seeded over co-cultures of L. lactis-FN and L. lactis-BMP-2S with differing amounts of inducer 
respectively. Scale bar is 300 µm. (B) Representative whole coverslip after von Kossa staining. 
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Figure 6.8 shows OCN expression and phosphate deposition relative to the FN coated glass 
which is given value of ‘1’. On the constitutive clones, both L. lactis-FN + 100 ng/mL BMP-
2 and L. lactis-BMP-2S show statistically significantly higher OCN and phosphate 
deposition with a mean fold change increase of 9 and 7 respectively in OCN and 10 and 9 in 
phosphate deposition. L. lactis-FN shows no difference and fold change remains close to ‘1’. 
Moreover, L. lactis-FN + 100 ng/mL BMP-2 and L. lactis-BMP-2S are not statistically 
different from each other, showing similar levels of differentiation.  
In the inducible clones, constant and high to low addition of nisin showed statistically 
significantly more OCN and phosphate deposition than FN coated glass with very 
comparable fold change levels to those seen in the constitutive clones. On the contrary, low 
to high nisin addition resulted in statistically similar results to that of FN coated glass.  
These results clearly show the differentiation potential of our L. lactis-BMP-2S in both a 
constitutive and inducible manner. 
Figure 6.7. Phosphate deposition quantitation. Graph shows integrated density corresponding to 
phosphate deposition. von Kossa stains were found to be significantly higher in the samples with 
BMP-2 than in the samples without BMP-2. For the inducible clones, phosphate was seen to be higher 
in the sample sets where the inducer was highest at the start of the culture. A minimum of nine images 
were taken from three technical replicates. Data is presented as the mean ± SD and analysed with a 
one way ANOVA with a Tukey post-hoc test. Significance levels are **** p < 0.0001. 
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Altogether, the cell proliferation (Figures 5.4 and 5.5.), ALP (Figures 6.1 and 6.2.), OCN 
(Figures 6.4, 6.5 and 6.7.) and von Kossa (Figures 6.6, 6.7 and 6.8) confirm the ability of the 
living interface to induce MSC differentiation.  
Figure 6.8. Overall osteogenic differentiation. Graphs detail fold changes for constitutive (top) and 
inducible L. lactis (bottom). Expression of OCN (above) and deposition of phosphate (below) was 
compared to that on FN coated glass (dotted line) and representative images are shown to the right. Data 
used here are the same as from Figures 6.5 and 6.7. Data is presented as the mean ± SD and analysed with a 
one way ANOVA with a Tukey post-hoc test. Scale bar is 100 µm for OCN and 300 µm for von Kossa. 
Significance levels are **** p < 0.0001. 
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6.3.2 In vivo mouse study 
 
The objective of this work was to evaluate the ability of biomaterial (collagen) scaffolds 
containing BMP-2 producing L. lactis to promote bone formation in vivo in an ectopic site. 
The model chosen was subcutaneous implantation as it is commonly used and an appropriate 
model to evaluate host responses to implanted biomaterials as well as the mineralisation 
capabilities of the therapy. The subcutaneous model also allows examination of the 
bacteria’s capability to direct bone formation in an in vivo environment without contributions 
from host osteogenic cells. This implantation site provides a stringent, non-osseous 
environment to examine the inherent capacity of these bacteria to form bone tissue in vivo 
and gives important information on the inflammatory and immune response to these 
constructs (Friess 1998, Geiger, Li et al. 2003, Carstens, Chin et al. 2005, Lee, Kim et al. 
2010). 
Prior to the completion of the in vivo work, it was imperative to establish a sensible scaffold 
for the bacteria as the use of a glass coverslip would be detrimental to animal health. We 
chose to use the well characterised, absorbable collagen sponge (ACS) as it has high 
biocompatibility, is degradable and shows a suitable interaction with cells and other 
macromolecules (Friess 1998, Geiger, Li et al. 2003). Further to this, it has been used in 
conjunction with the delivery of BMP-2 to in vivo test sites (Carstens, Chin et al. 2005). ACS 
is used with BMP-2 as the protein acts optimally when combined with an adequate matrix. 
This matrix acts to prolong the residence time of the protein as well as acting as support for 
invading osteoprogenitor cells; the favourable influence of collagen on cellular infiltration 
in would healing is well known (Kim, Lee et al. 2011). The efficacy and safety of the 
combination of the ACS and BMP-2 has been clearly proven in both animal and human trials 
(Nevins, Kirker-Head et al. 1996, Boyne, Marx et al. 1997, d'Aquino, De Rosa et al. 2009).  
Cell adhesion to sponges was first explored. MSCs were seeded (5000 cells/cm3) over 
collagens sponges that had been pre-cultured with different strains of L. lactis. MSCs were 
cultured for one day before fixation and staining with DAPI and phalloidin. It is apparent 
from Figure 6.9 that cells have attached to all sponges with varying success. Scaffolds 
functionalised with bacteria seem to show a much higher cell attachment than without 
bacteria. Even scaffolds with L. lactis-empty were seen to harbour more cells than the non-
bacterial samples. This is surprising as the collagen should induce cell adhesion. All cells 
display a stretched elongated morphology, indicative of their health and viability. 
Surprisingly, DAPI seemed to stain the collagen sponge as well as nuclei. This can be 
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concluded by the fact that the sponge can be seen as green in the scaffolds without bacteria. 
Bacteria were present in the sponges as the medium (DMEM) could be seen to turn yellow, 
an indication of acidification by L. lactis NZ9000.  
 
Figures 6.10 and 6.11 show activity of ALP in mU of ALP/mg protein on different 
functionalised collagen scaffolds. Cells were left to culture for 10 and 15 days before lysing 
and assaying for protein content and ALP activity.  
Figure 6.9. MSC adhesion to functionalised collagen sponges after 1 day. Cells were seeded over differently 
functionalised collagen sponges and MSCs can be seen to adhere all surfaces. Green = DAPI and red = actin. Scale 
bar = 100 µm. 
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Figure 6.10 shows ALP activity at day 10 in collagen sponges. It is clear that the samples 
with 100 ng/mL of BMP-2 added to the media (positive control) induced the highest amount 
of ALP activity, however, the negative control (no BMP-2), displayed a similar amount of 
ALP activity to that of our L. lactis displaying BMP-2 bacteria (albeit, slightly less than the 
secreted BMP-2). Further to this, our BMP-2 strains, both the membrane and secreted 
versions, produced higher amounts of ALP than our non BMP-2 expressing strains (not 
statistically different). The only statistically significantly difference in the samples was 
between 100 ng/mL BMP-2 and L. lactis-FN.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.11 highlights ALP activity at day 15 and shows that 100 ng/mL of BMP-2 (positive 
control) induced the highest amount of ALP activity. The next highest result is that of L. 
lactis-BMP-2S, which is the same result as for on glass coverslips shown in Figures 6.1 and 
6.2. This confirms that the bacteria and mammalian cells behave in a similar way as to on 
the glass coverslips. This results demonstrates that L. lactis-BMP-2S has the ability to induce 
osteogenesis in a collagen sponge and was chosen as the L. lactis strain to continue the in 
vivo trial.  
 
Figure 6.10. ALP activity of MSCs after 10 days on collagen sponges. Cells were seeded 
over differently functionalised collagen sponges. ALP activity is highest in L. lactis-BMP-
2S, however, is similar to the negative control. Three technical replicates were completed 
per sample. Data is presented as the mean ± SD and analysed with a one way ANOVA with 
a Tukey post-hoc test.  Statistical significance level is *p <  0.05. 
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In vivo study 
The preliminary in vitro study was used to ascertain which strain of L. lactis should be used 
in vivo. From the cell attachment and ALP studies, it was concluded that L. lactis-BMP-2S 
showed the best potential for bone production in vivo.  
µCT 
Mice were anaesthetised and imaged. Annex Figures 8.1 (two weeks) and 8.2 (four weeks) 
show reconstructed 2D images of the areas housing the collagen sponges and Tables 6.1 
(two weeks) and 6.2 (four weeks) show the calculated bone volume (mm3). No mineralised 
bone was seen in any sample, including the positive control. Conventionally, a large amount 
of BMP-2 is used in these studies, with more than 1 µg/mL being the normality. We used 
100 ng/mL and are therefore at least at a 10 fold reduction in BMP-2 levels. This low dosage 
could explain the lack of bone formation in the sponges. This amount was chosen as it was 
the amount used in the in vitro controls. If the experiment were to be done again, a higher 
concentration positive control would be needed. 
Figure 6.11 ALP activity of MSCs after 15 days on collagen sponges. Cells were 
seeded over differently functionalised collagen sponges. ALP activity is highest in L. 
lactis-BMP-2S. Three technical replicates were completed per sample. Data is 
presented as the mean ± SD and analysed with a one way ANOVA with a Tukey post-
hoc test.  Statistical significance level is *p <  0.05. 
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Table 6.1. Calculated bone volume (mm3) in collagen sponges after two weeks. 
Scaffold Empty  
scaffold 
100 ng/mL 
BMP-2 
L. lactis-
empty 
L. lactis-BMP-
2S 
1 0 0 0 0 
2 0 0 0 0 
3 0 0 0 0 
4 0 0 0 0 
5  0 0 0 
6    0 
 
 
Table 6.2. Calculated bone volume (mm3) in collagen sponges after four weeks. 
 
 
Histology 
The sponges were explanted from the mice and were stained with haematoxylin and eosin 
(H&E). Figure 6.14 shows H&E staining of 5 µm slices of the sponges. The light pink 
(detailed by the blue arrows) corresponds to regions of the sponge, the dark purple spots are 
cell nuclei and the lighter purple colour are the cell cytoplasm. It is apparent from the images 
that the sponges have been invaded by cells, including the middle of the sponge. The sponges 
have been vascularised as can be seen by the presence of a vein holding red blood cells 
(shown by green arrow). We expected an immune response from the animals due to the 
addition of the bacteria, with more white blood cells present in the bacterial samples, 
however, no differences in H&E staining were seen between the samples.  
 
Scaffold Empty  
scaffold 
100 ng/mL 
BMP-2 
L. lactis-
empty 
L. lactis-BMP-
2S 
1 0 0 0 0 
2 0 0 0 0 
3 0 0 0 0 
4 0 0 0 0 
5  0 0 0 
6    0 
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Empty sponge 
L. lactis Secreted BMP-2  
2
Empty L. lactis 
100 ng/mL BMP-2 
Empty sponge 100 ng/mL BMP-2 
20x 
40x 
Figure 6.12. Haematoxylin and eosin staining of sliced collagen sponges after four weeks. Images were 
taken at 20x (top) and 40x (bottom) on empty sponge, sponges with 100 ng/mL BMP-2, sponges with L. 
lactis-empty and sponges with L. lactis-BMP-2S. Blue arrows show areas of collagens sponge and the green 
arrow shows a vascularised area. 
L. lactis Secreted BMP-2  
2 
Empty L. lactis 
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6.4 Discussion 
 
Engineering the cellular microenvironment to direct stem cell behaviour is of fundamental 
importance to biomedical applications. It is known that that cells interact with their 
environment, the ECM, through integrins and growth factor receptors resulting in 
biochemical signalling cascades. Collectively, these different signals dictate a plethora of 
responses already hardwired into the genes of the cell which control many cellular 
phenotypes, including differentiation.  
This chapter highlights the osteogenic potential of L. lactis-BMP-2S at varying time points 
(10, 12, 21 and 28 days) and on different surfaces (PEA coated glass and ACS).  
ALP activity of MSCs after 10 and 12 days (Figures 6.1 and 6.2) on differing constitutive L. 
lactis clones showed that L. lactis-BMP-2S demonstrated the best osteogenic potential as 
MSC ALP activity was almost identical to that of MSCs cultured on a FN coat with 100 
ng/mL BMP-2 added to the medium. This was true at both 10 and 12 days. Therefore, L. 
lactis-BMP-2S shows the lowest proliferation rates at one and three days (Figures 5.4 and 
5.5) on both constitutive and inducible clones, and highest ALP activity at day 10 and 12. 
The results for L. lactis-BMP-2S were most similar to our positive control, a FN coat with 
100 ng/mL BMP-2 added to the medium. In contrast, L. lactis-FN, L. lactis-BMP-2W and 
L. lactis-BMP-2S and M-GFP showed high proliferation rates and low ALP activity, similar 
to that of a FN coat without BMP-2 added. These results suggested that L. lactis-BMP-2S 
showed the highest osteogenic potential which allowed us to select this clone for further 
study.  
Upon selection of L. lactis-BMP-2S for long term differentiation studies, a 21 day OCN and 
28 day von Kossa stain were completed. This was tested on both the constitutive and 
inducible clones. The OCN and von Kossa data validated L. lactis-BMP-2S’ ability to induce 
differentiation of MSCs in both its constitutive and inducible forms. In its constitutive form, 
differentiation from both the OCN and von Kossa showed similar results to that of the 
positive control. The inducible form was tested at different strengths of inducer (profiles 
shown in Figure 6.3). Unsurprisingly, the constant expression with 10 ng/mL nisin showed 
high differentiation and low to high showing negligible differentiation. Surprisingly, high to 
low addition of nisin resulted in similar differentiation to that of constant addition. This data 
explains that nisin addition is needed at early time points in the experiment, as by day 19 
nisin addition was at its maximum (10 ng/mL) in the low to high samples and insignificant 
differentiation was seen by 21 and 28 days. This details the importance the initial 
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cell/material interaction. This data supports the existing paradigm that cells react strongly to 
the initial stimuli. In the high to low sample, BMP-2 expression was relatively low by day 
10 and the same level of differentiation was seen between this and the constantly high 
expressed BMP-2 samples. 
These long-term (OCN and von Kossa), compounded by mid-term (ALP) and short-term 
(BrdU) differentiation results show that L. lactis-BMP-2S has strong osteogenic potential to 
direct the differentiation of MSCs to osteoblasts in vitro.  
Next, the differentiation capabilities were examined in 3D collagen sponges before being 
trialled in an in vivo subcutaneous mouse model. NZ9000 bacteria were used in this model 
as they are capable of producing higher amounts of protein, and the mouse’s vascular system 
would be able to remove any lactic acid produced by the bacteria, thus removing the biggest 
in vitro problem with the system (Eggleton and Evans 1930, Davies, Knibbs et al. 1970).   
MSCs were found to adhere to all sponges as collagen proteins hold multiple cell adhesion 
motifs (Heino 2007, Taubenberger, Woodruff et al. 2010) , regardless of L. lactis present. 
Interestingly, the presence of bacteria increased the adhesion of MSCs to the sponge when 
compared to the empty sponges. This was true of all L. lactis subtypes, and not only L. lactis-
FN. A mid-term ALP activity assay was again utilised to ascertain the differentiation 
aptitude of L. lactis in these sponges. Once again, ALP activity was seen to be highest in the 
L. lactis-BMP-2S samples, however, the differences were not statistically significant. 
Nonetheless, the osteogenic capabilities shown in 2D and the fact that L. lactis-BMP-2S 
showed highest osteogenesis in the 3D model shows that it has some osteogenic potential 
and therefore this bacteria was chosen for in vivo tests.  
A subcutaneous model was chosen to highlight the bacteria’s capacity to direct ectopic bone 
formation in an in vivo environment, devoid of the host’s osteogenic cells. In vivo µCT at 
two and four weeks showed no bone growth in any of our samples, including the positive 
control. This is likely due to the low amount of BMP-2 used in these samples. We decided 
to use BMP-2 at 100 ng/mL in the implanted sponges, the same as in the ALP experiment 
previous and in the in vitro models. However, it is reported that BMP-2 in collagen sponges 
is often up at the µg range, and is therefore at least a tenfold higher concentration than in our 
samples. However, the bacteria did not induce bone formation either and from the 
characterisation experiments, we expect 485 ng/mL of BMP-2 (Figure 4.3). This is clearly 
not the case in the 2D experiments as the bacteria samples are not fully saturated in the 
culture. For the 3D collagen sponge experiments, the bacteria are present in the sponge and 
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it is difficult to ascertain the number of bacteria present. In order to reach the µg range of 
secretion from our bacteria, we would need approximately 2 mL of saturated culture and 
would need a distinctly larger collagen sponge, however, it is difficult to directly assess the 
exact size of collagen sponge needed as it is impossible to measure the number of bacteria 
present in the sponge. The collagen sponges that were implanted were submersed in 1 mL 
of bacterial culture, however, it was apparent that there were considerable amounts of 
bacteria outside the sponge and therefore, there would not be 485 ng/mL BMP-2 present.  
In addition to the µCT, a H&E stain was used to determine the presence of cellular 
differences between the functionalised sponges, however, no differences could be seen. We 
were looking for signs of osteoblasts and osteoclasts, as well as host immune cells to see if 
the bacteria were destroyed. After four weeks, no osteogenic cells, or host immune cells 
could be seen. However, it was apparent from the backs of the mice that sponges implanted 
with bacteria led to increased swelling of the area, when compared with the mice with 
sponges without bacteria. This was seen for the first week of the experiment, and soon 
dissipated. If repeated, blood tests would be taken from the mice within the first week to 
check for increased signs of infection. This could mean that the bacteria were engulfed and 
destroyed by the host’s immune system within the first week of the trial, thus losing the 
source of the BMP-2, explaining the lack of differentiation. Although the 2D OCN and von 
Kossa inducible results (Figures 6.5, 6.7 and 6.8) detail the requirement for high BMP-2 
concentrations needed at the beginning of the culture only, the lower amount of BMP-2 (< 
1 µg) may result in decreased differentiation in a non-osseous site. The high amount of BMP-
2 needed, coupled with the likeliness of L. lactis death; could lead to the lack of bone growth 
in vivo. 
Although the in vivo experiment did not proceed as planned, it is apparent that genetically 
engineered L. lactis secreting BMP-2 can indeed induce the osteogenic differentiation of 
MSCs, to a similar level to that of a FN coated coverslip with BMP-2 added to the media at 
100 ng/mL in vitro. This result demonstrates that L. lactis can not only direct the attachment 
of MSCs through cell wall bound FNIII7-10, they also have the ability to change the 
phenotypical state of the cells seeded above through the osteogenic growth factor, BMP-2.  
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6.5 Conclusion 
 
This chapter shows that L. lactis-BMP-2S can be used as a successful interface between a 
synthetic surface and MSCs to control their differentiation towards an osteoblastic fate to a 
similar extent as an FN coated substrate with 100 ng/mL BMP-2 added to the media. L. lactis 
can be modified to produce BMP-2 in a constitutive and inducible fashion, and that the BMP-
2 is biologically active. Furthermore, differences in nisin addition emphasised the need for 
higher concentrations of BMP-2 towards the start of the experiment to allow for terminal 
differentiation of MSCs by 28 days. This result also demonstrates the power of our inducible 
system, in that we can allow cell growth to continue and upon user defined time points and 
concentrations, BMP-2 can be added to the system to induce the differentiation of the 
mammalian cells.  
In addition, L. lactis-BMP-2S was used in an in vivo mouse model to explore subcutaneous 
ectopic bone formation. However, no bone growth was seen over four weeks. This is likely 
due to the fact that the bacteria were removed by the host’s immune system and the low level 
of BMP-2 used.  
This chapter has shown that genetically engineered L. lactis can be used to colonise a surface 
and that the differentiation cues supplied by growth factors can influence phenotypical 
decisions of stem cells. 
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7. Discussion and conclusion 
 
7.1 Summary 
 
The main findings from this work show that in vitro, genetically engineered L. lactis can 
direct the attachment and differentiation of MSCs. A schematic representation of the system 
can be seen in Figure 7.1. Both short and long term experimentation highlight that L. lactis 
secreted BMP-2 is biologically active and can induce the differentiation of MSCs to a similar 
level as achieved when exogenous BMP-2 is added to the culture. In addition, the system 
has also been made inducible, whereby the user can define the time and amount of protein 
to be expressed. The well characterised nisin controlled gene expression system (NICE) 
(Mierau and Kleerebezem 2005) was used with differing levels of inducer; protein 
expression and the level of MSC differentiation was seen to directly correlate with amount 
of inducer added.  
However, findings from the in vivo model suggested that the system needs more 
development in order to transition to animal trials. A more robust positive control will need 
to be developed to allow for more accurate conclusions. A collagen sponge was implanted 
subcutaneously in the backs of mice, and ectopic bone formation was measured with micro-
CT. No bone growth was seen over four weeks as we believe the bacteria were destroyed by 
the host’s immune system. Moreover, this was only a pilot study and would needed to be 
tested more vigorously in the future.  
In summary, this thesis highlights the potential for non-pathogenic bacteria to be used as a 
substrate in the creation of dynamic surfaces for their use in regenerative medicine. 
Additionally, this system can be further modified, either in the production of other proteins 
or by the creation of other plasmids for controlled release in response to other inducers.  
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Figure 7.1. 3D schematic representation of the interaction between L. lactis and MSCs. (A) shows 
MSCs seeded on top of a monolayer of bacteria. (B) Shows a zoomed in representation of the area of 
interaction. (C) Shows from left to right, BMP receptors I and II, integrin subunits, FNIII7-10 and BMP-2. 
A 
B 
C 
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7.2 General discussion 
 
Bacteria based therapeutics is a rapidly growing field, with non-pathogenic strains being 
used to fight an array of biomedical problems. Bacteria are already being used to fight cancer 
(Wang, Vuletic et al. 2017, Zheng, Nguyen et al. 2017), obesity (Chen, Guo et al. 2014) and 
various gastrointestinal diseases (Steidler, Wells et al. 1995, Schotte, Steidler et al. 2000). 
This thesis paves the way for advanced biofilm based therapeutics, as L. lactis secreting 
BMP-2 was found to be biologically active and can control the differentiation of MSCs. L. 
lactis has been modified to present and express FNIII7-10 in a cell wall bound form and BMP-
2 in a cell wall bound and secreted form. It was found that the cell wall bound FNIII7-10 
fragment could prompt cell adhesion in a variety of cell types including MSCs and C2C12s. 
The osteogenic growth factor BMP-2 was expressed in a cell wall bound and secreted form. 
The cell wall bound BMP-2 monomer did not show any biological activity. This is likely 
due to BMP-2 dimerisation being essential to bind to the BMP-2 receptor, in addition, it has 
been proven that modifying the C-terminal of BMP-2 (with SpaX in this work) renders the 
molecule inactive (Kashiwagi, Tsuji et al. 2009). In contrast, secreted BMP-2 showed good 
levels of biological activity with comparable levels of late term osteogenic markers to the 
positive control (FN coat with 100 ng/mL BMP-2 added to the medium).  
This new work paves the way for advanced biofilm-driven cell therapies. Current stem cell 
culture systems fall far short of desired outcomes of enhanced growth and enhanced 
proliferation that can work in a bioreactor-like manner (Celiz, Smith et al. 2014). 
Furthermore, these culture systems are not dynamic and might be good either for growth 
(McMurray, Gadegaard et al. 2011) or for differentiation (McBeath, Pirone et al. 2004, 
Engler, Sen et al. 2006, Dalby, Gadegaard et al. 2007), but not for both. Dynamic culture 
systems have been developed but are limited typically to simple on/off states (Ebara, Yamato 
et al. 2004, Todd, Scurr et al. 2009, Wirkner, Weis et al. 2011, Lee, Garcia et al. 2015, 
Chaudhuri, Gu et al. 2016, Das, Gocheva et al. 2016). This work shows how simple 
biological cells such as L. lactis can be engineered to allow temporal expression of cell wall 
bound or secreted biologicals that can control MSC growth (FNIII7-10) and differentiation 
(BMP-2). It is easy to see how the complexity of this system can be tuned to express other 
proteins that could e.g. drive other phenotypes. Further, it is easy to see that as the system is 
compatible with 3D materials, adherent stem cell cultures, such as MSCs, can be scaled to 
3D ‘fermentation’ type bioreactors for mass production of cells. 
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This thesis focuses on BMP-2 and osteogenic MSC differentiation as bone is the second 
most transplanted tissue after blood (Shegarfi and Reikeras 2009) and thus, there is a 
growing need for lab grown osteoblasts for cellular therapies. The ageing populations of 
many countries only exacerbates the problem as diseases such as osteoporosis are becoming 
more prevalent (Manolagas 2010). This work shows the osteogenic capabilities of 
genetically engineered bacteria in both 2D and 3D. Users can coat surfaces with or 
incorporate BMP-2 secreting L. lactis to induce highly efficient differentiation of MSCs to 
osteoblasts in vitro, with 3D systems such as hydrogels allowing bioreactor scale cell 
production. These cells can then be harvested for a variety of downstream applications, 
ranging from autologous or allogenic cell transplants or for the creation of lab grown bone 
(Burchardt 1983, Deans and Moseley 2000, Aggarwal and Pittenger 2005).  
Using these simple biological cells, the system could be improved by creating an 
environment whereby BMP-2 compounded with other growth factors would assist in the 
creation of a bacterially expressed osteogenic ‘cocktail’. Bone morphogenetic protein-7 
(BMP-7), platelet-derived growth factor (PDGF), and fibroblast growth factor (FGF-2) are 
all known osteogenic factors that in addition to BMP-2 could be engineered into the system 
to provide temporal controlled release and hence more efficient differentiation of MSCs 
(Mohan and Baylink 1991) in a manner that would be extremely different to using 
biomaterials approaches. It is exactly this flexibility that is the real benefit of this concept. 
There are already a wide variety of constitutive and inducible expression systems available 
for L. lactis and with these tools, one can create a plethora of on-off controlled systems to 
deliver the protein of interest at a desired time point and dose (Sanders, Venema et al. 1997, 
Siren, Salonen et al. 2009, Douillard, O'Connell-Motherway et al. 2011, Benbouziane, 
Ribelles et al. 2013, Mu, Montalban-Lopez et al. 2013). This would allow the creation of a 
highly dynamic interface with a wide range of temporal information delivered to stem cells. 
 
7.3 Cell adhesion and proof of concept 
 
L. lactis MG1363 (it was later found that NZ9000 harbours roughly the equivalent amount 
of FNIII7-10) functionalised with the FN fragment FNIII7-10 showed high viability counts at 
four weeks with different antibiotics and that bacteria displaying this FNIII7-10 fragment can 
induce cell adhesion of a variety of cell types including MSCs. SEM, vinculin and integrin 
staining confirmed cell adhesion to L. lactis-FN. Most importantly, it was found that this 
interface of L. lactis-FN was able to sustain MSC differentiation for up to four weeks with 
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the addition of BMP-2 at 100 ng/mL to the samples. Bacteria were seen to be present in the 
mammalian-bacterial co-cultures at three weeks and are therefore still able to direct cell 
behaviour through the FNIII7-10 fragment. OCN, OPN and von Kossa signalling was 
increased in the BMP-2 positive samples.  
7.4 L. lactis characterisation 
 
The strain of L. lactis used was changed as MG1363 does not harbour the necessary genes 
(NisK and NisR) for inducible expression. The well characterised NZ9000 and its derivatives 
were used for the remainder of the work conducted in this thesis. L. lactis was modified to 
express cell wall bound and secreted forms of the osteogenic factor BMP-2. It was found 
that there are no commercial kits available for the detection of bacterially expressed BMP-2 
(no glycosylation) and therefore the marker protein GFP was used as a reporter. Sequencing, 
western blot and fluorescence assays demonstrated the presence of BMP-2-GFP in the 
constitutive clones. For the inducible clones, a 6xHisTag was used and the cloning and 
presence of protein was confirmed by sequencing and western blots and ELISAs. Upon 
completion of the constitutive cloning, it was found that NZ9000 was detrimental to MSC 
viability after two weeks as the acidic conditions through lactic acid production began to kill 
the mammalian cells. Therefore, the lactate dehydrogenase knockout NZ9020 was used to 
complete long term mammalian cell culture. Plasmids harbouring BMP-2 and FNIII7-10 were 
transferred to NZ9020 and mammalian cell viability was seen to be good at four weeks.  
 
7.5 Initial mammalian cell studies 
 
MSC behaviour on the constitutive and inducible L. lactis clones was tested. It was found 
that the FNIII7-10 fragment in both its constitutive and inducible forms were able to 
encourage MSC adhesion. It was also found that upon increased concentrations of nisin, cell 
spreading was seen to increase. This directly confirms the western blot data. Cell 
proliferation was also tested to see if the BMP-2 present could control cell cycle dynamics. 
It was found that the presence of BMP-2 slowed cell proliferation rates in both the positive 
control and in L. lactis-BMP-2S. This was the first sign that BMP-2 from L. lactis-BMP-2S 
was biologically active. Lastly, direct mammalian-bacterial cell dynamics were investigated. 
C2C12 murine myoblasts readily uptake all forms of L. lactis, albeit with different uptake 
rates. The presence of either protein, FNIII7-10 or BMP-2W was shown to increase bacterial 
cell uptake.   
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7.6 L. lactis derived osteogenesis 
 
The osteogenic potential of the L. lactis clones was first tested by their ability to induce ALP 
activity in MSCs. It was found that L. lactis-BMP-2S stimulated similar ALP levels to that 
found in the positive control. Moreover, ALP activity in L. lactis-FN and L. lactis-BMP-2W 
showed negligible ALP activity. This result, compounded by the low proliferation results 
highlighted L. lactis-BMP-2S as the best candidate for long term osteogenic differentiation. 
Next, long-term differentiation of MSCs on L. lactis-BMP-2S was tested. OCN and von 
Kossa staining showed higher osteogenic markers in the L. lactis-BMP-2S samples when 
compared with the negative controls. Additionally, the differentiation rates were seen to be 
similar to that of the positive control showing that L. lactis-BMP-2S can regulate MSC 
differentiation. In addition, the inducible results demonstrated the necessity of high nisin and 
therefore BMP-2 addition at the start of the experiment. This was concluded as 
differentiation rates as seen in the low to high nisin addition showed very little differentiation 
being similar to that of the negative control. Most interestingly, the high to low samples 
showed similar levels of differentiation as to that of constant addition. This shows that the 
behavioural cues driven by L. lactis are needed at the very beginning of the experiment and 
can begin to be decreased around day four.  
The potential for L. lactis derived osteogenic differentiation was next tested in an in vivo 
subcutaneous mouse model, whereby ectopic bone formation was studied in absorbable 
collagen sponges implanted into the backs of mice. No bone formation was seen after four 
weeks in any sample, including the positive controls. This experiment will have to be 
modified in the future in order to come to more accurate conclusions for the potential of this 
technology.  
 
7.7 Future work 
 
Many aspects of this work would be interesting to extend and could provide many more 
insights into how L. lactis could be utilised to realise its therapeutic potential.  
It would be exciting to investigate the in vivo models again as the pilot study did not achieve 
the desired results. The experiment would have to house a more adequate positive control to 
ascertain more accurate conclusions. In addition, many more variables would have to be 
tested. For example, blood tests at specified days after implantation would need to be 
156 
 
completed to determine the host’s immune response to bacteria based implantation. It would 
also be interesting to remove the implants at different time points and explore cell types 
present to see if there was an increased immune response at early time points. This would 
also aid in the data to see if the bacteria were destroyed by the immune system.  
Additionally, the use of other growth factors could assist in the creation of a bacterially 
expressed osteogenic ‘cocktail’. Bone morphogenetic protein-7 (BMP-7), platelet-derived 
growth factor (PDGF), and fibroblast growth factor (FGF-2) are all known osteogenic 
factors that in addition to BMP-2 could provide unmet, efficient osteogenic differentiation 
of MSCs. These could be controlled in an inducible fashion, to tailor the dose and time 
dependency of the growth factors to maximise osteogenic potential. There are already a wide 
variety of constitutive and inducible expression systems available for L. lactis, the acid-
inducible P170 promoter (Jorgensen, Vrang et al. 2014), a chloride inducible system 
(Sanders, Venema et al. 1997), a zinc regulated expression system (Mu, Montalban-Lopez 
et al. 2013), agmatine controlled expression (Linares, Alvarez-Sieiro et al. 2015) and 
thioredoxin gene fusion systems (Douillard, O'Connell-Motherway et al. 2011) amongst 
others. With these tools, the researcher can create a plethora of on-off controlled systems to 
deliver the protein of interest at a desired time point and dose. This would allow the creation 
of a highly dynamic interface with abounding informational cues for the cells seeded above.  
In addition to osteogenesis, many other therapeutic areas could be explored. For example, 
vascular endothelial growth factors (VEGFs) are diffusible mitogens with angiogenic 
properties. These growth factors support the development of blood vessels and wound 
healing and therefore, a bacteria expressing this growth factor would have a variety of 
properties.  
7.8 General conclusion 
 
This thesis shows the regenerative potential of genetically engineered bacteria. The non-
pathogenic bacteria, Lactococcus lactis has been modified to express a fragment of the 
mammalian cell adhesion peptide fibronectin as a cell wall bound protein. This has been 
shown to control cell adhesion. In addition, the system has been further modified to express, 
under dynamic temporal control, bone morphogenetic protein 2, a known osteoinducer to 
mesenchymal stem cells in a cell wall bound and secreted form. Whilst the cell wall bound 
BMP-2 exhibited no osteogenic effect, secreted BMP-2 showed good signs of biological 
activity, being comparable to 100 ng/mL of BMP-2. Short, mid and long-term tests all 
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showed the biological activity of secreted BMP-2, creating a new paradigm in surface 
engineering for regenerative medicine. The system can be further modified to produce a 
myriad of proteins in order to control a number of different therapeutic problems. Overall, 
this thesis has shown that genetically engineered bacteria can control the differentiation of 
mesenchymal stem cells.  
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8. Annex 
 
  
Figure 8.1. C2C12 murine myoblasts seeded over L. lactis-FN under alcian blue fixative for three hours 
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Annex Figure 8.2. µCT images of functionalised collagen sponges after 2 weeks. Live mice 
were imaged and regions containing the sponge were reconstructed in 3D. A = empty collagen 
sponges, B = sponges with 100 ng/mL BMP-2, C = sponges with L. lactis-empty and D = sponges 
with L. lactis-BMP-2S. No bone growth could be seen in any sample. 
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Annex Figure 8.3. µCT images of functionalised collagen sponges after 4 weeks. Live mice 
were imaged and regions containing the sponge were reconstructed in 3D. A = empty collagen 
sponges, B = sponges with 100 ng/mL BMP-2, C = sponges with L. lactis-empty and D = sponges 
with L. lactis-BMP-2S. No bone growth could be seen in any sample. 
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